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ABSTRACT OF THE DISSERTATION 
 
Yeast Prion Variants as Models of the Phenotypic and Pathological  
Consequences of Amyloid Polymorphism 
By 
Kevin Christopher Stein 
Doctor of Philosophy in Biology and Biomedical Sciences  
Molecular Cell Biology 
Washington University in St. Louis, 2014 
Dr. Heather True, Chairperson 
 
Protein aggregation is the hallmark of protein conformational disorders such as 
Alzheimer’s disease and prion diseases. Prions are infectious proteins that propagate a self-
templating amyloid structure, and have become a model for studying these diseases. 
Interestingly, a single protein can form a variety of distinct amyloid structures, a phenomenon 
referred to as amyloid polymorphism. In prion diseases, these different structures, called prion 
strains, dictate variation in pathology. However, the underlying basis for how structural variation 
modulates pathology remains unclear. 
Yeast prions have been a valuable model for studying protein conformational disorders. 
Prion proteins endogenous to yeast similarly misfold and form different self-propagating prion 
strains (called variants) that modulate cellular phenotypes. Additionally, in both humans and 
yeast, molecular chaperones act to process misfolded substrates. Here, I explore the interplay 
 xi 
between molecular chaperones and prion variants and reveal novel determinants for how distinct 
aggregate structures can dictate phenotype.  
Studies of the [PSI+] prion have served as the foundation for the biophysical analysis of 
prion strains for several years. I applied this knowledge to prion variants of another prion, 
[RNQ+]. I found a surprising diversity in the sequence elements that are required to maintain 
different [RNQ+] variants. Interestingly, I also found evidence to suggest that the prion 
conformation dictates the availability of interaction sites for chaperones. Moreover, different 
domains of the Hsp40 Sis1 are important for maintaining particular prion variants. In fact, Sis1 
and its human homolog have distinct prion conformer selectivity, suggesting that the selectivity 
of Hsp40s has changed throughout evolution. 
I also apply the concept of amyloid polymorphism to examine mutations in the human 
Hsp40 DNAJB6 that cause limb-girdle muscular dystrophy type 1D (LGMD1D). Using a 
chimeric protein of DNAJB6 and Sis1, I found that LGMD1D mutations impaired the 
propagation of prion conformers in a manner that depended on both the conformation and 
mutation. Additionally, while other functions of Sis1 were unaffected, over-expression of these 
mutants caused Hsp70-dependent cellular toxicity. These data show that impairing chaperone-
mediated processing of particular substrate conformers may be one mechanism involved in the 
development of chaperonopathies. 
Taken together, this dissertation highlights the complexity underlying the impact of 
amyloid polymorphism on dictating phenotypic diversity, and shows how amyloid conformation 











Chapter 1: Background and Significance 
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1.1       Protein Conformational Disorders and Amyloid Formation 
The ability of a cell to synthesize, fold, and properly maintain its proteome is crucial for 
cell viability. Impairing this essential process has devastating consequences, often leading to the 
development of diseases called protein conformational disorders. Protein misfolding and the 
formation of insoluble protein aggregates characterize these diseases. This aggregation disrupts 
cellular and tissue functions, and for many of these diseases, is ultimately fatal. 
There is a wide range of protein conformational disorders, which are generally divided 
into three broad categories [1,2]. Neurodegenerative diseases, such as Alzheimer’s disease and 
Parkinson’s disease, involve the accumulation of aggregates in the brain. Non-neuropathic or 
organ-limited diseases, such as type II diabetes, have aggregates present in one tissue other than 
the brain. Lastly, systemic disorders, like hemodialysis-related amyloidosis and AA amyloidosis, 
present with protein aggregates in multiple tissues.  
A number of these diseases are familial, arising through the inheritance of a specific 
mutation [2]. Oftentimes, this mutation is present in the protein that forms the primary 
constituent of the aggregate deposits, thereby giving strong evidence that protein misfolding and 
aggregation is the major contributor to disease pathogenesis [3]. Some protein conformational 
disorders only occur as familial cases, such as Huntington’s disease that is caused by a 
polyglutamine expansion [4]. However, several disorders predominantly arise sporadically, with 
a small percentage of familial cases. The same protein will aggregate in both sporadic and 
familial cases of the same disease, and these cases are symptomatically similar, suggesting that 
similar pathological mechanisms are involved. In addition to sporadic and familial cases, a 
subset of neurodegenerative diseases called prion diseases, or transmissible spongiform 
encephalopathies, can arise through infection [5]. In fact, under experimental conditions, some 
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evidence suggests that other protein conformational disorders might also be transmissible [4,6]. 
However, under natural conditions, it remains unclear to what degree other protein 
conformational disorders are infectious. 
There are a wide variety of unrelated proteins that aggregate in protein conformational 
disorders, from proteins with no defined function (e.g. PrP in prion diseases) to a number of 
RNA-binding proteins (e.g. TDP-43 and FUS in amyotrophic lateral sclerosis (ALS)) [7,8]. 
Nevertheless, the deposits are often described as forming a common structure called amyloid that 
is characterized by a fibrillar morphology comprised of cross-! sheets [9]. This suggests that 
there might be shared pathogenic mechanisms for protein conformational disorders. 
Interestingly, while the formation of amyloid is often studied in the context of protein 
conformational disorders, this structure transcends its association with disease. An increasing 
number of proteins from Escherichia coli to humans have been identified in which amyloid 
formation is proposed to be part of the protein’s physiological function [10,11]. Some of the 
best-described examples of this phenomenon are the existence of prion proteins in the budding 
yeast Saccharomyces cerevisiae [12,13]. These proteins, many of which are involved in 
transcriptional regulation, can confer beneficial phenotypes, in certain conditions, when present 
in their prion state [14,15]. Moreover, it has been suggested that any polypeptide, independent of 
sequence, can form amyloid given the right conditions [16]. Hence, amyloid formation is a 
generic phenomenon, the study of which can have implications on several biological processes. 
 
1.2  The Influence of Prion Strains and Amyloid Polymorphism on Pathological and 
Phenotypic Variation 
Stein KC and True HL. Under review in the journal 
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PLOS Pathogens, Pearls Collection. 
1.2.1 Introduction 
 The deposition of protein aggregates is a unifying feature of a large class of diseases 
known as protein conformational disorders, which includes Alzheimer’s disease and prion 
diseases. One of the most fascinating and puzzling aspects of such diseases is the phenomenon of 
amyloid polymorphism, whereby a single disease-associated protein forms different types of 
aggregate structures. This is best exemplified in prion diseases, where these different structures, 
called prion strains, are responsible for much of the variation in pathology and disease 
transmission. Here, we review the current knowledge of prion strains and amyloid 
polymorphism, highlighting how diversity in amyloid structure relates to phenotypic differences.  
 
1.2.2 Mammalian Prion Strains Dictate Differential Pathological Consequences 
Like other fatal human neurodegenerative diseases, transmissible spongiform 
encephalopathies (TSEs), or prion diseases, have cases that arise sporadically (Creutzfeldt-Jakob 
disease (CJD)) or are inherited (fatal familial insomnia, Gerstmann-Sträussler-Scheinker 
syndrome) [5]. Remarkably, prion diseases can also be acquired by infection (e.g. kuru in 
humans). TSEs afflict a wide variety of mammalian species (e.g. scrapie in sheep, chronic 
wasting disease in cervids, and bovine spongiform encephalopathy (BSE) in cattle). These 
disorders are caused by conversion of the protein PrPC to an abnormal infectious conformation 
called PrPSc that generally adopts an amyloid structure. The widely accepted prion hypothesis 
suggests that PrPSc is the sole transmissible agent of prion diseases, thus making it distinct from 
conventional pathogens having a nucleic acid component. However, it was long unclear how a 
protein-based infectious agent could explain the existence of prion strains. 
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Even early observations of prion diseases describe considerable diversity in disease 
symptoms with different PrPSc isolates [17]. This typically presents as variation in incubation 
period (the time from infection to the onset of symptoms), or the distribution patterns of PrPSc or 
spongiform pathology in the brain. In addition, certain prion isolates show different degrees of 
transmissibility between species, a phenomenon called the “species barrier”, whereby 
transmission between different species is generally less efficient than transmission within the 
same species. This was brought to the public’s attention in the mid-1990s with the outbreak of 
BSE (“mad cow disease”) and subsequent cross-species transmission to humans, causing a novel 
phenotype called variant CJD [17]. Some argued that this variation in pathology and 
transmissibility indicated that the infectious agent of prion strains must have a nucleic acid 
component, or be encoded by changes in the PrP sequence, in an analogous fashion as genetic 
polymorphisms that distinguish different strains of viral or bacterial infections. However, distinct 
prion strains were isolated having an identical primary structure, suggesting that the physical 
basis of prion strains was not simply determined by sequence variation. Indeed, these early 
studies demonstrated that two different strains of transmissible mink encephalopathy showed 
different resistance to proteases, suggesting that prion strains represent distinct conformations of 
the same protein [18].  
 
1.2.3 PrPSc Strains Encode Variation in Structural Properties of Amyloid 
In order to form distinct strains of PrPSc, PrPC undergoes a dramatic conformational 
change. PrPC consists of an unstructured N-terminal domain and a C-terminal domain comprised 
of three " helices and two short ! strands, making this structure ~40% " helix and ~5% ! sheet 
[19]. However, formation of PrPSc involves the conversion of the C-terminal domain into a ! 
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sheet-rich amyloid structure (~20% " helix, ~43% ! sheet), without any of the native " helices 
remaining [19].  
While PrPSc strains exhibit amyloid polymorphism, and many other disease-related 
proteins also form amyloid structures, there are a number of properties that are common to 
amyloid. Amyloid fibrils are generally unbranched structures that are 5-15nm in diameter and 
often comprised of multiple entwined protofilaments [20]. There are two generic amyloid folds. 
The most common is a cross-! sheet structure with ! sheets that run parallel to the fibril axis, and 
individual ! strands that form the ! sheets are oriented perpendicular to the fibril axis [9]. The ! 
strands can run in the same (parallel) or opposite (anti-parallel) direction, and are generally in-
register, whereby each strand aligns with the identical residue in the neighboring monomer of the 
! sheet [9]. The common motif formed by the ! sheets is called a steric zipper, in which the side 
chains of opposing ! sheets interdigitate using hydrogen bonds or van der Waals interactions to 
form a complementary interface that is free from exposure to solvent [21]. Such a strong 
underlying hydrophobic effect helps make amyloid a very stable structure [9]. 
By contrast, PrPSc is proposed to form the second generic amyloid fold called a ! 
solenoid [19]. Here, a single monomer will form three ! strands that loop around each other in a 
helix-like structure [20]. While it remains technically challenging to decipher many additional 
details about the structure of PrPSc, a number of observations indicate certain variables that can 
contribute to the structural differences of prion strains: 1) the length of the region protected in ! 
sheets, as well as what sequence is protected [22]; 2) whether the protein is truncated, as the C-
terminally truncated Y145Stop construct of human PrP has a very different region of the primary 
structure that forms the amyloid core as compared to longer versions of the protein [21] (and 
different truncated versions of PrPSc have been isolated from brains [5]); and 3) sensitivity to 
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protease digestion, with both protease-resistant and sensitive forms of PrPSc existing [23]. 
However, while these factors reveal the presence of amyloid polymorphism, their connection to 
pathological variation remains elusive. 
 
1.2.4 Biophysical Parameters Define Strains of the Yeast Prion [PSI+] 
 Significant insight into how prion strains can mediate phenotypic differences has come 
from studying the endogenous prion proteins that exist in the budding yeast, Saccharomyces 
cerevisiae [14]. The [PSI+] prion is formed from the translation termination factor Sup35, which 
can form self-propagating aggregates. Sequestration of Sup35 into the prion state impairs 
translation termination, causing ribosomes to read through stop codons (nonsense suppression). 
Strains of [PSI+] (called variants in yeast, but for simplicity, we will use the term strains) are 
characterized by the degree of nonsense suppression: cells propagating a strong [PSI+] strain 
exhibit greater nonsense suppression as compared to weak [PSI+] cells [24].  
A model describing the structural basis of these strain-dependent phenotypes has served 
as the foundation for understanding prion strains [25]. This model suggests that a set of 
biophysical parameters defines the nature of the prion strain that propagates. Structurally, these 
parameters are dictated by the length of the amyloid core, that is, the number of amino acid 
residues that are protected in ! sheets [26]. An expansion of the core, by incorporating more 
residues into hydrogen-bonded ! sheets, as in the case of weak [PSI+], correlated with an 
increase in aggregate stability [25,26]. It was reasoned that higher stability decreased how 
readily the amyloid could be fragmented, thus resulting in seeds that were fewer in number and 
had a larger average size. Consequently, fewer surfaces are available to recruit monomeric 
Sup35 in cells harboring weak [PSI+]. This leads to a larger pool of soluble Sup35 to function in 
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translation termination (i.e. less nonsense suppression) as compared to strong [PSI+] cells that 
have aggregates that sequester more Sup35 monomer. Hence, aggregate stability and amyloid 
core length were suggested to be the major determinants of strain-dependent phenotypes [25,26]. 
This same correlation was found to fit with synthetic prion strains of PrPSc: decreased 
aggregate stability correlated with a shorter incubation period of disease [27]. However, several 
recent examples of other PrPSc strains cannot be explained by the biophysical parameters 
established by the model of [PSI+] strains: 1) strains with different stability had a similar core 
length [28]; 2) decreased stability of other PrPSc strains correlated with a longer disease 
incubation time [29]; and 3) strains that are biochemically indistinguishable can confer distinct 
pathological consequences [30]. This exemplifies the wide variety of different aggregate 
structures that a single polypeptide can form, leaving it unclear how other factors might 
influence strain-mediated phenotypic variation. 
 
1.2.5 Differential Chaperone Interactions and Amyloidogenic Regions Influence the Complex 
Nature of [RNQ+] Strains  
 Another yeast prion called [RNQ+], which is formed from the Rnq1 protein, manifests 
phenotypically by promoting the formation of [PSI+] [31]. Different prion strains of [RNQ+] are 
characterized by how readily [PSI+] forms. The Rnq1 protein was found to form a remarkable 
variety of structural variants that exhibit tremendous variation in the ability to promote [PSI+] 
induction [31,32]. As with Sup35 in [PSI+] cells, aggregate stability was shown to be a defining 
factor in the propagation of particular [RNQ+] strains [33]. However, it was recently found that 
aggregate stability, along with several other biophysical properties that distinguish strains of 
[PSI+], were unable to distinguish other [RNQ+] strains [34,35].  
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Mutation analysis of the Rnq1 protein with five different [RNQ+] strains revealed 
additional factors that can contribute to amyloid polymorphism and phenotypic differences. 
Multiple regions predicted to be amyloidogenic were identified throughout the Rnq1 protein 
[34]. These regions are postulated to influence the formation of amyloid [36]. It was found that 
the propagation and phenotypic variation (i.e. [PSI+] induction) of each [RNQ+] strain relied on 
a distinct set of non-adjacent amyloidogenic regions (Figure 1A,B) [34], in stark contrast to 
[PSI+] strains that have a contiguous region of Sup35 protected in the amyloid core [26]. 
Moreover, both Sup35 and Rnq1 have prion-forming domains (PFD) that are rich in glutamine 
and asparagine (Q/N) residues and are necessary for prion propagation [11]. However, it was 
shown that the region outside of the Rnq1-PFD played a major, but strain-dependent, role in 
prion propagation by facilitating sequestration of monomer into aggregates, thereby highlighting 
the influence of non-canonical regions on prion strains. 
 In addition to the differential influence of primary structure, it was found that [RNQ+] 
strains likely have diverse interactions with molecular chaperones [34]. From yeast to humans, 
molecular chaperones are involved in processing misfolded and aggregated proteins. Such 
processing, in the case of yeast prions, is required for the continued maintenance of the prion 
state [14]. A peptide-binding array identified one of the Rnq1 amyloidogenic regions as 
important for Sis1 binding, which is a required component of prion propagation [37]. However, 
in another study, it was shown that Sis1 could bind other regions of Rnq1 [34]. Indeed, a distinct 
amyloidogenic region was particularly important for the propagation of one [RNQ+] strain and 
might serve as a second Sis1 binding site. This suggests that conformation could dictate the 
exposure of different binding sites and/or the affinity of chaperones for the same site (Figure 
1C). Moreover, chaperone binding to a specific site at an early stage of folding may influence the  
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Figure 1. Model showing how distinct amyloidogenic regions could influence amyloid 
polymorphism and associated phenotypic variation. (A) A single protein can have multiple 
amyloidogenic regions (colored as blue, orange, green, and red) that are not adjacent in the 
primary structure. (B) These regions can influence amyloid packing in a variety of ways, with 
non-adjacent regions possibly forming the amyloid core. (C) If a particular amyloidogenic region 
represents a chaperone-binding site (e.g. the Hsp40 Sis1 has affinity for the orange region), this 
region is exposed and available for binding in certain structures (top and bottom), but not others 
(middle). In addition, chaperone or cofactor binding prior to amyloid folding may influence the 
range of amyloid structures that can form or propagate, thereby providing a mechanism by which 
genetic and environmental modifiers may alter amyloid structure. 
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amyloid structure that forms. These differences are also likely to be true for [PSI+] strains [38], 
and agree with the hypothesis that PrPSc strains have different interactions with cofactors [39]. 
Additionally, this provides insight into how changes in extracellular environment may mediate 
prion strain generation and propagation [40,41]. Hence, variation in amyloid-chaperone sites of 
interaction is likely a major determinant of the phenotypic differences caused by prion strains. 
 
1.2.6 Amyloid Polymorphism is a Ubiquitous Feature of Disease-Associated Proteins 
In recent years, the prevalence of amyloid polymorphism has been extended to many 
different proteins associated with protein conformational disorders. For instance, based on 
histopathology and biochemical properties, A! forms heterogeneous deposits in the brains of 
patients with Alzheimer’s disease [9]. Heterogeneity was also observed in vivo for other proteins, 
including tau, "-synuclein, and transthyretin, suggesting that the phenomenon of amyloid 
polymorphism is widespread and not limited to prion proteins [9].  
Amyloid polymorphism has also been extensively studied using synthetic polypeptides 
[42-44]. It was demonstrated that the same sequence could form multiple different steric zipper 
structures, which were proposed to fall into eight different classes [43]. Furthermore, three 
different models of polymorphism were postulated to explain the diversity of structures that were 
observed: packing (different ! sheet arrangements of the same sequence), segmental (different 
sequences form similar ! sheet conformation), and heterozipper (different regions that are cross-
complementary form the ! sheet, either two regions in the same monomer, or between two 
monomers) [44]. When considering these data in the context of a full-length protein, which can 
have several amyloidogenic regions, combined with different cofactor requirements [39], it then 
becomes easier to envision a considerable number of stable amyloid structures that are 
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theoretically possible. Indeed, one conformation being uniquely thermodynamically stable above 
all other combinations seems unrealistic simply in terms of probability. Therefore, elucidating 
the complex interplay of variables that affect the formation and maintenance of polymorphic 
structures remains a nontrivial, but crucial, task to gain a full understanding of pathological 
variability and the etiology of protein conformational disorders. 
 
1.3  The [RNQ+] Prion: A Model of Both Functional and Pathological Amyloid 
Stein KC and True HL (2011) Prion 5, 291-8. 
1.3.1  Abstract 
The formation of fibrillar amyloid is most often associated with protein conformational 
disorders such as prion diseases, Alzheimer’s disease, and Huntington’s disease. Interestingly, 
however, an increasing number of studies suggest that amyloid structures can sometimes play a 
functional role in normal biology. Several proteins form self-propagating amyloids called prions 
in the budding yeast Saccharomyces cerevisiae. These unique elements operate by creating a 
reversible, epigenetic change in phenotype. While the function of the non-prion conformation of 
the Rnq1 protein is unclear, the prion form, [RNQ+], acts to facilitate the de novo formation of 
other prions to influence cellular phenotypes. The [RNQ+] prion itself does not adversely affect 
the growth of yeast, but the overexpression of Rnq1p can form toxic aggregated structures that 
are not necessarily prions. The [RNQ+] prion is also involved in dictating the aggregation and 
toxicity of polyglutamine proteins ectopically expressed in yeast. Thus, the [RNQ+] prion 
provides a tractable model that has the potential to reveal significant insight into the factors that 
dictate how amyloid structures are initiated and propagated in both physiological and 
pathological contexts.  
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1.3.2  Introduction 
Protein conformational disorders are associated with the misfolding and aggregation of 
proteins into cross-!-sheet structures called amyloid [2]. Interestingly, these disorders may result 
from a common underlying mechanism that has been described as prion-like [45]. Prions are 
proteins that form a self-propagating, amyloid-like structure that converts protein from its native 
state into the prion conformation [5]. When the mammalian protein PrP misfolds to its prion 
conformation, it is infectious. This infectious prion protein is the causative agent of one class of 
mammalian protein conformational disorders called transmissible spongiform encephalopathies. 
While the term amyloid is traditionally used in the context of cellular dysfunction and disease, 
many examples of amyloid structures with normal cellular functions are emerging (reviewed in 
[10,46,47]). Hence, elucidating how amyloid structures form and propagate is critical to 
understanding disease pathogenesis and determining how this type of folded structure can have a 
physiological function.   
Much information regarding amyloid formation has been gleaned from the yeast model 
system and the range of tools it provides. Several unrelated proteins have been demonstrated to 
form prions in yeast. Yeast prions are associated with changes in phenotype that are inherited 
epigenetically, thereby showing how amyloid structures can provide a means of regulating 
cellular functions and phenotypes. Three well-studied yeast prions are [PSI+], [URE3], and 
[RNQ+], formed by the proteins Sup35, Ure2, and Rnq1, respectively. When the essential 
translation termination factor Sup35p is sequestered into aggregates in [PSI+] cells, it alters 
translation termination and acts as an omnipotent nonsense suppressor [48,49]. [PSI+] provides 
growth advantages under certain conditions and as such, it is interesting to consider how this 
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type of element could impact the ability of yeast to adapt to changing environments and 
ultimately govern the evolution of new traits [15,50-56]. When the transcriptional regulator 
Ure2p forms the [URE3] prion, the transcription of genes involved in nitrogen catabolism is 
derepressed [57]. This allows the cell to utilize poor nitrogen sources in the presence of good 
nitrogen sources. 
In contrast to Sup35p and Ure2p, the physiological function of the Rnq1 protein has yet 
to be determined. The [RNQ+] prion, however, is required for the de novo formation of both 
[PSI+] and [URE3], and was originally classified as the [PIN+] element, for [PSI+] inducible 
[31,58-61]. The [RNQ+] prion has been found in wild yeast isolates [62,63], suggesting that it 
might not be detrimental in many genetic backgrounds and growth conditions and instead may 
play some functional role. While [PSI+] and [URE3] were discovered by phenotype, Rnq1p was 
identified as a putative prion protein by analyzing the yeast proteome for sequences similar to the 
glutamine and asparagine (Q/N)-rich prion-forming domains (PFDs) of Sup35p and Ure2p [64]. 
These domains are defined as the regions that are both necessary and sufficient for prion 
formation [65]. Definitive confirmation of the prion properties of Rnq1p was shown by 
transforming in vitro generated Rnq1p-PFD fibers (purified, recombinant Rnq1p-(132-405)) into 
[rnq-] yeast to convert cells to [RNQ+] [33,66]. Like other yeast prion proteins, as well as those 
associated with protein conformational disorders, Rnq1p has the propensity to form amyloid in 
vitro with parallel in-register cross-!-sheets [67]. Strikingly, prion proteins can form several 
unique prion variants (or strains) that have slight differences in their !-sheet structure that 
constitute distinct amyloid conformations [68,69]. Such different structures are presumably the 
underlying cause of the diverse phenotypic variation seen in both yeast and in prion diseases 
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[17,24,31,70]. In the case of Rnq1p, several different [RNQ+] variants have been described, and 
these correspond to different levels to which they facilitate the formation of [PSI+] [31].     
In this review, we summarize the properties and protein interactions of the [RNQ+] prion 
and highlight its similarities and differences to other yeast prions. This discussion provides a 
framework to study how [RNQ+] may represent another example of a functional amyloid. In 
addition, we describe how [RNQ+] can be used to model pathological amyloid, thereby showing 
how the same protein may form both toxic and non-toxic aggregates. 
 
1.3.3 The PFD of Rnq1p is complex and may not be confined to the Q/N-rich region 
The N-domain of Rnq1p may be involved in [RNQ+] maintenance 
While most polypeptides may be able to form amyloid structures given the right 
conditions, there are a number of intrinsic factors that determine whether a protein will aggregate 
under physiological conditions in vivo [71]. A high degree of hydrophobicity, minimal net 
charge, and an intrinsically disordered region often contribute to the propensity of many 
amyloidogenic proteins, such as PrP and the Alzheimer’s disease protein A!, to form !-sheets 
and aggregate [2]. In contrast, polyglutamine (polyQ) proteins are characterized by having a 
long, highly polar stretch of glutamine residues [72]. The PFDs of many yeast prion proteins are 
similarly polar as they are enriched in glutamines and asparagines [65]. Thus, our understanding 
of how amino acid composition influences aggregation and amyloid formation is incomplete.  
The PFD of Rnq1p was initially defined as the C-terminal Q/N-rich region (aa153-405) 
by sequence analysis using the PFDs of Sup35p and Ure2p, and this was later verified 
experimentally [64]. The N-terminal domain (aa1-152) of Rnq1p, on the other hand, has no 
known function. To better understand the regions of Rnq1p that are important for [RNQ+] 
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propagation, the effect of a series of RNQ1 truncations on [RNQ+] propagation was tested [73]. 
With the exception of one construct (aa172-405) that transmitted [RNQ+] more efficiently than 
the entire PFD (aa133-405 in this case), the efficiency of propagation decreased with decreasing 
fragment lengths. This result provided the first indication that, in addition to the PFD, the N-
domain may be involved in maintenance of the [RNQ+] prion. 
Other studies have also revealed a potential role for the N-domain in the propagation of 
[RNQ+]. An interaction between Rnq1p and the Hsp40 Sis1p is required for [RNQ+] propagation 
[74]. Mutation of one residue in Rnq1p in the putative Sis1p binding site (L94A) disrupts this 
interaction and eliminates the [RNQ+] prion [37,75]. This suggests that the N-terminus of Rnq1p 
facilitates the interaction with Sis1p to maintain [RNQ+]. Additionally, rnq1 alleles having 
missense mutations in the N-terminus of Rnq1p destabilize [RNQ+] propagation [76,77], further 
supporting the notion that this domain is involved in [RNQ+] propagation. Interestingly, 
however, these rnq1 mutants do not disrupt the interaction with Sis1p [76], suggesting that the 
N-terminal region may contribute functions beyond interaction with Sis1p. Finally, in a screen 
aimed to identify residues in the Rnq1p-PFD important for [RNQ+] propagation, none of the 
PFD mutants impaired [RNQ+] when tested in the context of full-length Rnq1p [78], and only 
one mutation in the PFD that affects [RNQ+] propagation has since been found [76]. 
Collectively, these data yield conflicting results as to whether the N-terminus of Rnq1p acts as a 
positive or negative regulator in the maintenance of the [RNQ+] prion. Elucidating the role of the 
N-domain will provide insight into how other intragenic or non-PFD regions may be involved in 
the formation and propagation of amyloid structures in a pathological or physiological setting.  
 
The Rnq1p-PFD is comprised of multiple recognition elements that act cooperatively 
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 In addition to regions outside of the Rnq1p-PFD being involved in [RNQ+] propagation, 
it seems clear that the Rnq1p-PFD is more complex than the PFDs of Sup35p or Ure2p. The 
Sup35p-PFD, for example, is much smaller (aa1-123) with two defined regions important for 
[PSI+] propagation: a short Q/N-rich tract (aa5-27) and a region of clearly defined oligopeptide 
repeats (aa41-95) [24,79]. These regions can be functionally separated into sequences important 
for prion formation and sequences important for prion propagation [80]. Likewise, the 
oligopeptide repeats in the mammalian prion protein, PrP, are involved in dictating prion 
infectivity [81-83]. In contrast, Ure2p does not have any oligopeptide repeats and the Rnq1p-
PFD has loosely defined oligopeptide repeats among four largely separated Q/N-rich regions 
[65]. Hence, the regions that influence the propagation and heritability of Rnq1p aggregates 
remain poorly defined. None of the four QN-rich regions of the Rnq1p PFD is sufficient to 
maintain [RNQ+] [84]. The presence of either QN2 (aa218-263) or QN4 (aa337-405) is required, 
but the presence of QN1 (aa185-198) or QN3 (aa279-319) strongly enhances propagation [84]. 
Thus, the Rnq1p-PFD has multiple sequence determinants that cooperate to propagate [RNQ+], 
thereby creating a complex, composite PFD with ill-defined roles for each of these sequence 
elements. Defining these roles will help us understand how the primary sequence of a protein is 
involved in dictating amyloid formation. 
 
1.3.4 [RNQ+] propagation depends on interactions with chaperones 
Differential roles of chaperones on prion propagation 
A conserved network of molecular chaperones helps proteins adopt and maintain their 
proper fold, thereby combating the misfolding and aggregation of proteins that can cause disease 
[85]. Chaperones also play a major role in the propagation of all yeast prions [86-88]. Proteins in 
 18 
the Hsp40 and Hsp70 families deliver aggregated substrates to the disaggregase Hsp104p for 
resolubilization [89,90]. This process serves to fragment prion aggregates into seeds that can be 
efficiently transmitted from mother to daughter cells during mitosis [91-93]. Both Hsp104p and 
the essential Hsp40 Sis1p are required for the propagation of [PSI+], [URE3], and [RNQ+] 
[64,74,94-96]. Several lines of evidence, however, suggest that these chaperones may be 
differentially involved in propagating these prions. [PSI+], [URE3], and [RNQ+] show distinct 
sensitivities to both expression levels and mutation of Sis1p and Hsp104p [75,95,97,98]. The 
overexpression of Hsp104p eliminates [PSI+], but does not affect propagation of [RNQ+] or 
[URE3] [49,74,94,96]. In contrast, [RNQ+] and [URE3] are more sensitive to Sis1p levels than 
[PSI+]. Sis1p overexpression does not affect [RNQ+] propagation [74], but when Sis1p is 
downregulated, both [RNQ+] and [URE3] are lost within 20 generations as compared to >60 
generations that it takes to lose [PSI+] [95,99]. When Hsp104p is inhibited by guanidine 
hydrochloride, though, the rate of loss is similar for all three prions and is comparable to the loss 
of [RNQ+] and [URE3] when Sis1p is downregulated [95]. One possible explanation as to why 
these prions show different sensitivities to Sis1p is that one of the other 12 Hsp40s present in 
yeast could partially compensate for Sis1p in [PSI+] propagation. However, none of the other 
Hsp40s are required for propagation of [PSI+], [URE3], or [RNQ+] [95,100]. Besides Sis1p, the 
only other Hsp40 shown to bind Rnq1p is Ydj1p [100,101]. Ydj1p is dispensable for [RNQ+] 
propagation [100], but the overexpression of Ydj1p cures some variants of [RNQ+] [31]. Such 
differences in chaperone requirements of [RNQ+], [PSI+], and [URE3] may indicate that the 
structural differences between different prions and/or variants are responsible for dictating how 
chaperones recognize or fragment prion aggregates. Our understanding of this highly specific 
interplay between molecular chaperones and prions is far from complete. Additional mechanistic 
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studies are required to better understand how chaperones regulate prion propagation – an 
understanding that could lead to therapeutic development for protein conformational disorders. 
 
Sis1p and [RNQ+] propagation 
Sis1p binds Rnq1p in equimolar ratios in [RNQ+] cells and this interaction is required for 
[RNQ+] propagation [37,74,75,100]. Both the human homolog of Sis1p, HDJ1, and the 
Drosophila homolog, DROJ1, can compensate for the loss of Sis1p in viability and [RNQ+] 
propagation, suggesting a conserved function of Sis1p acts in prion propagation [100]. The 
sequences of Class I and Class II Hsp40s were compared to analyze the specificity of Sis1p in 
prion propagation [100]. Both types of Hsp40s have an N-terminal J-domain that mediates their 
interaction with Hsp70s and stimulates Hsp70 ATPase activity [102]. A glycine-rich region is 
adjacent to the J-domain in both classes as well. In Sis1p, this domain is divided into two parts: a 
G/F domain rich in glycine and phenylalanine residues and a G/M domain rich in glycine and 
methionine. The function of these domains is unclear. Following the glycine-rich domain, Class I 
Hsp40s have a cysteine-rich domain that is not present in Class II Hsp40s like Sis1p. Lastly, both 
classes have a C-terminal domain (CTD) that can bind unfolded substrates in vitro [103]. The 
G/F domain is the most critical part of Sis1p in [RNQ+] propagation as its deletion eliminates 
[RNQ+], although the G/M domain and the CTD are also likely to be involved as deletion of 
these domains alters aggregates of Rnq1p [74]. The dependence of [RNQ+] on the G/F domain 
helps explain the specificity of Sis1p, as this region is fairly unique among Hsp40s. The region 
of aa101-113 in the Sis1p G/F domain is not present in other Hsp40s, and is required for [RNQ+] 
propagation: two point mutations in this region (N108I and D110G) impair maintenance of 
[RNQ+] [100]. Interestingly, in vitro, Sis1"G/F can still bind substrates and stimulate ATPase 
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activity of the Hsp70 Ssa1p [104], which can interact with Rnq1p [74]. This suggests that these 
functions of Sis1p are dispensable for [RNQ+] propagation, thereby making it unclear as to how 
Sis1p mediates propagation of [RNQ+]. Moreover, downregulation of Sis1p or Hsp104p cures 
[RNQ+] by increasing the size of Rnq1p aggregates in [RNQ+] cells [99] beyond a certain 
threshold that can be effectively transmitted to daughter cells [105]. Perplexingly, the 
overexpression of Ssa1p also causes an increase in Rnq1p aggregate size [106]. Thus, the 
chaperone dynamics involved in fragmenting Rnq1p aggregates to propagate [RNQ+] are still 
poorly defined. 
 
1.3.5 [RNQ+] as a functional amyloid: a two-prion system to regulate the formation of new 
heritable traits 
Discovery of [PIN+] 
Before Rnq1p was recognized to form the [RNQ+] prion [64], it was discovered that the 
de novo formation of [PSI+] depended on the presence of [PIN+], a non-Mendelian factor that 
was presumed to be a prion [58,59]. It was later found that [RNQ+] was the [PIN+] element and 
that while "rnq1 cells maintained [PSI+], the de novo formation of [PSI+] did not occur in 
"rnq1 cells [60,61]. Overexpressing other Q/N-rich proteins can also confer the Pin+ phenotype 
by enhancing the formation of [PSI+], but [RNQ+] does so most efficiently and does not require 
the overexpression of RNQ1 [60,107]. Once [PSI+] has formed, both [RNQ+] and [PSI+] can 
propagate independently [59,108], and the presence of [RNQ+] does not affect [PSI+]-mediated 
nonsense suppression nor most [PSI+]-dependent phenotypes [59]. This was the first published 
example of a productive interaction between heterologous prions [109]. It is interesting, then, to 
consider the biological consequences of [RNQ+] and its influence on [PSI+]. The presence of the 
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[PSI+] prion has profound phenotypic effects and confers growth advantages in certain 
conditions [15,110,111]. Not surprisingly, the reduced efficiency of translation termination can 
also be detrimental [15,111]. Different [PSI+]-mediated phenotypes are observed in different 
genetic backgrounds [15,111]. Even different stocks of the same strain can show different 
phenotypes: for instance, different stocks of the strain 74-D694 show phenotypic variation and 
some have even lost the ability to recover from stress ([15,111] and unpublished data). These 
differences highlight the complexity of many of these phenotypes and are partly due to additional 
mutations, but unfortunately, this has been referred to as conflicting evidence for the potential of 
[PSI+] to be beneficial [112,113]. Yet, the molecular nature of some [PSI+]-dependent 
phenotypes has been elucidated [111,114]. As these traits depend on the ability of [PSI+] to act 
as an omnipotent nonsense suppressor, it has been proposed that [PSI+] provides an epigenetic 
means for adapting to changing environments [15,50,51]. It is currently unclear whether [PSI+] 
exists in wild strains, as the primary method used to assay for [PSI+] in wild strains (Sup35-
PFD-GFP aggregation [62]) is inconclusive as it typically requires the presence of both [PSI+] 
and [RNQ+]. For example, some [PSI+] [rnq-] “BSC” strains (Cox and Tuite [51]) do not show 
fluorescent foci when expressing Sup35p-PFD-GFP (True and Lindquist, unpublished data). 
Nevertheless, the existence of [PSI+] in the wild would be predicted to be transient and may not 
easily survive the switch to laboratory cultivation. Since [RNQ+] is required for [PSI+] to form 
and is present in wild yeast isolates [62,63], it follows that the [RNQ+] prion may serve to poise 
cells to form [PSI+] when environmental conditions change. In this way, this two-prion system 
may regulate translation and the ability of yeast to quickly adapt by using otherwise unavailable 
genetic information. More recently, it was discovered that [RNQ+] is also required for the 
formation of [URE3] [31,115]. [URE3] regulates nitrogen catabolism and may provide growth 
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advantages in high concentrations of certain ions [116]. As such, the presence of [RNQ+] may 
allow the cell to adapt to environmental changes and utilize a variety of nitrogen sources. Further 
examination of these interactions may eventually establish the [RNQ+] prion as a functional 
amyloid. 
 
[RNQ+] exists in different aggregated structures 
 Distinct aggregated structures of the mammalian prion protein, PrP, form unique prion 
strains that dictate disease transmissibility and are thought to be the underlying cause of much of 
the variation in the pathology of prion diseases [17]. Definitive proof that changes in amyloid 
conformation can cause phenotypic variation came from studies of [PSI+] prion variants. Weak 
[PSI+] variants are characterized by lower levels of nonsense suppression and have aggregates 
that are larger, more stable, and show a slower rate of amyloid formation as compared to fibers 
that form strong [PSI+] variants [26,69,117,118]. A model was proposed to explain the 
molecular basis of prion variants, positing that fiber stability and the kinetics of amyloid 
formation were the two primary determinants of the prion variant that propagated [25]. In 
contrast, for [RNQ+] variants similarly formed from transforming in vitro fibers, only fiber 
stability correlates with the proposed model: aggregates of weaker [RNQ+] variants are more 
stable, but exhibit a faster rate of fiber formation [33]. This suggests that the factors that 
determine the physical basis of [RNQ+] variants may not be the same as those that define [PSI+] 
variants [25,33]. Elucidating how different prion variants form and propagate is critical to 
understanding how different aggregated structures can modulate disease pathology. Indeed, even 
with one prion protein, different mechanisms may act to generate different classes of prion 
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strains. Strains formed with PrP, for instance, do not all fit into one simple model that correlates 
biochemical and biophysical properties to in vivo propagation [30,119]. 
Interestingly, the de novo appearance of [PSI+] not only depends on the presence of 
[RNQ+], but also on the prion variant of [RNQ+]. [RNQ+] variants were initially classified by 
how well they induce [PSI+]. [PSI+] is induced at a low frequency with the low [RNQ+] variant, 
and increasing levels of [PSI+] induction are seen with the medium, high, and very high [RNQ+] 
variants [31]. This classification only partly correlates to the level of aggregated Rnq1p, with 
decreasing levels of soluble Rnq1p seen from the low [RNQ+] to the high [RNQ+] variant. The 
very high [RNQ+] variant was an outlier and showed the most soluble Rnq1p of the [RNQ+] 
variants [31]. This change in solubility of the Rnq1 protein in these variants is often difficult to 
detect [75], however, and not as marked as the changes seen with variants of [PSI+]. Moreover, 
there is no correlation with the size and distribution of Rnq1p aggregates as there is for [PSI+] 
variants: medium [RNQ+] and very high [RNQ+], for instance, exhibit nearly identical aggregate 
distributions [108,117]. Another means of categorizing [RNQ+] variants is based on the 
aggregation pattern seen in [RNQ+] cells expressing Rnq1p-GFP: single dot (s.d.) for a single 
focus of fluorescence, or multi dot (m.d.) for cells having multiple foci [120]. Curiously, the 
relationship between [RNQ+] and [URE3] does not follow the same trend as [RNQ+] and [PSI+]. 
All of the s.d. [RNQ+] variants induce [URE3] similarly, while m.d. high [RNQ+] is unique and 
has the highest level of [URE3] formation [31]. This suggests that [RNQ+] interacts differently 
with Sup35p and Ure2p to promote prion formation. Further investigation of these heterologous 
prion interactions will help elucidate one means by which prion variants can form de novo.  
 
Models of [RNQ+]-mediated [PSI+] formation  
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Two predominant models have been proposed to explain how [RNQ+] facilitates the 
formation of the [PSI+] prion [60,61]. The titration model postulates that in [rnq-] cells, some 
factor prevents the formation of [PSI+], but the [RNQ+] prion sequesters this inhibitor to allow 
for conversion to [PSI+] [60,61]. Alternatively, the cross-seeding model proposes that the Rnq1p 
aggregates in [RNQ+] cells physically interact with Sup35p and serve as an imperfect template 
for [PSI+] formation [60,61]. While these models are not mutually exclusive, no inhibitor has 
been found to date, even though much work has been directed toward this goal [60]. 
Additionally, in support of a physical interaction between Rnq1p and Sup35p, fibers of 
recombinant Rnq1p can seed the amyloid formation of recombinant Sup35p, albeit inefficiently, 
and Rnq1p and Sup35p have been shown to occasionally colocalize [107,121]. Furthermore, 
rnq1 mutations have been identified that have no detectable effect on the structure of Rnq1p 
aggregates, but impair the formation of [PSI+], suggesting that these residues may physically 
interact with Sup35p to induce [PSI+] [78]. Of course, these findings do not exclude the 
possibility that some cofactor is also involved in this process. Nevertheless, such cross-seeding 
or co-aggregation of amyloidogenic proteins may play a role in sporadic protein conformational 
disorders and this model provides the framework to understand how that may occur. 
 
Non-productive amyloid interactions 
 In addition to facilitating prion formation, [RNQ+] is involved in seemingly “non-
productive” prion interactions, the purpose of which is unclear. For example, [RNQ+] can induce 
formation of Sup35p aggregates that are not [PSI+], termed non-heritable amyloid [122]. Unlike 
[PSI+], which propagates independently after induction, the overexpression of Sup35p and 
continuous interaction with [RNQ+] are required to maintain these non-heritable aggregates, 
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which may represent by-products of [PSI+] formation. Additionally, the presence of [PSI+] can 
enhance the formation of [RNQ+] [60].  
Interestingly, [URE3] and [PSI+] can antagonize each other [123]. Shortly after that 
discovery, it was paradoxically found that certain [RNQ+] and [PSI+] variants are incompatible 
[120]. For example, s.d. [RNQ+] variants destabilize weak [PSI+] by increasing the size of 
Sup35p aggregates [106,120]. Such destabilization was not seen for the m.d. high [RNQ+] 
variant. This relationship was reciprocal for the s.d. medium [RNQ+] and s.d. very high [RNQ+] 
variants, as the cells that did not form unstable [PSI+] converted to [rnq-] instead. This 
incompatibility was also seen with newly-induced [PSI+]: after inducing the formation of strong 
[PSI+], 70% of s.d. medium [RNQ+] cells and 37% of s.d. very high [RNQ+] cells became [rnq-] 
[120]. Furthermore, all s.d. medium [RNQ+] cells that had stably acquired weak [PSI+] became 
[rnq-]. The mechanism behind these incompatible or non-productive prion interactions is 
unknown, but this may reveal how some protein aggregates can cap other aggregates or compete 
for cellular resources. 
 Mutations in RNQ1 have also been found to negatively affect [PSI+] propagation. 
Deletion of the first 100 amino acids of Rnq1p (Rnq1p"100) was found to inhibit the 
propagation of strong [PSI+] [124]. Overexpression of the Rnq1"100 protein eliminated both 
weak and strong [PSI+] in a [RNQ+]-dependent manner, regardless of any particular [RNQ+] 
variant. Additionally, Rnq1p"100 inhibits [URE3] propagation and reduces the toxicity of polyQ 
aggregates [124]. Rnq1p"100 was later classified as a prion ([RNQ1"100+]) that induces [PSI+], 
but the Rnq1p"100-mediated induction then results in the loss of either [RNQ1"100+] or [PSI+] 
[125].  
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Most recently, 23 point mutations within the N-terminus of Rnq1p were uncovered that 
are phenotypically similar to Rnq1p"100 [77]. The overexpression of these mutants resulted in 
the [RNQ+]-dependent elimination of [PSI+] by increasing the size of Sup35p aggregates [77]. 
Interestingly, when expressed from the native RNQ1 promoter, these mutants did not affect 
[PSI+], but impaired [RNQ+] propagation [76,77]. Most of these mutations map to the putative 
#-helical domains of Rnq1p, and while the authors propose that these regions are involved in 
facilitating protein-protein interactions, the mechanism underlying the antagonistic prion 
interactions is unclear. One possibility is that disrupting the structure of the N-terminus may 
cause a gain-of-function effect through non-productive interactions with Sup35p that may result 
in capping to cure [PSI+]. However, one can only speculate how these seemingly non-productive 
prion interactions relate to the potential role that [RNQ+] may play in inducing [PSI+] as a 
means of adapting to fluctuating environments. It is feasible, for example, that the 
incompatibility between certain protein conformers serves as a bifunctional switch to regulate 
[PSI+]-mediated adaptation. 
 
1.3.6 [RNQ+] as a model for pathological amyloid 
polyQ aggregation depends on [RNQ+] 
A number of inherited human diseases are caused by the expansion of glutamine repeat 
sequences beyond a certain threshold in particular proteins [72]. These expanded polyQ proteins 
are prone to aggregation that is associated with cytotoxicity and leads to neurodegeneration and 
ultimately death. Yeast models were created to provide a tractable means of studying the 
aggregation mechanisms of these proteins [126-128]. Interestingly, the overexpression of the 
chaperones intimately involved in prion maintenance (Sis1p, Hsp104p, and Hsp70s) modulated 
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aggregation of the huntingtin (Htt) protein that had a pathological polyQ expansion [126]. 
Deletion of HSP104 effectively eliminated aggregation. The importance of these chaperones in 
regulating polyQ aggregation was also validated in vitro [129]. The role of these chaperones in 
dictating polyQ aggregation and toxicity is linked to their role in propagating the [RNQ+] prion: 
both deletion of RNQ1 and curing of [RNQ+] suppress polyQ aggregation and its associated 
toxicity [127]. This also corroborated earlier findings that Pin+ factors enhance the formation of 
polyQ aggregates [61].  
[PSI+] also enhances polyQ toxicity and has an additive effect when [RNQ+] is present 
[128], although most yeast models of polyQ aggregation show a stricter dependence on [RNQ+]. 
In a reciprocal fashion, polyQ aggregates can induce aggregation (though not prion formation) of 
both Rnq1p and Sup35p [130,131], thereby showing how co-aggregation of polyQ and/or Q/N-
rich proteins may play a major role in disease pathogenesis. Similarly, while sequences flanking 
the expanded polyQ repeats can modulate this toxicity, these sequences have the same effect 
when expressed in trans, and other Q-rich proteins also influence polyQ toxicity [132,133]. 
Importantly, however, all of these effects rely on the presence of the [RNQ+] prion.  
 Insight into how Rnq1p modulates polyQ aggregation and toxicity came from the 
observation that mutations in endocytic proteins enhance toxicity in a [RNQ+]-dependent manner 
[134]. PolyQ aggregates partially sequester the endocytic machinery and actin, thereby inhibiting 
endocytosis. This defect was also seen in mammalian cells [134]. It was later discovered that 
proteins associated with the late stages of the maturing endocytic complexes are recruited into 
polyQ aggregates [135]. This co-aggregation is most likely due to the polyQ stretches present in 
many endocytic proteins. Similarly, Rnq1p and multiple chaperones also associate with 
aggregates of polyQ protein in [RNQ+] cells [132,134,136]. These protein interactions may help 
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initiate polyQ aggregation, and the Q/N-rich Rnq1p aggregates in [RNQ+] cells might template 
this process. Since Rnq1p has no known mammalian homolog, however, it is unclear whether a 
similar mechanism occurs in human disease. Nevertheless, the yeast model of polyQ aggregation 
provides a means of determining candidate proteins that may be involved in either suppressing or 
enhancing polyQ toxicity, and thereby provides a viable approach to identify novel therapeutic 
targets [137]. As such, the strict dependence of polyQ aggregation on the [RNQ+] prion shows 
how [RNQ+] can aid in studying pathological amyloid. 
 
Rnq1p overexpression is toxic in [RNQ+] cells 
 In addition to its role in facilitating polyQ toxicity, it was shown that the overexpression 
of Rnq1p in [RNQ+] cells can also result in gain-of-function toxicity [37]. This toxicity required 
strong overexpression of full-length Rnq1p, as overexpression of either the PFD or the N-domain 
alone was not toxic. Overexpression of Sup35p in [PSI+] cells can also be toxic [24]. In this 
case, it is clear that the essential termination complex is sequestered into [PSI+] aggregates and 
the toxicity is rescued by overexpression of Sup35p’s binding partner, Sup45p [138,139]. 
Analogously, the overexpression of Sis1p suppresses the toxicity of Rnq1p overexpression [37]. 
This rescue depends on the translocation of Rnq1p into the nucleus, resulting in increased Rnq1p 
aggregate formation [140]. Perhaps through a very different mechanism, overexpressing Rnq1p-
L94A in [RNQ+] cells is also toxic. Sis1p overexpression does not suppress the L94A-induced 
toxicity since this mutant impairs the Rnq1p-Sis1p interaction [37]. Interestingly, Rnq1p-L94A 
overexpression is also toxic in [rnq-] cells, which can be attributed to its ability to form “off-
pathway” aggregates in the absence of [RNQ+]. As seen for wild-type Rnq1p, however, directing 
Rnq1p-L94A to the nucleus via the addition of a nuclear localization signal suppresses toxicity 
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[140]. Furthermore, nuclear Rnq1p aggregates can act in trans to sequester Rnq1p from the 
cytosol and repress toxicity. It has been proposed that Rnq1p overexpression causes the 
accumulation of an off-pathway, toxic aggregate in the cytoplasm, but the nucleus provides an 
environment for more efficient formation into benign aggregates. These nuclear aggregates can 
also localize polyQ to the nucleus [140]. Yet, instead of suppressing toxicity, nuclear 
translocation of polyQ enhances toxicity by decreasing the formation of SDS-resistant polyQ 
aggregates [140]. Hence, while the nucleus may provide a better environment for the formation 
of a benign amyloid structure for Rnq1p, the nuclear environment renders polyQ more soluble 
and more toxic.  
 Ydj1p has also been shown to modulate Rnq1p-associated toxicity. Overexpression of the 
Rnq1p-PFD is toxic in "ydj1 [RNQ+] cells, even though it is not toxic in wild-type cells [101]. 
In contrast to full-length Rnq1p, this toxicity is associated with the formation of SDS-resistant 
aggregates. The expression of Ydj1p was suggested to suppress this toxicity by binding to the 
Rnq1p-PFD and limiting the pool of aggregates. This suppression requires several features of 
Ydj1p: the zinc finger-like region (ZFLR) that is implicated in transfer of substrates to Hsp70s 
[141], the C-terminal domain 1 (CTD1), which contains a hydrophobic peptide-binding pocket 
[142], and farnesylation of the CAAX box [101]. Interestingly, these same domains were required 
for the Ydj1p-dependent suppression of polyQ toxicity [101]. These common mechanisms 
highlight the utility of Rnq1p as a model to further investigate the cellular machinery that 
regulates proteotoxicity. Additionally, these models may help to determine what types of protein 




While the term amyloid is generally associated with the proteins that aggregate in protein 
conformational disorders, there are an increasing number of examples of amyloid structures 
having a functional role in normal biology [10,46]. Clearly, some amyloidogenic proteins have 
the potential to form both toxic and non-toxic structures. From a structural standpoint, this is best 
detailed with the prion protein Het-s in the filamentous fungi Podospora anserina. Structures of 
Het-s associated with toxicity are amyloids having antiparallel !-sheets, whereas the benign 
structures identified form parallel !-sheets [143]. Similarly, the [RNQ+] prion may 
simultaneously serve as an example of a functional amyloid and as a model for understanding 
pathological amyloid, thereby allowing us to examine a number of questions relevant to either a 
physiological or disease context: What is the toxic protein conformer?  How are protein 
aggregates toxic?  What types of heterotypic interactions do amyloidogenic proteins have?  How 
can a single protein form different aggregated structures?  How do these various structures cause 
changes in phenotype?  Studying these questions using the [RNQ+] prion will further our 
understanding of protein conformational disorders and perhaps also explain why evolution has 
preserved proteins that are susceptible to toxic conversion. Indeed, there are examples in biology 
of balancing selection, in which a certain trait has been conserved even though it is associated 
with disease, such as the sickle cell trait providing some resistance to malaria [144,145]. 
 
1.4  Molecular Chaperones 
It has long been recognized that the native folded state of a protein is determined by its 
sequence [16]. This native state represents a balance between forming a structure that is 
thermodynamically stable, having nonpolar amino acid residues within the protein’s interior, and 
a structure that has the necessary flexibility to perform its function [146]. However, in order to 
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find this equilibrium and ensure a properly folded protein, there are significant free energy 
barriers that must be overcome, especially with larger, more complex proteins [146]. Indeed, 
exposure of hydrophobic regions increases the propensity of a protein to aggregate [147]. Hence, 
in order to maintain proteostasis, as defined as a healthy proteome, an elaborate network has 
evolved that consists of ~1,300 different proteins in mammals that monitor the life cycle of 
proteins [146]. While there are a variety of cellular machineries that comprise this so-called 
proteostasis network, one of the largest groups is a class of proteins called molecular chaperones, 
which act as the cell’s means of surveillance to prevent the misfolding and aggregation of protein 
[146]. The classic group of molecular chaperones are heat shock proteins (HSPs), which are 
often stress-inducible, and were originally grouped based on their molecular weight, such as 
Hsp40s, Hsp70s, and Hsp100s [146].  
 
1.4.1 Hsp70 Machinery 
The Hsp70 chaperones are ubiquitous, and play a role in all aspects of a protein’s life 
cycle, including folding, re-folding, translocation, and degradation [148]. These proteins are 
divided into two domains, with an N-terminal adenine nucleotide-binding domain (NBD) and a 
C-terminal substrate-binding domain (SBD). Processing of client proteins relies on Hsp70 
cycling through alternate ATP- and ADP-bound states. Transitioning between these states 
requires an Hsp40 and usually a nucleotide-exchange factor (NEF). In the ATP-bound state, 
Hsp70s are in an “open” conformation and interact readily with clients, but have low binding 
affinity. ATP hydrolysis and conversion to the ADP-bound “closed” conformation is needed to 
stabilize the interaction between Hsp70s and clients [148]. As the basal Hsp70 ATPase activity is 
low, Hsp40s are responsible for stimulating the ATPase activity of Hsp70 >1,000 fold to the 
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ADP-bound state [146]. After substrate processing, dissociation of ADP and exchange for ATP 
is regulated by NEFs, returning Hsp70 to the “open” conformation and ready to bind another 
substrate. Thus, the activity of Hsp70 and its involvement in a variety of processes depends on 
additional molecular chaperones. 
In addition to stimulating ATP hydrolysis of Hsp70s, the canonical function of Hsp40s is 
to deliver substrates to Hsp70 [149]. Interestingly, humans have only 11 Hsp70s, but they have 
41 different Hsp40s that have a large amount of sequence variation [148]. This suggests that 
Hsp40s are specialized proteins, serving to dictate Hsp70 function and selectivity, with particular 
Hsp40s likely involved in particular cellular functions. There are three classes of Hsp40s that are 
loosely divided based on domain structure [102]. Common to all three groups is the J domain, so 
named because it shares homology with DnaJ, the Hsp40 present in E. coli. This domain is 
responsible for the interaction with Hsp70 and stimulating its ATPase activity. For class I 
Hsp40s, the J domain is N-terminal, followed by a domain that is rich in glycine and 
phenylalanine residues (G/F), a zinc finger motif, a C-terminal substrate-binding domain, and a 
dimerization domain at the end of the C-terminus [148]. Class II Hsp40s share a similar domain 
scheme, but lack the zinc finger motif. By contrast, class III Hsp40s are a non-canonical group 
that have diverse domain modules. While there is some functional redundancy between various 
Hsp40s [150], it is clear that the variation present in Hsp40 family members provides the cell and 
Hsp70 with the ability to handle a wide range of substrates. 
 
1.4.2 Chaperonopathies 
 Molecular chaperones have a protective role in the cell to help prevent the accumulation 
of misfolded protein. When a protein misfolds, chaperones will bind the hydrophobic regions of 
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the substrate that become exposed [151-153] and will determine whether the protein can be 
refolded or should be degraded. However, the cellular response and capability to handling 
misfolded substrates can be overwhelmed [154]. Indeed, it is suggested that there is a dramatic 
decline in the proteostasis network as a cell and organism ages, thereby contributing to the 
accumulation of protein aggregates and onset of age-related protein conformational disorders 
[155]. Molecular chaperones have been implicated in a number of these diseases, being found in 
protein inclusions that might act to sequester these chaperones [156,157]. Interestingly, there are 
an increasing number mutations being identified in chaperones that cause a variety of distinct 
disorders [157]. Collectively, these disorders are now being called chaperonopathies [158]. 
 One recently identified chaperonopathy is the limb-girdle muscular dystrophy type 1D 
(LGMD1D) that is caused by mutations in the Hsp40 DNAJB6 [159-162]. LGMD disorders 
comprise a heterogeneous group of muscular dystrophies that are characterized by progressive 
proximal weakness and muscle degeneration and have autosomal patterns of inheritance [163]. 
In the case of LGMD1D, a major pathological feature is the presence of protein aggregates and 
vacuoles in the affected skeletal muscle [159]. Interestingly, mutations in other chaperones, 
including VCP, BAG3, and "B-crystallin, also cause dominantly inherited myopathies that 
exhibit the accumulation of protein aggregates [164-166]. Hence, it is clear that disrupting 
chaperone function can lead to significant defects in proteostasis, especially in skeletal muscle, 
and contributes to the pathogenesis of various diseases. 
 
1.5  Summary and Significance 
 The formation of amyloid is a common phenomenon, not only occurring as part of the 
development of several diseases, but also serving as a functional entity in various unrelated 
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processes [2]. Across this spectrum, there are several generic structural features of amyloid that 
are independent of the protein determinant. However, on a smaller scale, there are several subtler 
variations that can occur within the amyloid fiber. This sort of variation associated with amyloid 
polymorphism can have dramatic consequences in terms of pathological and phenotypic 
differences. Moreover, molecular chaperones play a critical role in monitoring the formation of 
these amyloid morphotypes, and protein misfolding in general. Indeed, amyloid and its particular 
subtypes can overwhelm the activity of molecular chaperones and various mechanisms of protein 
quality control [154]. Therefore, studying the interplay of amyloid and chaperones, and the 
underlying mechanisms that influence these interactions, is crucial to gaining a better 
understanding of protein conformational disorders, and even normal biological processes that 
involve functional amyloid. 
This dissertation is separated into two major parts that both describe the use of yeast 
prion variants to study the effect of amyloid polymorphism on phenotypic variation. Chapters 
two and three explore the biochemical, intragenic, and trans-acting factors that contribute to the 
propagation of distinct prion variants of [RNQ+] and [PSI+]. I show that there are a wide variety 
of variables involved, including distinct requirements of the primary structure of the aggregating 
protein as well as different domains of chaperones. Thus, this highlights the complex nature of 
amyloid polymorphism and the resulting diversity in phenotypes. Then, in Chapters four and 
five, I explore the effects of mutations in the Hsp40 DNAJB6 that are associated with LGMD1D. 
Here, I show how amyloid polymorphism might be involved in the pathogenesis of this disorder 
and provide some mechanistic understanding for how the DNAJB6 mutations might cause 
disease. Finally, Chapter six describes the broader implications of this work and the important 
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2.1 Abstract 
 Amyloidogenic proteins associated with a variety of unrelated diseases are typically 
capable of forming several distinct self-templating conformers. In prion diseases, these different 
structures, called prion strains (or variants), confer dramatic variation in disease pathology and 
transmission. Aggregate stability has been found to be a key determinant of the diverse 
pathological consequences of different prion strains. Yet, it remains largely unclear what other 
factors might account for the widespread phenotypic variation seen with aggregation-prone 
proteins. Here, we examined a set of yeast prion variants of the [RNQ+] prion that differ in their 
ability to induce the formation of another yeast prion called [PSI+]. Remarkably, we found that 
the [RNQ+] variants require different, non-contiguous regions of the Rnq1 protein for both prion 
propagation and [PSI+] induction. This included regions outside of the canonical prion-forming 
domain of Rnq1. Remarkably, such differences did not result in variation in aggregate stability. 
Our analysis also revealed a striking difference in the ability of these [RNQ+] variants to interact 
with the chaperone Sis1. Thus, our work shows that the differential influence of various 
amyloidogenic regions and interactions with host cofactors are critical determinants of the 
phenotypic consequences of distinct aggregate structures. This helps reveal the complex 
interdependent factors that influence how a particular amyloid structure may dictate disease 
pathology and progression.  
 
2.2 Author Summary 
 Protein conformational disorders, including many neurodegenerative diseases, result 
when a protein misfolds and undergoes a conformational change to form self-templating 
aggregates, called amyloid. Interestingly, the proteins that misfold in these diseases tend to form 
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a wide variety of distinct aggregate structures. In prion diseases, these different amyloid 
conformations are called prion strains. The different conformations of prion strains are 
responsible for modulating disease progression, pathology, and transmission. Previous work with 
yeast prions has provided tremendous insight into how distinct prion conformers can cause such 
phenotypic variability. Here, we used a set of [RNQ+] prion variants to show the complex web of 
interactions involved in the propagation of distinct aggregate structures. We found that several 
different non-adjacent regions of Rnq1, even outside the prion-forming domain, make varying 
contributions to the propagation of distinct variants of the [RNQ+] prion. Moreover, our data 
support the hypothesis that the [RNQ+] variants differentially interact with the molecular 
chaperone Sis1. These data strongly suggest that the variable phenotypic manifestations of 
different aggregate conformations depend upon a unique set of primary structural elements and 
differential interactions with host cofactors. 
 
2.3 Introduction 
The misfolding of proteins to form cross-! sheet amyloid structures is characteristic of a 
variety of diseases, including many neurodegenerative disorders, such as Alzheimer’s disease 
[1]. Increasing evidence suggests that these protein conformational disorders are caused by a 
similar etiological mechanism, in which the amyloid that forms represents an infectious, self-
templating structure that is often described as prion-like [167,168]. Prion diseases are caused 
when the native form of the prion protein (PrPC) misfolds and aggregates to form the amyloid 
structure called PrPSc [5]. PrPSc is considered infectious because it transmits its pathogenic 
conformation by templating the conversion of other native PrPC monomers to PrPSc in a self-
propagating fashion [169]. 
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To add another layer of complexity, it now appears that the proteins that misfold in these 
disorders can adopt an array of different aggregated conformations, called prion strains in prion 
diseases [43,44,170]. Prion strains often have unique biochemical properties and encode different 
degrees of infectivity [17]. These differences are thought to be the underlying cause of the 
widespread pathological variation seen in prion diseases. It was recently shown that distinct self-
propagating structures of "-synuclein, the protein that misfolds in Parkinson’s disease, also exist 
and promote the formation of tau inclusions to different extents [171]. Yet, with estimates that a 
single amyloidogenic protein like PrP may propagate over 30 distinct aggregate conformers 
[172], it is unclear what underlying factors contribute to such widespread structural and 
phenotypic diversity. 
A tremendous amount of insight into the physical basis of prion strains, and amyloid 
polymorphism in general, has come from studying the prion strains that are endogenous to the 
budding yeast Saccharomyces cerevisiae (here also called prion variants). Like mammalian 
amyloidogenic proteins, yeast prion proteins form self-propagating, ! sheet-rich amyloid 
structures. These self-perpetuating yeast prions exhibit dominant, non-Mendelian inheritance that 
promotes variation in cellular phenotypes [14]. One of the most well-studied yeast prions is the 
[PSI+] prion, formed from the translation termination factor Sup35. Sup35 is soluble and 
functional in [psi-] cells, but Sup35 misfolds and is sequestered into prion aggregates in [PSI+] 
cells, resulting in a nonsense suppression phenotype [48,49]. Two [PSI+] prion variants were 
initially categorized based on the degree of nonsense suppression [24]. Cells propagating the 
strong [PSI+] variant showed increased nonsense suppression relative to cells propagating the 
weak [PSI+] variant. Yet, like prion strains of PrPSc, it has become clear that a large continuum 
of different [PSI+] variants also exists [173-175].  
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Studies of conformationally distinct amyloid fibers of the prion-forming domain (PFD) of 
Sup35 formed in vitro have helped reveal a foundation to explain the structural and phenotypic 
differences between [PSI+] variants [25,26,68,69,176]. Like most yeast prions, and even several 
disease-associated proteins, Sup35 has a PFD that is rich in glutamine and asparagine (Q/N) 
residues, and is necessary for the maintenance of [PSI+] [8,14,24,177-179]. In distinguishing 
[PSI+] variants, it was shown that the contiguous length of the Sup35-PFD that forms the 
amyloid core correlates with a set of interdependent biochemical properties, including fiber 
stability, average aggregate size, and replication kinetics [25,26,69,117,180,181]. Collectively, 
these parameters dictate a balance between fiber fragmentation and fiber growth, which is the 
major biophysical determinant of the resulting [PSI+] phenotype [25]. In the case of strong 
[PSI+] cells, the shorter and more fragile amyloid core of the Sup35 aggregates gives rise to 
more fragmentation and greater sequestration of Sup35 into aggregates, thereby resulting in more 
nonsense suppression. The more stable structure of Sup35 aggregates in weak [PSI+] cells, on 
the other hand, does not as readily fragment or capture monomer; hence, a larger pool of 
functional protein remains to participate in translation termination. These biochemical 
parameters have served as the foundation to describe the structural basis of prion strains, and 
have been shown to apply to various PrPSc strains [27,182]. However, these correlations do not 
always hold true for the wide variety of structural variants that are possible for [PSI+], PrPSc, and 
even another yeast prion, [RNQ+] [28,29,32,33,172,183]. Thus, it remains a mystery what other 
variables help determine the extensive phenotypic differences exhibited by different prion 
strains. 
Interestingly, while [PSI+] modulates translation termination, the major phenotypic 
manifestation of the [RNQ+] prion (also called [PIN+] and formed from the Rnq1 protein) is 
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inducing the de novo formation of [PSI+] [11,58-61,64]. The formation of [PSI+], but not its 
continued propagation, relies on the presence of the [RNQ+] prion [59]. Five different variants of 
the [RNQ+] prion have been categorized based on how frequently they facilitate [PSI+] 
formation, from low rates to very high rates [31]. These [RNQ+] variants were also classified by 
the aggregate pattern observed in cells expressing GFP-tagged Rnq1 [120]. Cells predominately 
showing one fluorescent focus were called single-dot (s.d.) [RNQ+], while cells having many 
foci were called multiple-dot (m.d.) [RNQ+]. Recently, it was demonstrated that Rnq1 can form 
over 40 variants of the [RNQ+] prion [32], and different [RNQ+] variants were also found in wild 
yeast isolates [35]. While the mechanism of how [RNQ+] affects [PSI+] formation remains to be 
elucidated, a number of studies suggest that [RNQ+] acts as an imperfect template that interacts 
with Sup35 to cross-seed the induction of [PSI+] [78,107,121]. Indeed, similar to Sup35, Rnq1 
has a Q/N-rich PFD that is necessary for prion propagation and may facilitate the interaction 
with Sup35 [64,73,78]. However, while some differences in biochemical and cellular properties 
have been noted between [RNQ+] variants, none of these properties explain how [RNQ+] 
variants differentially promote [PSI+] formation [31-33,108,120,184].  
Here, we set out to determine what factors distinguish [RNQ+] prion variants to allow for 
such dramatic phenotypic differences in [PSI+] inducibility. We found that each [RNQ+] variant 
relies on a distinct set of non-adjacent regions for both propagation and interaction with Sup35. 
While there is normally much emphasis on Q/N-rich prion-like domains, we show that regions 
outside of the canonical Rnq1-PFD influence [RNQ+] propagation in a variant-dependent 
manner. Furthermore, our data provide striking support for the hypothesis that different 
interactions between amyloid and molecular chaperones, and potentially other cellular cofactors, 
influence the phenotypic manifestations of distinct prion variants. This work helps reveal the 
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structural and biological complexity underlying prion strains, showing that a large set of 
interdependent factors likely contribute to the ability of distinct aggregate conformations to 
modulate disease phenotype and transmissibility.  
 
2.4 Results 
2.4.1 Fiber fragmentation parameters do not distinguish [RNQ+] variants 
[PSI+] variants are easily distinguished by a set of parameters that define an equilibrium 
between fiber growth and fiber fragmentation [25]. We asked whether these parameters could 
similarly distinguish a set of previously published [RNQ+] variants. This set consisted of four 
s.d. [RNQ+] variants having [PSI+] induction levels from low to very high, and one m.d. [RNQ+] 
variant with a high level of [PSI+] induction [31]. We first examined whether differences in the 
fragmentation of the [RNQ+] variants could explain the differences in [PSI+] inducibility. The 
properties that dictate fragmentation often include aggregate stability, aggregate size, and 
chaperone interactions. To test the stability of the Rnq1 aggregates, we subjected [RNQ+] [psi-] 
cell lysates to a gradient of increasing temperature, as different amyloid conformations can have 
different melting temperatures (Tm) [69]. In agreement with previous studies [32,78,108], we 
found that only the m.d. high [RNQ+] variant was thermal labile, having a much lower Tm 
(~58°C) as compared to the similar Tm (~86°C) of all the s.d. [RNQ+] variants (Figure 1A). We 
also analyzed the sensitivity of Rnq1 aggregates to protease digestion, as work with the 
mammalian PrPSc prion has shown that prion strains can display different sensitivities to 
digestion with proteinase K (PK) [17]. Strains of "-synuclein also show different levels of PK 
sensitivity [171]. After incubating cell lysates with PK at 37°C, we again found that only m.d. 
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high [RNQ+] was an outlier in displaying increased PK resistance as compared to the s.d. 
[RNQ+] variants (Figure 1B and Figure S1). 
We then analyzed the average size distribution of the Rnq1 aggregates using semi-
denaturing agarose gel electrophoresis (SDD-AGE), which resolves the Rnq1 aggregated 
species. By electrophoretically separating the protein longer, we observed some more 
distinctions between the [RNQ+] variants than previously described [108]. There was a gradual 
decrease in aggregate size between s.d. low, s.d. medium, and s.d. high [RNQ+] (notice the 
aggregates of s.d. low [RNQ+] that appear stuck in the well) (Figure 1C). However, both s.d. 
very high and m.d. high [RNQ+] had predominantly larger aggregates. 
 Another major factor that distinguishes the ability of yeast prion variants to fragment in 
vivo is their interaction with chaperones. Prion replication requires recognition of prion 
aggregates by the Hsp40 co-chaperone Sis1 and fragmentation by Hsp104 to create “seeds” (or 
propagons) that cause further monomeric conversion to the prion state [14,90]. Sis1 interacts 
with Rnq1 specifically in [RNQ+] cells [74] and this interaction is required for propagation of 
[RNQ+] [99]. Additionally, more Sis1 is associated with Rnq1 aggregates as compared to Sup35 
aggregates [185], which may suggest that Sis1 plays a more significant role in the propagation of 
[RNQ+] as compared to [PSI+]. Therefore, as another measure of fragmentability, we asked 
whether the level of Sis1 associated with Rnq1 differed between [RNQ+] variants. To test this, 
we immunoprecipitated Sis1 from [rnq-] cells or cells propagating the [RNQ+] variants and 
immunoblotted for Rnq1. While Sis1 did not co-immunoprecipitate Rnq1 in [rnq-] cells, Sis1 
and Rnq1 were similarly associated in all [RNQ+] cells (Figure 1D), in agreement with a 
previous study [184]. Furthermore, all the [RNQ+] variants depended on Sis1 expression to 
similar levels for their maintenance (data not shown).  
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These data do not preclude the possibility that the [RNQ+] variants are fragmented to 
different extents. However, they show that the standard parameters used to monitor 
fragmentation neither distinguish the [RNQ+] variants, as they do for [PSI+] variants, nor 
correlate to [PSI+] inducibility. 
 
2.4.2 Fiber growth parameters do not explain phenotypic differences of [RNQ+] variants 
In addition to differences in fiber fragmentation, [PSI+] variants also show differences in 
fiber growth parameters. Knowing the functional role of Sup35 in translation termination allows 
these differences to be easily monitored phenotypically. The most common means involves 
colorimetrically measuring the degree of nonsense suppression of the ade1-14 allele that has a 
premature stop codon in the ADE1 gene [186]. The large soluble pool of Sup35 in [psi-] cells 
allows for faithful translation termination at the premature stop codon. This results in the 
accumulation of a metabolic intermediate and incomplete synthesis of adenine, thereby making 
these cells unable to grow on medium lacking adenine, and colonies grown on rich media are 
red. By contrast, Sup35 aggregates in strong [PSI+] cells readily recruit and sequester soluble 
Sup35 into aggregates to cause nonsense suppression [24,118]. Hence, strong [PSI+] cells have 
less soluble Sup35, propagate a mitotically stable aggregate structure, and form light pink or 
white colonies that grow well on medium lacking adenine. Weak [PSI+] cells, on the other hand, 
have an intermediate phenotype. Thus, the fiber growth characteristics of [PSI+] variants are 
often monitored by: mitotic stability, the amount of soluble protein, and the resulting [PSI+] 
phenotype.  
In contrast to Sup35, the functional role of Rnq1 is not known. Hence, in order to 
phenotypically monitor [RNQ+], we previously developed a chimeric protein called the [RNQ+] 
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Reporter Protein (RRP) [78], which consists of the Rnq1-PFD(153-405) fused to the middle and 
C-terminal domains of Sup35 that provide the GTPase activity required for translation 
termination [187]. RRP allows us to monitor the [RNQ+] prion state by colony color phenotype 
in a manner analogous to [PSI+]. RRP is functional in translation termination in [rnq-] cells that 
remain red, while it co-aggregates with Rnq1 in [RNQ+] cells to generate colonies that are 
phenotypically pink or white [32,33]. Thus, the [RRP+] phenotype, like the [PSI+] phenotype, 
serves as a measure of the prion variant-specific sequestration of monomeric protein. Hence, to 
examine fiber growth parameters, we first determined the [RRP+] phenotype for the set of 
[RNQ+] variants studied in this work. Interestingly, we found that the three “higher” [RNQ+] 
variants had a stronger nonsense suppression phenotype as compared to s.d. low and s.d. medium 
[RNQ+] (Figure 2A). Previous work demonstrated that s.d. very high [RNQ+] cells had the 
greatest amount of soluble Rnq1 [31]. Hence, this suggests that, in contrast to other published 
[RNQ+] variants [33], the [RRP+] phenotype of the set of [RNQ+] variants in this study does not 
correlate to the level of soluble Rnq1. Moreover, it was surprising that the [RRP+] phenotype 
correlated to [PSI+] inducibility for these [RNQ+] variants, as this was not the case for other 
[RNQ+] variants [32,33], or for several other prion properties of [RNQ+] (this work and 
[31,108,184]).  
The mitotic stability of prion variants is another measure of fiber growth as this property 
relies on the degree to which monomer is sequestered into aggregates. This property has been 
shown to distinguish [PSI+] variants and other [RNQ+] variants [24,32,33]. Hence, to test the 
mitotic stability of the [RNQ+] variants, we plated overnight cultures of cells expressing RRP 
and propagating each of the [RNQ+] variants onto rich media, and then counted the number of 
colonies that were red or had red sectors (indicating loss of the [RRP+] phenotype and the 
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[RNQ+] prion). We found that both s.d. low and s.d. very high [RNQ+] showed higher levels of 
mitotic loss compared to the other three [RNQ+] variants (Figure 2B). This loosely correlates 
with the amount of soluble Rnq1 present in these cells: s.d. low and s.d. very high [RNQ+] have 
been shown to have the greatest amount of soluble Rnq1 [31]. However, because s.d. low 
[RNQ+] has less soluble protein as compared to s.d. very high [RNQ+] [31], we would have 
expected s.d. low [RNQ+] to have higher mitotic stability. Hence, mitotic stability did not 
correlate to either the [RRP+] phenotypes or the level of soluble Rnq1 of this set of [RNQ+] 
variants, in contrast to what was shown with [PSI+] variants and other [RNQ+] variants [33,118].  
 
2.4.3 The region outside of the Rnq1-PFD has variant-specific influence on fiber growth  
While regions outside of PFDs remain under-studied, various work has implicated non-
PFD regions as affecting prion propagation [180,188]. Indeed, the N-terminal domain that lies 
outside of the putative Rnq1-PFD can influence the propagation of [RNQ+] [76-78]. As such, to 
gain insight into how the [RNQ+] variants are physically distinct, we hypothesized that the Rnq1 
N-terminal domain might impact [RNQ+] propagation in a variant-specific manner. To address 
this, we used a modified version of RRP containing full-length (FL) Rnq1 (aa 1-405) fused to the 
MC domains of Sup35, in contrast to the original version of RRP that contained just the Rnq1-
PFD (aa 153-405). Using sup35! cells that were complemented by episomal SUP35, we used a 
plasmid shuffle technique to replace Sup35 with plasmids expressing RRP, FL RRP, or Sup35. 
Strikingly, FL RRP was not able to functionally replace Sup35 in cells propagating the m.d. high 
[RNQ+] variant (Figure 2C). Importantly, there was no effect on viability when cells still 
expressed Sup35. Moreover, the inviability depended on the presence of both the m.d. high 
[RNQ+] variant and the Rnq1 protein, as eliminating (curing) the prion or deleting RNQ1 before 
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replacing Sup35 with FL RRP resulted in viable cells (Figures 2C and S2). (As expected, the 
cells were white in the latter case, indicating that FL RRP propagates the aggregated structure of 
m.d. high [RNQ+] in the absence of the Rnq1 protein since FL Rnq1 is still expressed as part of 
FL RRP.) In light of previous work showing that m.d. high [RNQ+] cells have relatively little 
soluble Rnq1 [31], these data suggest that the presence of the Rnq1 N-terminus on FL RRP 
promotes sequestration of FL RRP into Rnq1 aggregates to such a large extent that there is too 
little soluble FL RRP to function in translation termination. In contrast, [rnq-] cells and cells 
propagating each of the s.d. [RNQ+] variants were viable when expressing FL RRP (Figures 2C 
and S3). In fact, cells propagating each of the s.d. [RNQ+] variants and harboring FL RRP were 
darker pink as compared to the equivalent cells expressing RRP, thus indicating that translation 
termination was more efficient.  
Based on the different phenotypes that resulted from using RRP versus FL RRP, we 
wanted to more directly test, without the use of RRP, whether the Rnq1 N-terminus influenced 
the ability of newly synthesized Rnq1 to join pre-existing Rnq1 aggregates. We used a galactose-
inducible promoter to express HA-tagged Rnq1 or Rnq1-PFD in cells that are grown in media 
containing galactose. Then we monitored the ability of Rnq1 monomer to join untagged pre-
existing aggregates of the different [RNQ+] variants using a well-trap assay. This assay allows us 
to easily determine the amount of soluble Rnq1 in the cell, as aggregated Rnq1 is retained in the 
wells of an SDS-PAGE gel when samples are not boiled [189]. As expected for [rnq-] cells, upon 
inducing expression of HA-Rnq1 or Rnq1-PFD, we found that all pre-existing and newly 
synthesized Rnq1 protein was soluble (Figure 2D). By contrast, all newly synthesized HA-Rnq1 
joined the pre-existing aggregates for each of the [RNQ+] variants, as indicated by the absence of 
a band in the unboiled lanes. Interestingly, we saw variant-specific effects when we expressed 
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just the Rnq1-PFD. For m.d. high [RNQ+], newly synthesized Rnq1-PFD, like HA-Rnq1, 
completely joined the pre-existing aggregates in the given time duration. All of the s.d. [RNQ+] 
variants, on the other hand, maintained a soluble pool of Rnq1-PFD. These data indicate that 
recruitment of Rnq1-PFD monomers into aggregates occurs more readily for m.d. high [RNQ+] 
in comparison to the s.d. [RNQ+] variants. Additionally, it suggests that the Rnq1 N-terminus is 
important for facilitating monomer addition and fiber growth with the s.d. [RNQ+] variants, 
similar to what we demonstrated above for m.d. high [RNQ+] using FL RRP.  
Finally, we wanted to test whether this influence of the Rnq1 N-terminal domain on fiber 
growth was necessary for propagation of the [RNQ+] variants. To do this, we deleted RNQ1 in 
RRP-expressing yeast cells that were complemented with a URA3-marked plasmid expressing 
RNQ1. Cells that lose this plasmid would express only the Rnq1-PFD as part of RRP, and would 
not express the Rnq1 N-terminal domain. After growing cultures in non-selective media, we 
plated [rnq-] cells and cells propagating each of the [RNQ+] variants on media to select for either 
maintenance (SD-ura) or loss (5-FOA) of the RNQ1 plasmid. In agreement with our previous 
results [78], m.d. high [RNQ+] did not propagate when Rnq1 was lost, as it was phenotypically 
[rnq-] on 5-FOA medium and did not grow on medium lacking adenine and containing 5-FOA 
(Figure 2E). This suggests that the Rnq1-PFD is not sufficient to propagate this variant. In stark 
contrast, all of the s.d. [RNQ+] variants could still maintain [RNQ+], albeit to varying degrees. 
This indicates that propagation of m.d. high [RNQ+] has a greater reliance on the non-prion-
forming N-terminal domain than the s.d. [RNQ+] variants. Furthermore, it suggests that 
propagation of the s.d. [RNQ+] variants might differentially depend on the presence of the N-
terminal domain. Indeed, we passaged the rnq1! cells harboring the s.d. [RNQ+] variants that 
had lost the RNQ1 plasmid and found that, after further growth, these cells did not maintain the 
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same [RRP+] phenotype as the RNQ1 [RNQ+] cells expressing RRP (compare Figure 2A to 
Figure 2F). For instance, both s.d. low and s.d. medium [RNQ+] had a much stronger nonsense 
suppression phenotype as compared to their phenotype when Rnq1 was present.  
Taken together, these data suggest that the [RNQ+] variants show differences in fiber 
growth parameters, which are mediated, in part, by the Rnq1 N-terminal domain. However, 
despite these differences in properties of fiber growth and fragmentation, these data do not 
wholly distinguish the [RNQ+] variants or explain their differential ability to induce [PSI+]. This 
is in line with previous work that also shows a lack of correlation [184]. Hence, these data 
highlight the complex nature of both [PSI+] induction and the phenotypic consequences that are 
possible with distinct aggregate structures. 
 
2.4.4 [RNQ+] variants show differential reliance on amyloidogenic regions 
To help elucidate the basis of the structural diversity of the [RNQ+] variants and the 
phenotypic differences they modulate, we postulated that each of the [RNQ+] variants, like 
[PSI+], has a different part of the primary structure that is important for prion propagation. 
Propagation of strong [PSI+] incorporates fewer residues of the Sup35-PFD in the amyloid core 
as compared to weak [PSI+], and this difference is tightly correlated to the biochemical and 
phenotypic differences seen between [PSI+] variants [26,176,180]. Hence, determining the 
regions of Rnq1 that are important for propagation of each of the [RNQ+] variants would provide 
insight into how the [RNQ+] variants are structurally different and can mediate differences in 
[PSI+] formation. To help identify these sequence elements, we used five different algorithms 
that were developed to find regions of a protein predicted to facilitate the formation of amyloid 
[190-194]. These algorithms found 11 putative amyloidogenic regions spread throughout both 
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the N-terminal domain and the PFD of Rnq1 (Figure 3). We will refer to these regions hereafter 
as A1 through A11.  
We set out to analyze the influence of these regions on the propagation of the different 
[RNQ+] variants. We mutated each of these regions in its entirety to alanine to make 11 Rnq1 
mutant constructs and confirmed expression levels similar to wild-type (WT) Rnq1 (Figure S4). 
After using a plasmid shuffle technique to replace WT Rnq1 with these mutants in cells 
propagating each of the [RNQ+] variants, we then examined three biochemical properties 
commonly used to monitor prion replication: 1) the relative distribution of Rnq1 aggregates 
using SDD-AGE, 2) the amount of soluble Rnq1 by solubility assay, and 3) the thermal stability 
of Rnq1 aggregates. These assays provide complementary information about the propagation of 
[RNQ+]; for example, detection of monomeric Rnq1 with SDD-AGE is variable for unknown 
reasons, thus using the solubility assay is informative. Additionally, since these assays examine 
different aspects of prion propagation, we hypothesized that we might see a difference by one 
assay and not another. Therefore, collectively, these assays allowed us to make conclusions 
about how mutation of the amyloidogenic regions in Rnq1 affected [RNQ+] propagation. 
For each assay, we categorized the reproducible effects of the alanine mutants as mild, 
moderate, curing [RNQ+], or having no effect (Figure S5). Taking all three assays into account, 
we then scored the overall influence of disrupting the amyloidogenic regions on each [RNQ+] 
variant (Figure 4A). As expected, since our data above showed the involvement of the N-
terminus in [RNQ+] propagation, we found that the N-terminal alanine mutants revealed regions 
of both common and unique importance for the [RNQ+] variants. For instance, mutation of the 
A1 or A3 regions both affected the biochemical properties of all of the [RNQ+] variants. 
However, these mutants also showed variant-specific effects. With s.d. high [RNQ+], for 
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example, expression of the A1 and A3 mutants resulted in a dramatic shift in relative aggregate 
size distribution, but the other N-terminal mutations had minimal effect on propagation of s.d. 
high [RNQ+] (Figure 4B). By contrast, the A3 mutant cured the m.d. high [RNQ+] variant, while 
the A1 mutant resulted in a shift in aggregate size. These data show that particular regions within 
the non-PFD N-domain have differential roles on prion propagation depending on what [RNQ+] 
variant is present. This indicates that this domain helps define the physical basis of distinct 
[RNQ+] variants. 
Prion-forming domains are historically considered the region that forms the amyloid core 
of prion aggregates [73,80]. As such, PFDs are predicted to encode variant-specific differences, 
as is the case for weak and strong [PSI+] [26,176,180]. Indeed, we have previously shown that 
deletion of part of the Rnq1-PFD differentially affects the propagation of some [RNQ+] variants 
[78]. Hence, we expected to uncover conformation-specific effects with mutation of the 
amyloidogenic regions in the Rnq1-PFD. We found that mutation of the A11 region affected 
propagation of all of the [RNQ+] variants, but to varying degrees. For instance, the A11 mutant 
was the only mutant that cured s.d. low [RNQ+] (Figure 4C). On the other hand, none of the PFD 
alanine mutants cured s.d. medium [RNQ+], only mutation of the N-terminal A3 region did 
(Figure 4D). This suggests that the A3 and A11 regions are the most important of the 
amyloidogenic regions for propagation of s.d. medium and s.d. low [RNQ+], respectively. 
Strikingly, disruption of 8 of the 11 amyloidogenic regions affected propagation of s.d. very high 
[RNQ+], with several alanine mutants quickly curing this variant (A1, A5, A10, A11) (Figure 
4E). Additionally, upon further growth, the s.d. very high [RNQ+] variant was also cured by 
mutation of the A2, A3, A4, and A9 regions. Importantly, loss of [RNQ+] was confirmed by the 
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absence of SDS-resistant aggregates by SDD-AGE after re-transforming a plasmid expressing 
WT Rnq1 and selecting for loss of the Rnq1 alanine mutant plasmid (Figure S6). 
Overall, it has previously been shown that different, non-adjacent Q/N-rich regions of the 
Rnq1 protein make differential contributions to [RNQ+] propagation [84]. Our data now show 
that a unique set of non-contiguous regions, even regions that are not Q/N-rich, defines the 
propagation of the [RNQ+] variants. This strongly supports the hypothesis that the [RNQ+] 
variants propagate distinct structural conformations and likely mediate differential induction of 
[PSI+] by exposing a different structural template.  
 
2.4.5 [RNQ+] variants have additional Sis1 binding sites 
We wanted to better understand the role that these putative amyloidogenic regions play in 
propagating the different conformations of [RNQ+]. We noted that most of these regions were 
primarily hydrophobic, with some regions being previously identified as separating the Q/N-rich 
regions of the Rnq1-PFD [84]. It was unsurprising that the prediction algorithms identified these 
regions, as hydrophobic residues are generally recognized as sites that facilitate protein 
interactions, whether normal or abnormal interactions [195]. We conjectured two predominant 
ways that mutation of these amyloidogenic regions could affect the prion replication cycle of 
[RNQ+]: 1) disrupting the aggregate structure, or 2) disrupting the ability of chaperones to bind 
the Rnq1 aggregates. Interestingly, one of the amyloidogenic regions of Rnq1, A3 (aa 92-102), 
was previously identified as containing a binding site for the Hsp40 chaperone Sis1 [37]. 
Disruption of this site using the Rnq1-L94A mutation impairs Sis1 binding and eliminates the 
[RNQ+] prion [37,75]. Moreover, the bacterial Hsp40 has been predicted to bind several different 
hydrophobic stretches in each protein of nearly the whole proteome [152,153]. In line with this, 
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we found that the ANCHOR algorithm, which predicts protein-binding sites in disordered 
stretches [196,197], identified all of our amyloidogenic regions (except the lone hydrophilic A9 
region) to be putative chaperone-binding sites (Figure 5A). As such, we first wanted to test 
whether Sis1 could bind other regions of Rnq1 outside of the known A3 binding site. To do this, 
we expressed Rnq1-PFD (which lacks the A3 binding site) in place of full-length Rnq1 in cells 
propagating each of the [RNQ+] variants. Upon immunoprecipitating Sis1, we found that Sis1 
could still bind the PFD of Rnq1 in [RNQ+] cells, but not in [rnq-] cells (Figure 5B), suggesting 
that some of the amyloidogenic regions in the Rnq1-PFD may serve as additional binding sites 
for Sis1. Interestingly, in contrast to Figure 1D in which Sis1 bound equal levels of full-length 
Rnq1 in all of the [RNQ+] variants, there was distinctly less Rnq1-PFD bound to Sis1 in the m.d. 
high [RNQ+] variant. While we confirmed that these cells were still [RNQ+] at this time point 
(data not shown), this suggests that propagation of the m.d. high [RNQ+] conformer might 
uniquely require the presence of the A3 binding site. Indeed, this would provide some 
mechanistic explanation for our finding that the Rnq1-PFD as part of RRP is not sufficient for 
propagation of the m.d. high [RNQ+] variant in particular (Figure 2E).  
 
2.4.6 Rnq1 amyloidogenic regions differentially contribute to the interaction of Sis1 with the 
[RNQ+] variants  
Since Sis1 only binds Rnq1 in [RNQ+] cells, it is challenging to distinguish whether loss 
of Sis1 binding results in curing [RNQ+], or if curing [RNQ+] by disrupting some other aspect 
required for prion propagation results in loss of Sis1 binding. As the A3 region was previously 
shown to be a major binding site for Sis1, we hypothesized that disruption of this region by the 
Rnq1-L94A mutation would provide a useful comparison for examining how mutation of the 
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amyloidogenic regions influences Sis1 binding and propagation of [RNQ+]. Therefore, to 
determine the effect of Rnq1-L94A on [RNQ+] propagation, we expressed Rnq1-L94A in place 
of WT Rnq1 in cells propagating each of the [RNQ+] variants and monitored the maintenance of 
[RNQ+] by SDD-AGE. Like the variant-specific differences we observed above, we found that 
Rnq1-L94A also differentially affected the [RNQ+] variants: s.d. very high [RNQ+] could still 
propagate while the other four [RNQ+] variants were cured (Figure 5C). However, upon growing 
cells additional generations, we found that s.d. very high [RNQ+] was eventually cured as well 
(data not shown). This delayed curing suggests that s.d. very high [RNQ+] does not rely on the 
L94 Sis1 binding site in the A3 region to the same extent as the other [RNQ+] variants. 
Importantly, over-expressing Sis1 before replacing WT Rnq1 with Rnq1-L94A rescued 
propagation of the [RNQ+] variants, as an SDS-resistant species was still maintained (Figure 5C) 
and was transmissible (data not shown). Therefore, these data indicate that over-expression of 
Sis1 compensates for the disruption of Sis1 binding caused by the Rnq1-L94A mutation. 
In using Rnq1-L94A as a model of how disruption of Sis1 binding affects [RNQ+], we 
hypothesized that if mutation of the Rnq1 amyloidogenic regions impaired the binding of Sis1, 
then Sis1 over-expression would at least partially rescue the propagation of the [RNQ+] variants. 
As a corollary, we postulated that if the mutations instead disrupted the Rnq1 aggregate 
structure, then these mutants would still cure [RNQ+] despite Sis1 being over-expressed. 
Therefore, as we did using Rnq1-L94A, we over-expressed Sis1 before replacing WT Rnq1 with 
the alanine mutants and tested whether propagation of the [RNQ+] variants was rescued using 
SDD-AGE to monitor the presence of SDS-resistant aggregates. As expected from our data with 
Rnq1-L94A, Sis1 over-expression rescued the propagation of m.d. high [RNQ+] and s.d. medium 
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[RNQ+] that were both cured by mutation of the A3 region, which encompasses L94 (Figure 
5D).  
Propagation of s.d. very high [RNQ+], on the other hand, was impaired by mutation of 
several different amyloidogenic regions (Figure 4). This allowed us to gain a more complete 
picture of how multiple regions of Rnq1 influence propagation of this prion variant. Strikingly, 
Sis1 over-expression differentially rescued propagation with these mutants, even when 
comparing N-terminal and C-terminal mutants (Figure 5E). Sis1 over-expression did not rescue 
s.d. very high [RNQ+] propagation when the A4, A5, or A11 regions were mutated to alanine. 
This suggests that these regions likely disrupt the aggregate structure of s.d. very high [RNQ+], 
thereby impairing the recruitment and conversion of monomeric Rnq1. By contrast, Sis1 over-
expression did rescue the propagation of s.d. very high [RNQ+] when the N-terminal A1, A2, 
and A3 regions were mutated, along with the C-terminal A9 and A10 regions. Thus, these data 
support our hypothesis that mutation of these regions impairs Sis1 binding, which is overcome 
by Sis1 over-expression.  
In order to more finely monitor the degree to which Sis1 over-expression rescued 
propagation of s.d. very high [RNQ+], we determined the amount of soluble Rnq1 using a well-
trap assay. As SDD-AGE does not allow us to consistently visualize monomeric Rnq1, the well-
trap assay provided a more sensitive measure of soluble Rnq1, and hence, of how much of the 
Rnq1 protein is not incorporated into aggregates. In agreement with our results using SDD-AGE, 
we found that in cells originally propagating the s.d. very high [RNQ+] variant, all of the Rnq1 
protein of the A4, A5, and A11 mutants was in soluble form when Sis1 was over-expressed, and 
could enter the SDS-PAGE gel in the fraction that was not boiled (Figure 5F). At the other end 
of this spectrum, all of the Rnq1 protein was in its aggregated form with the A3 and A10 
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mutants, thus phenocopying WT Rnq1. Mutation of the A1, A2, and A9 regions, on the other 
hand, resulted in an intermediate amount of soluble Rnq1 when Sis1 was over-expressed. These 
data show that Sis1 over-expression rescues propagation of s.d. very high [RNQ+] to widely 
varying degrees when the different amyloidogenic regions are mutated. We hypothesize that 
mutation of the A1, A2, and A9 regions likely allosterically impact Sis1 binding, and so are only 
partially rescued by Sis1 over-expression. The A3 and A10 regions, on the other hand, may 
represent direct binding sites for Sis1 in the context of the s.d. very high [RNQ+] conformation. 
In fact, the peptide-binding array that discovered the affinity of Sis1 for the L94 region (A3) of 
Rnq1 also showed some affinity, albeit weaker, for the A10 region [37]. This further supports 
our hypothesis that the [RNQ+] variants expose different parts of the Rnq1 protein to interact 
with Sis1. 
 
2.4.7 [RNQ+] variant conformation dictates dependence on Sis1 binding sites 
 The data above suggest that propagation of the s.d. very high [RNQ+] variant likely relies 
on Sis1 binding to both the A3 and A10 regions. The other [RNQ+] variants, however, clearly 
show a difference in the importance of these regions for prion replication. Both the s.d. medium 
and m.d. high [RNQ+] variants were cured when the A3 region was mutated, but these 
conformations could still propagate with the A10 mutant (Figure 4). By contrast, mutation of 
neither of these regions eliminated the aggregates of s.d. low or s.d. high [RNQ+]. As such, we 
hypothesized that the A3 and A10 regions might have some redundancy with these [RNQ+] 
variants, whereby the A10 region serves as another Sis1 binding site, as our data suggest for s.d. 
very high [RNQ+], albeit to a lesser degree. To test this, we created the double mutant of Rnq1 
having both the A3 and A10 regions mutated to alanine, termed Rnq1-A3+A10. We then 
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replaced WT Rnq1 and confirmed similar expression (Figure S4). Upon continual growth, we 
monitored how quickly [RNQ+] was cured using SDD-AGE. Interestingly, mutation of both 
regions cured s.d. low and s.d. high [RNQ+], but at different rates: s.d. high [RNQ+] was cured 
much faster than s.d. low [RNQ+] (Figure 6). Furthermore, the double mutant cured both s.d. 
medium and m.d. high [RNQ+] faster than either single mutant (data not shown). These results 
indicate that both putative Sis1 binding sites in the A3 and A10 regions influence propagation of 
the [RNQ+] variants, but the extent to which these regions are utilized is variant-specific. 
  
2.4.8 Rnq1 amyloidogenic regions have [RNQ+] variant-dependent effects on [PSI+] formation 
 By identifying the Rnq1 amyloidogenic regions as major factors in distinguishing the 
ability of the [RNQ+] variants to propagate, we next wanted to determine whether these 
differences had any functional consequence on the differential ability of the [RNQ+] variants to 
induce [PSI+]. We envisioned two ways that these regions could affect the formation of [PSI+] 
in a variant-specific manner: 1) through mediating the differential binding of Sis1, where Sis1 
plays a role in facilitating interaction with Sup35, and 2) having a different set of Rnq1 residues 
that facilitate the interaction with Sup35 through cross-seeding. 
 To test the first possibility, we asked whether over-expression of Sis1 would enhance the 
rate of spontaneous [PSI+] formation, as it has been shown to do for [URE3] [115]. The 
spontaneous conversion to [PSI+] is normally a rare event, occurring at a rate of ~5.8x10-7 [56]. 
We transformed [rnq-] [psi-] cells or [psi-] cells propagating m.d. high, s.d. high, or s.d. very 
high [RNQ+] with a plasmid that over-expressed Sis1 or an empty vector control. We then 
selected for nonsense suppressors and screened for cells that had spontaneously converted to 
[PSI+]. We found that Sis1 over-expression significantly increased the level of spontaneous 
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[PSI+] formation in [RNQ+] cells, but not in [rnq-] cells (Figure 7A). The apparent increase in 
[PSI+] formation was not due to any noticeable difference in the distribution of [PSI+] variants 
obtained (data not shown). Moreover, there were no significant differences in the levels of 
Hsp104 or Ssa, both of which are known to modulate the existence of [PSI+] (Figure S7) 
[94,198]. This indicates that Sis1 helps facilitate the formation of [PSI+], thereby suggesting that 
the differential interaction between Sis1 and the [RNQ+] variants might contribute to their 
different capabilities of cross-seeding Sup35. 
Next, we wanted to determine if the [RNQ+] variants might have different regions of 
Rnq1 involved in facilitating [PSI+] formation. Previously, we have shown that some mutations 
in Rnq1 that have no detectable effect on the Rnq1 aggregate structure can decrease the ability of 
[RNQ+] to induce [PSI+] [78]. This suggested that these residues are involved in facilitating the 
interaction and cross-seeding of Sup35 to form [PSI+]. Thus, we asked whether disruption of the 
Rnq1 amyloidogenic regions would show variant-specific effects on [PSI+] induction. In cells 
propagating each of the [RNQ+] variants and harboring the Rnq1 alanine mutants in place of WT 
Rnq1, we over-expressed Sup35, which greatly enhances the de novo formation of [PSI+]. We 
then analyzed [PSI+] formation by monitoring growth on media lacking adenine. Strikingly, we 
found that disruption of the Rnq1 amyloidogenic regions had a variety of effects on [PSI+] 
induction (Figures 7B-E and S8). As we expected, we found that some mutations that affected 
[RNQ+] also affected the formation of [PSI+]. For instance, mutation of the N-terminal A1 
region affected propagation of all of the [RNQ+] variants. While we anticipated that this 
destabilization would cause decreased formation of [PSI+], it actually enhanced [PSI+] 
formation for the s.d. low, s.d. medium, and m.d. high [RNQ+] variants, as we saw an increase in 
Ade+ colonies (Figure 7B). By contrast, mutation of the A7 region had very little effect on 
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propagation of any of the [RNQ+] variants, but it enhanced [PSI+] induction in most of them 
(Figure 7C). This suggests that this region might have general importance in facilitating the 
interaction with Sup35. Moreover, disruption of the A9 region showed quite varied effects, 
greatly decreasing [PSI+] formation with s.d. high [RNQ+], but increasing it with s.d. low and 
m.d. high [RNQ+] (Figure 7D), despite not grossly affecting the overall structures of these three 
[RNQ+] variants (Figure 4A). Overall, these variant-specific effects indicate that the [RNQ+] 
variants have different regions of the Rnq1 protein that are important for [PSI+] induction 
(Figure 7E). Moreover, these regions are not confined to the Rnq1-PFD.  
 
2.5 Discussion 
 It has previously been shown that a single amyloidogenic protein, Rnq1, can form a wide 
variety of different prion variants, many of which differentially influence the formation of [PSI+] 
[31,32]. Similarly, it is estimated that PrPSc likely exists in over 30 different prion strains [172]. 
However, the physical and mechanistic basis underlying different prion strains and their 
associated phenotypes has only been elucidated using two variants of the [PSI+] prion. Our work 
reveals additional layers of complexity that help explain the widespread diversity of amyloid 
polymorphism and phenotypic variation. Here, we show in vivo that different amyloidogenic 
regions, both within and outside of the putative PFD, as well as different interactions with 
cofactors, are key determinants in distinguishing, and likely generating, distinct prion variants. 
This provides significant insight into how certain prion strains can be biochemically 
indistinguishable, but confer different pathological consequences [30]. 
Previous work has emphasized the importance of fiber stability in distinguishing prion 
variants [25,27,33,69,182]. The less stable Sup35 fibers of strong [PSI+] cause increased 
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fragmentation into a greater number of smaller prion seeds that recruit more Sup35 monomer 
[25]. Similarly, less stable prion strains of PrPSc correlated with shorter incubation periods 
[27,182]. In this study, we show a similar trend with the m.d. high [RNQ+] variant. This [RNQ+] 
variant propagated less stable Rnq1 aggregates as compared to the s.d. [RNQ+] variants (Figure 
1A). This correlated with several properties that show that m.d. high [RNQ+] cells readily 
sequester Rnq1 monomer: solubility [31], mitotic stability, [RRP+] phenotype, and inviability 
with FL RRP (Figure 2). Hence, we propose that the decreased stability of m.d. high [RNQ+], 
like strong [PSI+], results in an increased number of propagons, as previously reported [184], 
which then enhances the ability of Rnq1 monomer to join pre-existing aggregates.  
However, the decreased fiber stability does not explain all the properties of m.d. high 
[RNQ+], nor all the differences between the [RNQ+] variants. Despite the lower stability, which 
is predicted to increase fiber fragmentation into smaller aggregates, m.d. high [RNQ+] 
propagated aggregates of a larger average size than other [RNQ+] variants (Figure 1C). Also, 
both s.d. high and s.d. very high [RNQ+] were more thermal stable, which is predicted to cause 
less nonsense suppression, but these variants caused a similarly strong nonsense suppression 
phenotype as compared to m.d. high [RNQ+] (Figures 1 and 2). Therefore, our data suggest that 
thermal stability, while a crucial parameter, does not serve as a perfect measure of fiber 
fragmentation, and cannot explain the existence of many different aggregate structures, nor the 
large variability in phenotype. Moreover, our work and that of another group show that many 
additional properties that helped elucidate the physical basis of [PSI+] variants, similarly do not 
distinguish the [RNQ+] variants and their phenotypic effects on [PSI+] [31,32,108,184]. These 
data indicate that additional factors influence prion strain propagation and the resulting 
phenotypes, and highlight the wide variety of polymorphic structures that can exist [44], with 
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[PSI+] and [RNQ+] variants possibly exhibiting different types of polymorphism (e.g. packing 
versus segmental).  
Several studies have examined the primary structural elements that are important for 
prion propagation, with particular emphasis on the prion-forming domains. A different length of 
the same stretch of contiguous residues of Sup35 was found to be protected in the amyloid 
structure of different [PSI+] variants [26]. Other work has shown that prion transmission 
involves the differential contribution and cooperation of discontinuous intragenic regions of the 
Rnq1-PFD [84]. Our data extend these findings, as we showed that disruption of certain 
discontinuous amyloidogenic regions in the Rnq1-PFD show variant-specific effects on [RNQ+] 
propagation (Figures 4 and S5). For instance, mutation of the A11 region, despite impairing 
propagation of all the [RNQ+] variants we analyzed, did so to varying degrees. Also, mutation of 
the A9 region eliminated s.d. very high [RNQ+] and affected propagation of s.d. medium 
[RNQ+], but had no noticeable impact on the other [RNQ+] variants, in agreement with some of 
our previous work [78]. Importantly, there were no reproducibly significant differences in 
protein expression of the alanine mutants that could explain their differential effects (Figure S4). 
Hence, these data clearly establish that the involvement and cooperation of non-adjacent regions 
of the PFD can vary with the type of prion variant that propagates.  
In addition to the Rnq1-PFD, we found that the often-overlooked N-terminal non-Q/N-
rich domain of Rnq1 has a prion variant-dependent influence on prion propagation (Figures 2 
and 4). Sequences flanking the aggregation-prone part of proteins, even between regions that are 
far apart in the primary structure, have previously been implicated in influencing aggregation 
dynamics [188,199-205]. For instance, amyloid fibers formed with Sup35NM as compared to 
those formed with full-length Sup35 have morphologically and biochemically distinct properties 
 61 
[206-208]. Similarly, it was recently shown that the region outside of the amyloid core has 
different structural dynamics for different [PSI+] variants [38]. Two models have been proposed 
to explain how regions outside the PFDs may be involved in amyloid assembly and propagation: 
1) serving to dock monomers, with the PFD forming the amyloid core and the non-PFD outside, 
or 2) incorporating within the core of the fiber assembly itself [188]. Our data strongly suggest 
that the non-PFD domain of Rnq1 helps facilitate monomer addition into aggregates (Figure 2). 
However, we also show that mutation of N-terminal amyloidogenic regions differentially 
disrupted propagation of the [RNQ+] variants (Figure 4). Hence, we propose that both of these 
models could be correct, depending on what prion variant is propagating. In fact, as our work 
indicates that regions outside the unstructured Q/N-rich domains can have a major influence on 
propagation of particular prion variants, our data may help explain particular inconsistencies 
when using the full-length protein or truncated derivatives to examine the in vivo and in vitro 
properties of prion variants [118,184]. 
Along with the influence on prion propagation, we also show that different primary 
structural elements likely dictate different phenotypic and pathological ramifications of prion 
strains. We found that mutation of certain amyloidogenic regions of Rnq1 causes variant-
dependent alterations in the interaction with Sup35, thereby altering the degree of [PSI+] 
formation (Figures 7 and S8). In several cases, there was minimal to no detectable effect on 
maintenance of Rnq1 aggregates. Hence, while it is proposed that amino acid composition, rather 
than the exact sequence, is the primary driver of amyloid maintenance [209,210], our data 
suggest that even relatively subtle variation in primary sequence can have profound effects on 
some properties of prion variants, but not others. Therefore, we have now established that the 
contribution of different regions of an amyloidogenic protein can help account for the biological 
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differences seen between prion strains, such as the variation in [PSI+] formation mediated by the 
[RNQ+] variants. 
We also discovered a striking difference in the relationship of the [RNQ+] variants with 
Sis1. Mutation of the A10 region in the Rnq1-PFD eliminated the ability of only the s.d. very 
high [RNQ+] variant to propagate (Figure 4), but this was rescued by over-expression of Sis1 
(Figure 5), suggesting that the A10 region might be a secondary Sis1 binding site, in agreement 
with a previous peptide-binding array [37]. Interestingly, s.d. very high [RNQ+] was also the 
least affected by mutation of the known Sis1 binding site in the A3 region (using the Rnq1-L94A 
mutant). At the other end of this spectrum, s.d. medium [RNQ+] and m.d. high [RNQ+] were 
most sensitive to disruption of the A3 region, but there was no detectable effect when the A10 
region was mutated. In stark contrast, for s.d. low and s.d. high [RNQ+], it was only when both 
the A3 and A10 regions were mutated that these prion variants were eliminated, with 
propagation of s.d. high [RNQ+] being abolished faster than s.d. low [RNQ+] (Figure 6). 
Surprisingly, disruption of the known Sis1 binding site using the A3 mutant did not entirely 
phenocopy the effects of Rnq1-L94A. We hypothesize that this might be attributed, at least in 
part, to higher steady state levels of Rnq1-L94A (Figure S4), and possibly in addition, how the 
residues surrounding L94 that are mutated in the A3 mutant are involved in propagation of 
particular [RNQ+] variants. Collectively, while we cannot definitively exclude the possibility 
that the Rnq1 alanine mutants are affecting multiple factors important for prion propagation, our 
data strongly support the hypothesis that propagation of the [RNQ+] variants relies on Sis1 
differentially binding various sites exposed by the distinct Rnq1 aggregate structures. As we 
demonstrated that the over-expression of Sis1 can enhance the formation of [PSI+] in [RNQ+] 
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cells (Figure 7A), we propose that such differential binding may influence the phenotypic impact 
of the [RNQ+] variants on [PSI+] inducibility. 
It is suggested that similar chaperone dynamics might also influence the physical basis of 
[PSI+] variants. As Hsp104 can bind Sup35 in [PSI+] cells [90] and is required for propagation 
of the [PSI+] prion [94], one would predict that abrogation of the Hsp104 binding site in Sup35 
would eliminate the ability of [PSI+] to propagate. However, propagation of a strong [PSI+] 
variant was maintained, albeit impaired, when Hsp104 binding was disrupted using sup35!129-
148 [211]. This suggests that Hsp104 must be able to bind other sites in Sup35. Moreover, recent 
work shows that this binding site can adopt different conformations for different [PSI+] variants, 
which might influence Hsp104 binding [38]. In fact, particular [PSI+] variants have been isolated 
that require increased levels of Hsp104 to stably propagate [212,213]. Our work now provides a 
mechanistic explanation of these previous findings, supporting the hypothesis that different 
chaperone dependencies may be dictated by the exposure or conformation of different regions of 
the protein [214]. Indeed, these different amyloid-chaperone relationships likely explain why 
differences in the host environment, due to different genetic backgrounds or environmental 
conditions, can modulate prion propagation [41,215]. Moreover, our data support the hypothesis 
that different host cofactors might interact with different amyloid structures to influence 
pathology [39].  
With such a large variety of distinct structures that can be adopted with the same protein 
[42-44,172], it was unclear how general the model that elegantly explains the physical basis of 
[PSI+] variants might be. We found that the parameters that define this model do not distinguish 
a set of [RNQ+] variants or explain their phenotypic effects. Our work now shows that disparate, 
non-adjacent amyloidogenic regions and complex interactions with chaperones contribute to 
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defining the propagation of distinct prion variants. These data help elucidate what factors are 
involved in determining a wide array of structural differences and their associated phenotypic 
consequences. This may provide insight as to why some prion strains are indistinguishable based 
on typical biochemical properties, but have very different pathological phenotypes [30]. 
Furthermore, our study highlights the intricate interplay between several factors, including 
cofactor-amyloid interactions, which likely underlie the ability of distinct amyloid structures to 
co-aggregate with different proteins and cause variation in disease pathology.  
 
2.6 Materials and Methods  
2.6.1 Yeast Strains and Media 
All yeast strains used in this study were derivatives of 74-D694 (ade1-14 ura3-52 leu2-
3,112 trp1-289 his3-!200) and are described in Table S1. Yeast were grown and manipulated 
using standard techniques. As indicated, cells were grown in YPD (1% yeast extract, 2% 
peptone, 2% dextrose) or synthetic media (0.67% yeast nitrogen base without amino acids, 2% 
dextrose or 2% galactose+1% raffinose) lacking one or more nutrients (e.g. SD-his lacks 
histidine) to select for appropriate plasmids. YPD+3mM guanidine hydrochloride (GdnHCl) was 
used to test prion curability. The plasmid shuffle technique was used by plating cells on media 
containing 1mg/mL 5-fluoroorotic acid (5-FOA) to counterselect against cells that maintained 
URA3-containing plasmids. Reverse plasmid shuffle of WT Rnq1 was performed by 
transforming these Ura- cells with a URA3 plasmid, and screening for Ura+ His- cells. 
Wild-type [rnq-] and [RNQ+] yeast strains (L1751, L1943, L1945, L1767 [psi-], L1953, 
L1749) were a kind gift from Dr. Susan Liebman [31,108]. Derivatives of these strains 
expressing RRP were constructed as described previously using pRS306-RRP [78]. Integration of 
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RRP in the SUP35 locus was confirmed by PCR and western blot. The rnq1!::kanMX4 strains 
were made as described previously [78]. The sup35!::hphMX4 strains were made by first 
passaging Mat a and Mat " 74-D694 [PSI+] [RNQ+] sup35!::hphMX4 strains on YPD+3mM 
GdnHCl. These were confirmed to be [psi-] by maintaining a red color when streaked back to 
YPD, and also confirmed to be [rnq-] by well-trap assay. These strains were then mated to RNQ1 
plasmid shuffle strains containing pRS313-RNQ1 and propagating one of the [RNQ+] prion 
variants. Diploids were sporulated and colonies that were HygBR, Ura+, 5-FOAs, G418s, and 
His- were selected. The [RNQ+] variant was confirmed by well-trap assay and [PSI+] induction. 
 
2.6.2 Plasmid Construction 
 All plasmids used in this study were confirmed by sequencing and are listed in Table S2, 
and all oligonucleotides are listed in Table S3. Construction of pRS306-RRP, pRS313-RNQ1, 
pRS316-RNQ1, pRS413GPD-L94A, and pEMBL-SUP35 were described previously [32,75,78]. 
The following plasmids were gifts: pRS414GPD-SIS1 (S. Lindquist [74]), pYK810 (M. Tuite 
[83]), and pYES2-GAL-HA-RNQ1 (E. Craig [99]). Galactose-inducible RNQ1(153-405) was 
made by amplification using oligonucleotides 1626 and 0040, digestion with HindIII/XhoI, and 
ligation into pYES2-GAL-HA-RNQ1.  
 To create pRS315-SUP35 and pRS315-RRP, the SUP35 promoter was first amplified 
using oligonucleotides 1367 and 0316. This product and pRS315 were digested with SalI/BamHI 
and ligated to make pRS315-SUP35p. The SUP35 open-reading frame and terminator were then 
amplified using oligonucleotides 1348 and 0322, digested with BamHI/XbaI, and ligated into 
pRS315-SUP35p. A BamHI/SacI fragment of RRP was digested from pRS316-RRP that was 
previously described [78] and ligated into pRS315-SUP35p. To make pRS315-full-length-RRP, 
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full-length RNQ1 was amplified using oligonucleotides 0477 and 0320, digested with 
BamHI/SacII and ligated with pRS316-RRP. Full-length RRP with the SUP35 promoter and 
terminator were then amplified using oligonucleotides 1366 and 0322, digested with XhoI/SacI, 
and ligated into pRS315.  
 All RNQ1 alanine mutants were cloned using bridge PCR. The N-terminus of RNQ1 was 
amplified using oligonucleotide 0488 and the oligonucleotide containing the corresponding rnq1 
mutant. The C-terminus of RNQ1 was amplified using the reverse complement of the mutant-
specific oligonucleotide with 0489. The two amplicons were then used as a template to amplify 
the full-length rnq1 mutant using oligonucleotides 0488 and 0489. This product was digested 
with EcoRV/SalI and ligated into the previously described pRS313 plasmid containing the RNQ1 
promoter and terminator [78], thereby expressing the Rnq1 mutants at protein levels close to WT 
(Figure S4). As an exception, rnq1-A11 and the RNQ1 terminator were amplified using 
oligonucleotide 0491 in place of 0489 and digested with EcoRV/XhoI. The N-terminus of rnq1-
A3+A10 was amplified using oligonucleotides 0488 and 0018 with pRS413TPI1-rnq1-A3 as the 
template, while the C-terminus was amplified using oligonucleotides 0014 and 0489 with 
pRS313-rnq1-A10 as the template. Similar to what we previously saw with Rnq1-L94A [75], the 
rnq1 mutants A1, A3, and A3+A10 were cloned into pRS413TPI1 as these mutants had lower 
steady state protein levels as compared to WT Rnq1 when expressed from the endogenous RNQ1 
promoter. Expression from the TPI1 promoter resulted in slightly higher protein levels for Rnq1-
A1 as compared to WT Rnq1, but WT protein levels for Rnq1-A3 and Rnq1-A3+A10 (Figure 
S4). Furthermore, the A1, A2, and A11 mutants consistently ran higher than WT Rnq1 by SDS-
PAGE despite having the same number of amino acids. To make pRS413TPI1, the TPI1 
promoter was amplified using oligonucleotides 1429 and 1430, digested with SacI/XbaI, and 
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ligated into pRS413ADH cut with the same enzymes to replace the ADH1 promoter. Finally, 
pRS413TEF-RNQ1(132-405) was cloned with oligonucleotides 1436 and 0489 and digested with 
EcoRV/SalI. 
 
2.6.3 Protein Analysis  
Sedimentation of Rnq1 by solubility assay and SDD-AGE were performed using 
established methods [32,78]. For well-trap and thermal stability assays, yeast cell lysates were 
prepared by vortexing with glass beads in buffer (100mM Tris pH 7.5, 200mM NaCl, 1mM 
EDTA, 5% glycerol, 0.5mM DTT, 3mM PMSF, 50mM N-Ethylmaleimide (NEM), complete 
protease inhibitor from Roche). Lysates were pre-cleared by centrifugation at 3,300g for 15 sec. 
For well-trap assays, protein concentration was normalized, and samples were treated in sample 
buffer (50mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 100mM DTT) for 5 minutes at room 
temperature or 100°C. For thermal stability assays, samples were also incubated at a temperature 
gradient (45°C to 95°C) for 5 minutes. Samples were then analyzed by SDS-PAGE and western 
blot using a polyclonal "Rnq1 antibody. 
 
2.6.4 Limited Proteolysis 
[RNQ+] cell lysates were prepared as above for well-trap assays, with the exception of 
adding PMSF to the buffer. Protein concentration was normalized to ~3µg/µl, followed by 
addition of proteinase K (Sigma-Aldrich) to varying concentrations. Samples were incubated at 
37°C in a water bath for 30 min or 1 hr as indicated. The reaction was stopped by adding sample 
buffer and boiling samples at 100°C for 5 min, followed by SDS-PAGE and western blot using 
an "Rnq1 antibody. Cell lysates propagating the m.d. high [RNQ+] variant consistently showed 
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higher starting concentrations of the Rnq1 protein, likely because the very thermal stable Rnq1 
aggregates of s.d. [RNQ+] were not completely broken down. 
 
2.6.5 Immunoprecipitation 
 For co-immunoprecipitation of Sis1 and Rnq1, cultures were grown overnight, washed, 
and lysed by vortexing in buffer (50mM Tris pH 8, 150mM NaCl, 1mM EDTA, 0.2% Triton X-
100, 1mM PMSF, 50mM NEM, complete protease inhibitor from Roche) containing glass beads. 
Lysates were pre-cleared by centrifugation at 9,300g for 30 sec at 4°C. Protein was normalized 
to 1mg/mL. Following incubation with or without "Sis1 antibodies for 1 hr at 4°C, Protein G 
Sepharose (GE Healthcare) beads were added and incubated for 1 hr at 4°C. Beads were pelleted 
by centrifugation at 800g for 30 sec, followed by washing three times, and boiling at 100°C for 5 
min. Samples were analyzed by SDS-PAGE and western blot using "Rnq1 and "Sis1 antibodies. 
 
2.6.6 Phenotypic Colorimetric Assays 
 Taking advantage of the ability of [RNQ+] cells harboring RRP to suppress ade1-14, we 
monitored [RRP+] phenotypes as done previously [32]. Equal numbers of cells were normalized 
by OD600, serially diluted five-fold, and spotted to the indicated media. SD-ade plates were 
incubated at 30°C for 6 days, while all other types of media were incubated for 3 days, followed 
by overnight at 4°C for color development. Mitotic stability assays were performed as before 
with at least three independent cultures for each [RNQ+] variant [33].  
 
2.6.7 Joining Assay 
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 Cells were transformed with pYES2-GAL-HA-RNQ1 or pYES2-GAL-RNQ1(153-405). 
Overnight cultures grown in glucose-based selection media were washed and diluted to OD600 
0.3 in induction media containing 2% galactose + 1% raffinose, followed by harvesting after 3 
hrs of growth. Cell lysates were prepared and analyzed by well-trap assay.  
 
2.6.8 [PSI+] Formation 
 To monitor the spontaneous conversion to [PSI+], cells were first transformed with 
pRS414GPD-SIS1 or an empty vector control. Then, using suppression of ade1-14 to monitor 
[PSI+] formation, at least three independent cultures were grown overnight and 200µl of culture 
was plated on SD-ade-trp and 200µl of a 1:10,000 dilution was plated on SD-trp. SD-ade-trp 
plates were grown overnight at 30°C, followed by two weeks at 4°C, then two weeks at 30°C, as 
it has been reported that cold enhances prion formation [60]. To calculate the number of cells 
plated on SD-ade-trp, the colonies on SD-trp were counted, averaged, and multiplied by the 
dilution factor of 10,000. Over 7.1x106 cells were plated on SD-ade-trp for each condition. Ade+ 
colonies were then scored as [PSI+] by spotting to YPD and SD-ade, as well as YPD+3mM 
GdnHCl to confirm curability. The rate of [PSI+] formation was then calculated as the ratio of 
[PSI+] colonies to the total number of cells plated. 
The induction of [PSI+] by over-expression of Sup35 was performed as previously 
described [32]. Briefly, cells expressing the indicated Rnq1 construct were transformed with 
pEMBL-SUP35. Overnight cultures were normalized by OD600 and spotted in five-fold serial 
dilutions to SD-his, SD-ade, and SD-ade-his. At least five independent experiments were 
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Figure 1. Biophysical parameters associated with fiber fragmentation do not distinguish 
[RNQ+] variants. (A) Rnq1 aggregates of s.d. [RNQ+] variants have similar thermal stability 
and are more stable than m.d. high [RNQ+]. Lysates were treated with a temperature gradient, 
followed by SDS-PAGE and western blot using an "Rnq1 antibody. Rnq1 was quantified using 
ImageJ, normalized to the 100°C band, and plotted using Origin 9.0 software. Data are 
representative of at least five independent experiments. (B) Rnq1 aggregates of m.d. high 
[RNQ+] have increased protease resistance as compared to the s.d. [RNQ+] variants. Lysates of 
[rnq-] cells or cells propagating the indicated [RNQ+] variant were incubated with 2µg/mL 
proteinase K (PK) at 37°C for 1 hr, followed by SDS-PAGE and western blot with an "Rnq1 
antibody. (C) Relative Rnq1 aggregate distribution for each [RNQ+] variant does not correlate to 
rate of [PSI+] induction. Lysates of yeast cells propagating s.d. low, s.d. medium, s.d. high, s.d. 
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very high, and m.d. high (m.d.) [RNQ+] were subjected to SDD-AGE and western blot using an 
"Rnq1 antibody. Data are representative of at least three independent experiments. (D) Co-
immunoprecipitation of Sis1 and Rnq1. Sis1 was immunoprecipitated from cell lysates using an 
"Sis1 antibody (gift from E. Craig), analyzed by SDS-PAGE, and immunoblotted with "Rnq1 
and "Sis1 antibodies. The input of the total cell lysate (I) represents 10% of the sample that was 
bound by the "Sis1 antibody (B). The bound fraction from the same sample not incubated with 




Figure 2. The non-prion forming domain of Rnq1 shows variant-specific influence on fiber 
growth. (A) Higher [RNQ+] variants confer stronger [RRP+] phenotypes. Cells harboring RRP 
and the indicated [RNQ+] variant were normalized by OD600, serially diluted five-fold, and 
spotted onto YPD, SD-ade, and YPD+3mM GdnHCl (GdnHCl). Representative spottings are 
 74 
shown. (B) Mitotic stability of [RNQ+] variants. Averages indicate the percentage of colonies 
that lost [RRP+] and error bars represent standard error of the mean calculated from at least three 
independent experiments. (C) Expression of full-length (FL) RRP in m.d. high [RNQ+] cells is 
lethal. Normalized numbers of yeast cells propagating s.d. high [RNQ+], m.d. high [RNQ+], or 
cured of m.d. high [RNQ+], and expressing Sup35, RRP, or FL RRP were serially diluted five-
fold and spotted to select for loss (- Sup35) or co-expression (+ Sup35) of wild-type Sup35. 
Representative spottings are shown. (D) Rnq1-PFD readily joins pre-existing Rnq1 aggregates of 
m.d. high [RNQ+] as compared to s.d. [RNQ+] variants. Cells transformed with plasmids 
expressing HA-RNQ1 or RNQ1-PFD from the GAL1 promoter were subcultured in galactose 
media. Lysates were incubated for five minutes at 100°C (+) or at room temperature (-), followed 
by SDS-PAGE and western blot using an "Rnq1 antibody. Data are representative of three 
independent experiments. (E) RRP is not sufficient to propagate m.d. high [RNQ+] without 
expression of Rnq1. Normalized numbers of rnq1! cells harboring RRP were serially diluted 
five-fold and spotted to select for maintenance of Rnq1 expression (+ Rnq1), or loss of Rnq1 (- 
Rnq1) on media to monitor color (5-FOA) and nonsense suppression (SD-ade+5-FOA) 
phenotypes. Representative spottings are shown. (F) Loss of Rnq1 results in altered [RRP+] 
phenotypes. Normalized numbers of rnq1! cells harboring RRP that lost Rnq1 expression, as 
shown in (E), were serially diluted five-fold and spotted onto YPD, SD-ade, and GdnHCl media 




Figure 3. Consensus amyloidogenic regions of Rnq1 identified by prediction algorithms. 
(A) Diagram of the Rnq1 protein highlighting the N-terminal domain (N) between residues 1-
152, the putative prion-forming domain (PFD) between 153-405, and the identified 
amyloidogenic regions. (B) Residues and sequences of the predicted amyloidogenic regions and 
which algorithm identified that region: 1) Zyggregator (http://www-
vendruscolo.ch.cam.ac.uk/zyggregator.php); 2) PASTA (http://biocomp.bio.unipd.it/pasta/); 3) 




Figure 4. Distinct regions of Rnq1 are important for each [RNQ+] variant. (A) Summary of 
how disruption of the amyloidogenic regions by alanine mutations affects propagation of the 
[RNQ+] variants. Mutants are categorized as having no effect (white), mild effect (yellow), 
moderate effect (orange), or not propagating [RNQ+] (red) after successive passaging. These 
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effects on [RNQ+] propagation were summarized from at least three independent experiments of 
each of the following assays: solubility assay, thermal stability, and SDD-AGE. See Figure S5 
for more detail. If only one assay showed mild effects, e.g. SDD-AGE of s.d. low [RNQ+] cells 
harboring the A6 mutant, this was scored as having no effect in this summary table. (B) Mutation 
of the Rnq1 N-terminal domain shows [RNQ+] variant-dependent effects. Lysates from cells 
propagating s.d. high or m.d. high [RNQ+] and expressing wild-type (WT) Rnq1 or the N-
terminal alanine mutants (A1 - A5) were resolved by SDD-AGE, followed by western blot using 
an "Rnq1 antibody. (C – E) Mutation of Rnq1 amyloidogenic regions differentially affects 
[RNQ+] variants. Yeast lysates propagating (C) s.d. low [RNQ+], (D) s.d. medium [RNQ+], or 
(E) s.d. very high [RNQ+] expressing WT Rnq1 or the set of alanine mutants (A1 - A11) were 




Figure 5. Rnq1 amyloidogenic regions differentially modulate interactions with Sis1. (A) 
Prediction of protein interaction sites in Rnq1 using the ANCHOR algorithm 
(http://anchor.enzim.hu/). Denoted at the top are the amyloidogenic regions A1 – A11. (B) Co-
immunoprecipitation of Sis1 and Rnq1(132-405). Sis1 was immunoprecipitated using an "Sis1 
antibody (gift from E. Craig) from cell lysates expressing Rnq1(132-405) in place of WT Rnq1, 
followed by SDS-PAGE and immunoblotting with "Rnq1 and "Sis1 antibodies. The input of the 
total cell lysate (I) represents 10% of the sample that was bound by the "Sis1 antibody (B). The 
bound fraction from the same sample not incubated with antibody (N) was used as a control. (C) 
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Rnq1-L94A differentially affects [RNQ+] variant propagation and is rescued by Sis1 over-
expression. Cell lysates with (+) or without (-) over-expression (OE) of Sis1 and propagating the 
indicated [RNQ+] variant with WT Rnq1 or Rnq1-L94A were subjected to SDD-AGE and 
western blot using an "Rnq1 antibody. (D – F) Elimination of [RNQ+] by mutation of Rnq1 
amyloidogenic regions is differentially rescued by Sis1 over-expression. As in (C) for (D) cells 
propagating s.d. medium [RNQ+] or m.d. high [RNQ+] and expressing WT Rnq1 or the A3 
mutant, or (E) cells propagating s.d. very high [RNQ+] expressing WT Rnq1 or mutants A1 - A5 
or A9 - A11. (F) Yeast lysates propagating s.d. very high [RNQ+], over-expressing Sis1, and 
expressing WT Rnq1, or mutants A1 - A5 or A9 - A11 were incubated for five minutes at 100°C 
(+) or at room temperature (-), followed by SDS-PAGE and western blot using an "Rnq1 




Figure 6. [RNQ+] variants rely on putative Sis1 binding sites to different extents. 
Propagation of s.d. high [RNQ+] is eliminated faster than s.d. low [RNQ+] when Rnq1-A3+A10 
is expressed. Yeast cells propagating the indicated [RNQ+] variant and expressing either WT 
Rnq1 or Rnq1-A3+A10 were successively passaged three or six times after plasmid shuffle. Cell 
lysates were subjected to SDD-AGE and western blot using an "Rnq1 antibody, and are 




Figure 7. Sis1 over-expression and Rnq1 amyloidogenic regions influence the formation of 
[PSI+]. (A) Over-expression of Sis1 enhances the spontaneous formation of [PSI+] in [RNQ+] 
cells. [rnq-] [psi-] and [RNQ+] [psi-] cells were transformed with a Sis1 over-expressing plasmid 
(Sis1 OE) or an empty vector control (EV). Cultures were plated on medium that selected for 
[PSI+] cells as well as a non-selective medium to determine the total number of cells plated. 
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Averages and error bars representing standard error of the mean were calculated from at least 
three independent experiments. Statistical significance was assessed using Student’s t-test (*p < 
0.05, **p < 0.01). (B – E) Cells expressing WT Rnq1 or the indicated mutant Rnq1 were 
transformed with a plasmid to over-express Sup35. [PSI+] induction was monitored by spotting 
five-fold serial dilutions of normalized cell numbers on SD-ade and SD-ade-his. Representative 
spottings are shown of cells expressing the mutants (B) A1, (C) A7, or (D) A9 in comparison to 
expression of WT Rnq1. (E) Summary of data showing how disruption of the amyloidogenic 
regions by alanine mutations affects [PSI+] induction in each of the [RNQ+] variants. Mutants 
were categorized as having no effect (white), < 5-fold increase (green) or decrease (orange) in 
[PSI+] induction, or > 5-fold increase (blue) or decrease (red) in [PSI+] induction. Black boxes 
indicate that [RNQ+] was eliminated, while black hash marks indicate that [RNQ+] propagation 
was altered (see Figure 4). Data are summarized from at least five independent experiments. 
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2.9 Supplemental Figures and Tables 
 
Figure S1. Differential proteinase K resistance of Rnq1 in [RNQ+] variants. Rnq1 
aggregates of the m.d. high [RNQ+] variant reproducibly show enhanced protease resistance as 
compared to s.d. [RNQ+] variants. Lysates of cells propagating the indicated [RNQ+] variant 
were incubated with a gradient of different proteinase K (PK) concentrations at 37°C for 30 min, 
followed by SDS-PAGE and western blot analysis using an "Rnq1 antibody. 
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Figure S2. Inviability of FL RRP in m.d. high [RNQ+] cells depends on Rnq1 expression. 
Cultures of three different clones of rnq1! cells propagating m.d. high [RNQ+], along with 
controls of [rnq-] cells, cells cured of m.d. high [RNQ+], and m.d. high [RNQ+] cells, all 
expressing FL RRP were normalized by OD600, serially diluted five-fold, and spotted on media to 
select for loss (- Sup35) or co-expression (+ Sup35) of wild-type Sup35. Representative 
spottings are shown. 
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Figure S3. Expression of FL RRP in cells propagating s.d. [RNQ+] variants. Cultures of 
[rnq-] cells or cells propagating s.d. low, s.d. medium, or s.d. very high [RNQ+] and expressing 
Sup35, RRP, or full-length (FL) RRP were normalized by OD600, serially diluted five-fold, and 
spotted to select for loss (- Sup35) or co-expression (+ Sup35) of wild-type Sup35. 
Representative spottings are shown. 
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Figure S4. Protein expression of Rnq1 alanine mutants. Normalized protein from cell lysates 
expressing the indicated Rnq1 alanine mutant, or an empty vector (EV), in place of WT Rnq1, 





Figure S5. Summary of effects on [RNQ+] propagation by mutation of Rnq1 amyloidogenic 
regions according to assay. For the indicated assay, mutants are categorized as having no effect 
(white), mild effect (yellow), moderate effect (orange), or not propagating [RNQ+] (red) after 
successive passaging. (A) Examples of how the Rnq1 solubility assay was scored. Cells 
propagating m.d. high [RNQ+] (m.d.), s.d. low [RNQ+] (Low), or s.d. very high [RNQ+] (VH), 
and harboring either wild-type (WT) Rnq1 or the indicated Rnq1 alanine mutant, were 
fractionated by high-speed ultracentrifugation into total (T), supernatant (S), and pellet (P) 
fractions, followed by SDS-PAGE and western blot using an "Rnq1 antibody. Mutants were 
characterized as follows: 1) mild effect, if there was a slight increase in the amount of soluble 
Rnq1; 2) moderate effect, if the supernatant and pellet fractions contained roughly equal amounts 
of Rnq1; or 3) cured, if all of Rnq1 accumulated in the supernatant. (B) Examples of how the 
thermal stability of Rnq1 aggregates was scored. Cells propagating the indicated [RNQ+] variant 
with either WT Rnq1 or the indicated Rnq1 alanine mutant were lysed and treated with a 
temperature gradient, followed by SDS-PAGE and western blot using an "Rnq1 antibody. 
Mutants were characterized as follows: 1) mild effect, if there was a slight, but reproducible shift 
in the more intense bands; 2) moderate effect, if the number of intense bands shifted by four or 
more lanes; 3) cured, if there was roughly equal amounts of Rnq1 in each lane, which was 
confirmed by well-trap assay; or 4) more stable, if Rnq1 was reproducibly present in fewer lanes. 
(C) Summary table of the effects of Rnq1 mutants on [RNQ+] propagation. Unless the 
phenotypic change is noted, colors indicate: decreased aggregate densitometry (SDD-AGE), 
decreased stability (Thermal stability), or increased pool of soluble Rnq1 (Solubility assay). Data 




Figure S6. Disruption of Rnq1 amyloidogenic regions eliminates propagation of [RNQ+] 
variants. Cells originally propagating the indicated [RNQ+] variant and expressing WT Rnq1 or 
a Rnq1 alanine mutant from a HIS-marked plasmid (as in Figure 4) were transformed with a 
RNQ1 URA3-marked plasmid. These cells were then screened for loss of the indicated Rnq1 
construct in order to express WT Rnq1 from the URA3-marked plasmid as the only copy of 
Rnq1. For instance, P-WT and P-A3 refer to post (P) expression of the HIS-marked copy of WT 
Rnq1 and Rnq1-A3, respectively, and now both expressing WT Rnq1. The presence of Rnq1 
aggregates in these Ura+ his- cells was then monitored using SDD-AGE and western blot using 




Figure S7. Expression levels of Ssa and Hsp104 are unchanged when Sis1 is over-expressed. 
Cells with the indicated [RNQ+] status were transformed with a Sis1 over-expressing plasmid (+) 
or an empty vector control (-). Lysates were subjected to SDS-PAGE and western blot using 





Figure S8. Formation of [PSI+] is altered by mutation of Rnq1 amyloidogenic regions. [rnq-
] cells or cells propagating the indicated [RNQ+] variant and expressing WT Rnq1 or mutants 
(A) A2, (B) A3, (C) A4, (D) A5, (E) A6, (F) A8, (G) A10, or (H) A11 were transformed with a 
plasmid over-expressing Sup35. [PSI+] induction was monitored by spotting five-fold serial 
dilutions of normalized numbers of cells on SD-ade and SD-ade-his. Representative spottings 
from at least five independent experiments are shown.  
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Table S1. Yeast strains used in this study. 
Strain Description Reference 
1060 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC [rnq-] [78] 
693 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC s.d. low [RNQ+] [33] 
694 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC s.d. medium [RNQ+] [33] 
2311 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC s.d. high [RNQ+] This study 
2042 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC s.d. very high [RNQ+] This study 
459 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC m.d. high [RNQ+] [33,78] 
2043 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 [rnq-] This study 
2044 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 s.d. low [RNQ+] This study 
2045 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 s.d. medium [RNQ+] This study 
2369 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 s.d. high [RNQ+] This study 
2053 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 s.d. very high [RNQ+] This study 
2047 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::RMC rnq1!::kanMX4 m.d. high [RNQ+] This study 
1890 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] [rnq-] This study 
2259 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] s.d. low [RNQ+] This study 
2260 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] s.d. medium [RNQ+] This study 
2416 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] s.d. high [RNQ+] This study 
2262 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] s.d. very high [RNQ+] This study 
2261 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 sup35!::hphMX4 [psi-] m.d. high [RNQ+] This study 
2055 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 rnq1!::kanMX4 [psi-] [rnq-] This study 
831 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 rnq1!::kanMX4 [psi-] s.d. low [RNQ+] [78] 
833 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 rnq1!::kanMX4 [psi-] s.d. medium [RNQ+] [78] 
2310 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 This study 
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rnq1!::kanMX4 [psi-] s.d. high [RNQ+] 
2057 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 rnq1!::kanMX4 [psi-] s.d. very high [RNQ+] This study 
835 Mat " ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 rnq1!::kanMX4 [psi-] m.d. high [RNQ+] [78] 
L1751 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 [psi-] [rnq-] [31] 
L1943 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 [psi-] s.d. low [RNQ+] [31] 
L1945 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 [psi-] s.d. medium [RNQ+] [31] 
L1767 
[psi-] 
Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 
[psi-] s.d. high [RNQ+] [108] 
L1953 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 [psi-] s.d. very high [RNQ+] [31] 
L1749 Mat a ade1-14 ura3-52 leu2-3,112 trp1-289 his3-!200 [psi-] m.d. high [RNQ+] [31] 
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Table S2. Plasmids used in this study. 
Plasmid Description Reference 
5245 pRS306-RRP [78] 
6246 pRS315-SUP35 This study 
6501 pRS315-RRP This study 
6479 pRS315-full-length-RRP This study 
SL6602 pRS414GPD-SIS1 [74] 
6244 pEMBL-SUP35 This study 
5908 p413GPD-rnq1-L94A [75] 
6312 pRS313-RNQ1 [78] 
6352 pRS413TPI1-rnq1-A1 This study 
6392 pRS313-rnq1-A2 This study 
6389 pRS413TPI1-rnq1-A3 This study 
6322 pRS313-rnq1-A4 This study 
6411 pRS313-rnq1-A5 This study 
6477 pRS313-rnq1-A6 This study 
6478 pRS313-rnq1-A7 This study 
6397 pRS313-rnq1-A8 This study 
6165 pRS313-rnq1-A9 This study 
6398 pRS313-rnq1-A10 This study 
6416 pRS313-rnq1-A11 This study 
6548 pRS413TPI1-rnq1-A3+A10 This study 
6357 pRS413TEF-RNQ1(132-405) This study 
5195 pRS316-RNQ1 [78] 
5049 pYK810 [83] 
6545 pYES2-GAL-HA-RNQ1 [99] 
6613 pYES2-GAL-RNQ1(153-405) This study 
 
 96 
Table S3. Oligonucleotides used in this study. 
Oligonucleotide Description Sequence 
1366 5’ Sup35prom-XhoI 5'CGCCTCGAGGACGACGCGTCACAGTG 
1367 5’ Sup35prom-SalI 5'CGCGTCGACGACGACGCGTCACAGTG 
0316 3’Sup35prom-BamHI 5'CCCGGATCCTGTTGCTAGTGGGCAGATATAG 






0014 5'-TO-RNQ-4 5'GGTGGCAACGGTGGTTACC 
0018 3'-TO-RNQ-8 5'AAAGCACCACCAGATTGTCC 




0488 5' Rnq1-EcoRV 5'GGGGATATCATGGATACGGATAAGTTAATCTCAGAGG 
0489 3' Rnq1-SalI 5'CCCGTCGACTCAGTAGCGGTTCTGGTTGCCG 
0491 3' Rnq1 terminator-XhoI 5'CCCCTCGAGGCAACACATACCTTACAAAGC 
1429 5’ TPI1prom-SacI 5’GCGGAGCTCCTACGTATGGTCATTTCTTC 
1430 3’ TPI1prom-XbaI 5’GCGTCTAGATTTTAGTTTATGTATGTG 
1244 5' Rnq1-A1 5'CAAATGTCAACTATTGAATCAGCAGCTGCAGCAGCCGCAGCAGCCGCCATGGACAACCGTAGT 
1245 3' Rnq1-A1 5'CACCACTACGGTTGTCCATGGCGGCTGCTGCGGCTGCTGCAGCTGCTGATTCAATAGTTGACATTTG 
1472 5’ Rnq1-A2 5'GTGGTGGTGCAGCTGCTGCGGCCGCTGCAGCGGCAGACTCTAAGGGTTC 
1473 3’ Rnq1-A2 5'GAGTCTGCCGCTGCAGCGGCCGCAGCAGCTGCACCACCACCAGCAGCACG 
1442 5’ Rnq1-A3 5'GCAGCAGCAGCTGCGGCAGCCGCAGCGGCGGCACACTCATCAAATAAAGG 
1443 3’ Rnq1-A3 5'TGCCGCCGCTGCGGCTGCCGCAGCTGCTGCTGCTAGTTGCGTTTGGGAAG 
1426 5’ Rnq1-A4 5’CTTCTAACAGAGGGTTTGCCGCAGCGGCTGCCGCGGCAGCGGCAAGTGGTTCTGGCGGC 
1427 3’ Rnq1-A4 5’GCCGCCAGAACCACTTGCCGCTGCCGCGGCAGCCGCTGCGGCAAACCCTCTGTTAGAAG 
1474 5’ Rnq1-A5 5'GTGCTTCCGCCGCGGCTGCCGCGGCTGCTGCAGCCGCTAAGTCAGGTAACAATTCCC 
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1475 3’ Rnq1-A5 5'CTTAGCGGCTGCAGCAGCCGCGGCAGCCGCGGCGGAAGCACCCATACTTTG 
1444 5’ Rnq1-A6 5'GCTGCTGCTGCTGCGGCGGCTGCGGCTGCAGCTGCCATGAATTCCAACAAC 












1478 5’ Rnq1-A8 5'GCTGCTGCCGCAGCGGCCGCCGCGGCTGCAGCTGCCTTAGGTGGTGGACAAACTC 
1479 3’ Rnq1-A8 5'CTAAGGCAGCTGCAGCCGCGGCGGCCGCTGCGGCAGCAGCACCACCAGATTGTCCC 




1247 3' Rnq1-A9 5'TTGCTGCTGGTTGTTTTGGCCTTGTTGAGCGGCTGCCGCTGCGGCGGATTGAGTTTGTCCACCACC 
1480 5’ Rnq1-A10 5'GTGCAGCCGCAGCTGCGGCTGCCGCGGCAGCTGCCGCCCTGGGCAATAACTCCAATTC 
1481 3’ Rnq1-A10 5'CAGGGCGGCAGCTGCCGCGGCAGCCGCAGCTGCGGCTGCACTGGAGTGGCCTTGTTGC 
1498 3’ Rnq1-A11 5’GAGCAGCGGCGGCAGCAGCAGCGGCGGCTTCGTGCTGTCCATTGGAG 
1525 5’ Rnq1-A11 5’CGAAGCCGCCGCTGCTGCTGCCGCCGCTGCTCAACAGAACAATAACGGC 
0040 3'-XhoI-RNQ 5'CCGCTCGAGTCATCAGTAGCGGTTCTGGTTGCC 
1626 5’Rnq1-153-405-HindIII 5’GCGAAGCTTATGCAAGGTCAGGGACAAGG 
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Molecular chaperones act as a major cellular line of defense through monitoring and 
processing misfolded substrates. This system helps prevent the aggregation of proteins that is 
associated with protein conformational disorders like Alzheimer’s disease and prion diseases. In 
these diseases, a variety of different aggregate structures can form, called prion strains or 
variants, which cause variation in disease pathogenesis. Hence, chaperones are tasked with 
recognizing and processing a large spectrum of misfolded substrates to maintain proteostasis. 
Here, we use the yeast prion variants [RNQ+] and [PSI+] to explore the interactions of 
chaperones with distinct aggregate structures. We found that prion variants show striking 
variation in their relationship with Hsp40s. Specifically, the yeast Hsp40 Sis1 and its human 
ortholog Hdj1 had differential capacities to process prion variants. Such selectivity involves 
different domains of Sis1, with some prion conformers having a greater dependence on particular 
Hsp40 domains. Moreover, [PSI+] was more sensitive to modulation of Hsp70 activity as 
compared to [RNQ+] variants, which depended on Hsp70 and Hsp104 to similar extents. 
Collectively, these data indicate that Hsp40 selectivity has changed through evolution and that 
distinct chaperone machinery is required to process different aggregate structures. Elucidating 
the intricacies of chaperone-aggregate interactions will be crucial to understanding how this 
system can go awry in disease and contribute to the pathological variation observed in many 
protein conformational disorders. 
 
3.2 Introduction 
The aggregation of several different proteins is associated with the development of 
protein conformational disorders, including various neurodegenerative diseases like Alzheimer’s 
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disease, Parkinson’s disease, and prion diseases [2]. Interestingly, the proteins that aggregate in 
these disorders can misfold to form a variety of aggregate structures having distinct 
conformations [20]. In prion diseases, these different self-perpetuating structures, called prion 
strains, cause changes in pathological phenotypes and dictate disease transmissibility. It is the 
responsibility of molecular chaperones, as the master regulators of protein quality control from 
bacteria to humans, to recognize and process these diverse misfolded substrates and mitigate the 
devastating consequences these aggregates can have on cellular homeostasis [216]. Yet, how 
chaperone machinery can handle a large array of substrate conformations remains unclear.  
Yeast prion strains (called prion variants) have served as a valuable model for examining 
the interactions between chaperones and distinct amyloid structures [14]. The [PSI+] and 
[RNQ+] prions are two of the best-studied yeast prions. [PSI+] is formed from the translation 
termination factor Sup35 [48,49]. Sequestration of Sup35 in prion aggregates results in 
modulating the efficiency of translation termination, causing readthrough of stop codons, called 
nonsense suppression [217]. Different variants of [PSI+] sequester Sup35 to different degrees. 
Hence, [PSI+] variants are associated with different amounts of soluble Sup35, and 
consequently, different levels of nonsense suppression [24,118]. Stronger [PSI+] variants cause 
more nonsense suppression (less faithful translation termination) as compared to cells 
propagating weaker [PSI+] variants. The [RNQ+] prion, on the other hand, is formed from the 
Rnq1 protein that has no clear function [11]. However, [RNQ+] is responsible for inducing the de 
novo formation of the [PSI+] prion [60,61], and [RNQ+] variants are distinguished based on how 
readily [PSI+] forms in [RNQ+] cells [31].  
Just as molecular chaperones play a pivotal role in processing substrates in humans, 
chaperones process the aggregates of the [PSI+] and [RNQ+] prions. This processing is required 
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for transmission of the prion state to daughter cells and its continued maintenance in a yeast 
population [218]. A combination of chaperones from the Hsp40 and Hsp70 families, along with 
the disaggregase Hsp104, is involved in the proper maintenance of yeast prions [89,90]. Hsp104 
is a AAA+ ATPase that assembles into a ring-shaped hexamer having a central pore to thread a 
variety of substrates [219,220]. Such substrate threading fragments large prion aggregates into 
smaller seeds that can be inherited by daughter cells [86]. Expression of Hsp104 is required for 
propagation of both [PSI+] and [RNQ+] as fragmentation is a necessary feature for prion 
maintenance [64,94]. However, proper processing of prion aggregates relies on Hsp70s, which 
act to transfer substrates to Hsp104 [86]. Like Hsp104, Hsp70s like Ssa1, which plays a major 
role in prion propagation [221], are ATPases whose activity relies on a constant cycling between 
nucleotide binding states [148]. Hsp70s will bind substrates in the ADP-bound state and release 
substrates in the ATP-bound state. Other chaperones are required to mediate this ATPase cycle. 
Nucleotide exchange factors (NEFs) promote the ATP-bound state, exchanging ADP for ATP 
and causing Hsp70 to have low affinity for non-native polypeptides. By contrast, Hsp40s are 
responsible for transferring substrates to Hsp70 and stimulating the Hsp70 ATPase activity 
[148]. Thus, Hsp40s promote the ADP-bound state of Hsp70s, thereby causing Hsp70s to have 
high affinity for non-native polypeptides and allowing further substrate processing. Interestingly, 
Hsp40s are proposed to be the predominant regulator dictating Hsp70 function and substrate 
selectivity. 
Sis1 is the Hsp40 that is required for propagation of [PSI+] and [RNQ+] [90,95,99]. Sis1, 
like its human ortholog Hdj1, is a Type II Hsp40 that is divided into four major domains. The N-
terminal J domain, a region conserved by all Hsp40 proteins, is required for Hsp70 interaction 
and stimulation, as well as for yeast viability [102,150,222]. Additionally, Sis1 has a C-terminal 
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domain (CTD) responsible for binding substrates [223], with the last 15 residues of the protein 
comprising the dimerization domain (DD) [224]. In between the J domain and CTD is a region 
rich in glycine and phenylalanine residues (G/F) followed by a region rich in glycine and 
methionine (G/M) residues. These regions are generally viewed as linker regions, but their 
function remains poorly understood. Interestingly, the G/F domain is required for propagation of 
[RNQ+], and we found that this was true for several different [RNQ+] variants (Stein et al., in 
review). Propagation of [PSI+] variants, on the other hand, differentially depends on this domain 
(Stein et al., in review) and Sis1 expression [215]. Moreover, mutations in the G/F domain 
associated with a myopathy show variant-dependent effects (Stein et al., in review). Yet, it 
remains unclear whether prion variants are differentially sensitive to changes in other Sis1 
domains or have various other chaperone requirements. 
Here, we explored the relationship between molecular chaperones and their interactions 
with different aggregate structures. We found striking differences in the chaperone interactions 
required for propagation of the [PSI+] and [RNQ+] prions and their associated structural 
variants. Hdj1 was unable to fully complement the function of Sis1 in propagating every prion 
variant of [PSI+] and [RNQ+]. This was likely because propagation of different prion variants 
relied on the presence of different domains of Sis1. In general, the [RNQ+] variants were more 
sensitive to changes in Sis1 and how it interacts with Hsp70, while [PSI+] variants were more 
sensitive to changes in Hsp70-Ssa1. These data indicate that distinct aggregate structures require 
different chaperone interactions for proper processing. Hence, gaining insight into the complex 
nature of these interactions is necessary in order to fully understand how defects in the 




3.3.1 Sis1 and its Human Ortholog Hdj1 show Distinct Conformer Specificity 
Hsp40s are suggested to dictate much of the substrate specificity of the chaperone 
network [148]. As Sis1 is capable of propagating a large spectrum of prion conformations 
([95,215] and Stein et al., in review), we wondered whether its human ortholog, Hdj1, can 
functionally substitute for Sis1 in propagating different types of prion variants. To test this, we 
used four different prion conformers of the [PSI+] prion, representing two weaker [PSI+] 
variants (Sc37 and weak [PSI+]) and two stronger [PSI+] variants (Sc4 and strong [PSI+]) 
[24,69]. Since [PSI+] modulates translation termination, [PSI+] variants are easily distinguished 
based on colony color using the ade1-14 allele, which has a premature stop codon in the ADE1 
gene [186]. Cells propagating distinct [PSI+] variants have different amounts of soluble Sup35 
[118], and thus differentially suppress ade1-14 to cause different amounts of red pigment to 
accumulate. Stronger [PSI+] colonies, having less soluble Sup35 and more nonsense 
suppression, are whiter in color as compared to colonies propagating weaker [PSI+] variants that 
are darker pink. All Sup35 is soluble in [psi-] cells, which makes these colonies red.  
To determine if Hdj1 was capable of propagating these distinct [PSI+] variants, we used 
sis1! cells that expressed SIS1 from a URA3 plasmid, and used the plasmid shuffle technique to 
express Hdj1 or WT Sis1. Interestingly, the [PSI+] variants showed striking differences in their 
sensitivity to Hdj1 expression. While the weaker [PSI+] variants were darker pink when WT 
Sis1 was expressed, these cells were red and phenotypically [psi-] when Hdj1 was expressed 
(Fig. 1A). By contrast, expression of Hdj1 in stronger [PSI+] cells appeared to have no 
phenotypic consequences, as lighter pink colonies were seen when either Sis1 or Hdj1 was 
expressed. To confirm these results, we used SDD-AGE, which resolves aggregated Sup35 from 
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soluble Sup35 and has shown that [PSI+] variants have different aggregate distributions: Sup35 
aggregates in weaker [PSI+] cells have a larger average aggregate size as compared to stronger 
[PSI+] cells [117]. In agreement with our phenotypic results, both weaker [PSI+] variants had no 
Sup35 aggregates when Hdj1 was expressed (Fig. 1B). However, Hdj1 expression caused a 
minor shift in the aggregate distribution with the stronger [PSI+] variants, despite being 
phenotypically similar to cells expressing Sis1. Nevertheless, these results indicate that the 
[PSI+] variants show drastically different sensitivity to Hdj1 expression, suggesting that Hdj1 is 
unable to propagate weaker [PSI+] conformers. 
Next, we asked if Hdj1 showed differential capabilities in handling [RNQ+] variants. 
Previously, it was shown that expression of Hdj1 was fully capable of propagating an 
uncharacterized [RNQ+] variant [100]. Here, we used five different [RNQ+] variants that show 
differences in their ability to induce the formation of the [PSI+] prion [31]. Moreover, these 
[RNQ+] variants show differences in their in vivo distribution of aggregates using Rnq1-GFP, 
where single-dot (s.d.) [RNQ+] variants have one focus of fluorescence, while multiple-dot 
(m.d.) cells have multiple foci [120]. Hence, cells propagating the s.d. low [RNQ+] variant have 
the s.d. pattern of fluorescence and induce the formation of [PSI+] at low levels. In performing 
SDD-AGE to analyze the propagation of these variants as we did for [PSI+], we found that Hdj1 
had diverse capabilities in maintaining the [RNQ+] variants (Fig. 1C). Like weak [PSI+], s.d. 
medium [RNQ+] was mostly eliminated by expression of Hdj1 and showed the presence of few 
aggregates. Moreover, propagation of all of the other s.d. [RNQ+] variants was impaired, as 
indicated by the presence of fewer aggregates, while m.d. high [RNQ+] appeared to be 
unaffected by Hdj1 expression. Collectively, these data suggest that Sis1 and Hdj1 have different 
specificity in processing distinct prion conformers. 
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3.3.2 Differential Dependence on Hsp40 Domains Dictates Conformer Specificity 
As Hdj1 and Sis1 had differential ability to propagate particular prion variants, we 
hypothesized that there might be distinct differences in domain functionality of these Hsp40s. 
Thus, we wanted to determine what domains might underlie these differences. To gain insight 
into this question, we created a suite of chimeras having various combinations of the four major 
domains present in Hdj1 and Sis1, and confirmed comparable expression as the wild-type (WT) 
proteins (Fig. S1). We refer to these chimeras by delineating the origins of each domain, with 
“S” for Sis1 and “H” for Hdj1 (Fig. 2A). As Hdj1 was unable to propagate certain prion variants, 
these chimeras allowed us to ask which Sis1 domains would rescue this defect. 
Using sis1! cells propagating weak [PSI+] or Sc37, as these prion structures were 
eliminated when Hdj1 was expressed, we replaced WT Sis1 with one of the chimeric proteins. 
Interestingly, we found that the chimeras were differentially capable of propagating these 
structures, despite both being weaker [PSI+] variants (Fig. 2B,C). For instance, the chimera 
HSHH expressed the Sis1 G/F domain in place of that of Hdj1. This chimera largely rescued 
propagation of Sc37, as indicated by the presence of less soluble Sup35 as compared to 
expression of Hdj1, based on phenotype (Fig. 2B) and SDD-AGE (Fig. 2C). However, HSHH 
provided very little rescue of propagation of weak [PSI+], as these cells were phenotypically 
similar to [psi-] cells and had a greatly reduced aggregate band by SDD-AGE. Moreover, 
replacing additional Hdj1 domains with those of Sis1 (e.g. HSSH, HHSS, and SSSH) also 
partially rescued both prion variants. Yet, HHSS was more capable of propagating Sc37 than 
weak [PSI+], as there was a large soluble pool of Sup35 with weak [PSI+] cells expressing 
HHSS that was not seen with cells propagating Sc37. However, none of the chimeras completely 
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rescued propagation of Sc37, while SSSH appeared to fully rescue propagation of weak [PSI+], 
as indicated by a lack of soluble Sup35. 
We also tested whether the Sis1-Hdj1 chimeras would rescue propagation of the s.d. low 
and s.d. medium [RNQ+] variants that were most impaired by Hdj1 expression. Using SDD-
AGE, we found that propagation of these variants showed dramatic differences in terms of what 
chimera was capable of mediating prion propagation (Fig. 2D). For s.d. medium [RNQ+], it was 
only the two chimeras that contained the Sis1 CTD (HHHS and HHSS) that rescued propagation 
as compared to Hdj1. Strikingly, HHHS did not rescue propagation of s.d. low [RNQ+], but 
several other chimeras did (Fig. 2D). Collectively, these data indicate that propagation of both 
[PSI+] and [RNQ+] variants relies on distinct domains of the Hsp40 machines.  
 
3.3.3 Propagation of Different Prion Variants Relies on Distinct Regions of Sis1 
As a complementary approach to asking whether particular prion variants differentially 
require the presence of certain Sis1 domains, we took advantage of a variety of Sis1 mutants that 
have previously been used to interrogate the importance of Sis1 regions on prion propagation 
[74,97,100]. This included deletion mutants of major Sis1 domains that supported viability in 
sis1! cells (Sis1-#G/F, Sis1-#G/M, Sis1-#CTD), the dimerization domain (Sis1-#DD), smaller 
regions of the G/F domain (Sis1-#86-96 and Sis1-#101-113), and a point mutation in the G/F 
domain (Sis1-D110G). We transformed each of these mutants to replace WT Sis1in sis1! cells 
that propagated one of the [PSI+] or [RNQ+] variants. 
For both weaker [PSI+] variants, we found that deletion of the G/F or G/M domains 
impaired prion propagation, as these cells were phenotypically darker pink as compared to cells 
expressing WT Sis1 (Fig. 3A), and there was an increase in soluble Sup35 according to SDD-
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AGE (Fig. 3B). Additionally, deletion of the Sis1 CTD had a major impact on prion propagation, 
mostly eliminating both variants, while deletion of the DD and residues 86-96 had minimal 
effect. However, paradoxically, deletion of residues 101-113 had a greater effect on propagation 
of weak [PSI+] as compared to Sc37, with a complete loss of Sup35 aggregates in weak [PSI+] 
cells, but a point mutation within this stretch of Sis1, D110G, impaired propagation of Sc37 to a 
larger extent, as indicated by the darker pink color and a dramatic shift in the average aggregate 
distribution (Fig. 3). These data again suggest that the weaker [PSI+] variants are differentially 
sensitive to mutations in Sis1. Moreover, Sis1 mutants showed very minimal effect on 
propagation of stronger [PSI+] variants, with the greatest impact being the toxicity of Sis1-
#CTD in the presence of stronger [PSI+] (Fig. S2), as seen previously [97].  
Next, we tested how the Sis1 mutants affected propagation of the [RNQ+] variants using 
a sedimentation assay that separated cell lysates into soluble and insoluble fractions. In the 
[RNQ+] state with WT Sis1, almost all Rnq1 protein is sequestered into aggregates and 
accumulates in the insoluble fraction, whereas any impairment in prion propagation results in an 
increased soluble pool of Rnq1 [74]. Some prion variants, such as s.d. very high [RNQ+] have a 
larger pool of soluble Rnq1 than others [31]. As we previously found, deletion of the G/F domain 
eliminated all five [RNQ+] variants (Fig. 3C and Stein et al., in review). Interestingly, other than 
Sis1-#G/F, both s.d. high [RNQ+] and m.d. high [RNQ+] were particularly resistant to changes 
in Sis1. There was some increased soluble Rnq1 when Sis1-#101-113 was expressed in s.d. high 
[RNQ+] cells, but it was only deletion of the G/M domain that really impaired propagation of 
these two [RNQ+] variants (Fig. 3C). Sis1-#G/M also affected propagation of the three other 
[RNQ+] variants, thereby showing the general importance of this domain in prion propagation. 
However, deletion of this domain showed varying degrees of impairment, minimally increasing 
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the soluble pool of Rnq1 in s.d. low [RNQ+] cells and mostly eliminating the propagation of s.d. 
medium and s.d. very high [RNQ+]. Interestingly, s.d. medium and s.d. very high [RNQ+] were 
particularly sensitive to deletion of the Sis1 CTD and the DD. Moreover, deletion of residues 86-
96 resulted in increased soluble Rnq1 for only s.d. very high [RNQ+] cells, suggesting that this 
region is important for propagation of only the s.d. very high [RNQ+] prion variant. Collectively, 
these data suggest that Sis1 utilizes distinct domains in order to propagate a wide spectrum of 
aggregated structures.  
 
3.3.4 [RNQ+] Variants all depend on the Interaction of Hsp40 with Hsp70 
 A complex of chaperones is often required to process misfolded substrates. It is suggested 
that Hsp40s, in general, are responsible for recognizing substrates [148]. Then, in the case of 
yeast prions, Sis1 in combination with an Hsp70, such as Ssa1, will transfer substrates to Hsp104 
for fragmentation and continued propagation [90]. While the Sis1 J domain is critical for the 
interaction of Sis1 with the nucleotide-binding domain of Hsp70s [225], part of the Sis1 CTD 
interacts with the EEVD motif in the substrate-binding domain of Hsp70s [226-228]. Indeed, a 
mutation in the Sis1 CTD (L268P) was previously found to impair the interaction of Sis1 and 
Ssa1 in vitro, which inhibited the propagation of an uncharacterized [RNQ+] variant [104].  
Using Sis1-L268P as a means of disrupting the Sis1-Hsp70 interaction, we asked whether 
all prion variants similarly relied on the Sis1-Hsp70 interaction for proper maintenance. We 
expressed Sis1-L268P in place of WT Sis1 in sis1! cells propagating one of the [RNQ+] or 
[PSI+] variants. Unexpectedly, despite the [RNQ+] variants showing dramatic differences in 
sensitivity to changes in Sis1, the Sis1-L268P construct eliminated the propagation of all five 
[RNQ+] variants, as all of the Rnq1 protein accumulated in the soluble fraction after 
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ultracentrifugation (Fig. 4). By contrast, propagation of the stronger [PSI+] variants was 
unchanged, while propagation of the weaker [PSI+] variants was impaired, but not eliminated 
(data not shown). This suggests that propagation of all [RNQ+] variants depends on the 
interaction between Sis1 and Hsp70, but propagation of [PSI+] does not absolutely require this 
interaction. 
 
3.3.5 [RNQ+] Variants do not show the Same Sensitivity to Modulating the Hsp70 ATPase 
Cycle as [PSI+] 
As Hsp70s clearly play an important role in substrate processing, we next wanted to 
determine whether altering Hsp70 function differentially affected propagation of prion variants. 
The Hsp70-dependent processing of substrates depends on an iterative nucleotide-binding cycle 
between ADP- and ATP-bound states that depends on the activity of Hsp40 and NEFs [148]. We 
asked whether modulation of Hsp70 activity might affect particular [RNQ+] variants to different 
extents, as has been observed with [PSI+] variants [229].  
To address this, we first utilized a mutant of Ssa1, called Ssa1-21, that is known to 
dominantly affect propagation of the [PSI+] prion [230]. Ssa1-21 harbors the L483W mutation, 
which resides in the C-terminal substrate-binding domain of Ssa1 and causes elevated ATPase 
activity [231]. In order to examine the effect of Ssa1-21, we created ssa2! [RNQ+] strains as loss 
of Ssa2 enhances the effect of Ssa1-21 [230,232]. We then transformed these cells with a 
plasmid expressing SSA1-21 from the endogenous SSA1 promoter, along with an SSA1 plasmid 
or an empty vector as controls. To monitor the influence on prion propagation, we performed 
well-trap assays, which allows us to easily determine the amount of soluble Rnq1 in the cell, 
since aggregated Rnq1 is retained in the wells of an SDS-PAGE gel when cell lysate fractions 
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are not boiled [189]. Interestingly, there was no increased pool of soluble Rnq1 in cells 
propagating any of the [RNQ+] variants when Ssa1-21 was expressed (Fig. 5A). Importantly, as 
genetic background is a critical variable for revealing the effects of Ssa1-21 [233], we found that 
an isogenic ssa2! strain propagating strong [PSI+] showed that [PSI+] propagation was impaired 
with Ssa1-21 expression as compared to Ssa1-expressing cells and empty vector controls (Fig. 
5B). However, [PSI+] was not cured as previous studies had shown [230,232,234].  
Despite not seeing an effect using the Ssa1-21 construct, we hypothesized that over-
expression of Ssa1 might impair propagation of certain [RNQ+] variants. Additionally, as NEF 
activity is an important modulator of Hsp70 activity, we also wanted to determine whether the 
[RNQ+] variants would be differentially sensitive to over-expression or deletion of the NEF 
SSE1, as is the case for other prions and prion variants [229,233]. Using well-trap assays, we 
found that neither over-expression of Ssa1 nor Sse1 altered the amount of soluble Rnq1, as 
compared to empty vector controls, for any of the [RNQ+] variants (Fig. 5C). Furthermore, 
deletion of SSE1 also had no effect on [RNQ+] propagation (Fig. 5D), despite the previous 
finding that [PSI+] variants are sensitive to deletion of SSE1 to different extents [229]. These 
data suggest that [RNQ+] is less sensitive to the alterations in Hsp70 activity as compared to 
[PSI+]. 
 
3.3.6 [RNQ+] Variants Similarly Rely on Hsp104-ClpB Chimeras 
Along with Sis1, the other protein that is essential for propagation of all known yeast 
prions is Hsp104 [64,94,96,235]. Upon transfer of substrates from Hsp40-Hsp70, Hsp104 
fragments prion aggregates into smaller seeds that are transmissible to daughter cells and 
maintain the prion state [236]. Hsp104 has been divided into an N-terminal domain with no clear 
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function along with two ATPase domains that are separated by a coiled-coil middle (M) domain 
[237]. The M domain is responsible for mediating the physical interaction with the Hsp70 
machinery [238-240]. Interestingly, the E. coli ortholog of Hsp104, ClpB, is unable to cooperate 
with the yeast co-chaperones to propagate [PSI+], [RNQ+], and [URE3], unless the Hsp104 M 
domain is present [90,241]. We have recently shown that modulating the activity of the Hsp104 
M domain differentially affects [RNQ+] and [PSI+] variants [242], possibly through altering 
interactions with co-chaperones. Therefore, we wondered whether these differences between 
ClpB and Hsp104 would similarly affect all [RNQ+] variants. Hence, we took advantage of a set 
of chimeras that consisted of different combinations of domains from Hsp104 and ClpB [90] to 
ask if distinct prion structures showed differential dependence on other regions of Hsp104. 
 We used [RNQ+] hsp104! yeast strains and replaced WT Hsp104 with one of the ClpB-
Hsp104 chimeras, along with WT ClpB, WT Hsp104, and an empty vector as controls. We then 
monitored [RNQ+] propagation by the presence of aggregates using SDD-AGE. Unexpectedly, 
we found that only WT Hsp104 and the chimera 444B were able to maintain Rnq1 aggregates 
(Fig. 6). The chimera 444B was the only chimera that was previously shown to propagate a 
stronger [PSI+] variant [90]. This indicates that the second ATPase domain of ClpB is able to 
functionally substitute for that of Hsp104. Moreover, these data suggest that the propagation of 
the [RNQ+] variants relies similarly on the different domains of Hsp104. 
 
3.4 Discussion 
Our study highlights the extent to which molecular chaperones differentially interact with 
various aggregate conformations. Previous work has focused on the fact that different prions or 
prion variants show distinct sensitivity to chaperone levels [215,229,243]. We have recently 
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shown that propagation of several different [RNQ+] variants all require the presence of the Sis1 
G/F domain, while [PSI+] variants show differential dependence on this domain (Stein et al., in 
review). Here, we show that other domains of Sis1 are also important in a prion variant-
dependent manner. This suggests that substrate conformation, not simply the substrate protein, is 
a critical determinant of how chaperone machinery interacts and processes substrates. In fact, we 
recently found that the [RNQ+] variants likely have different regions of the Rnq1 protein that are 
available for chaperone binding [34]. 
Hsp40s are responsible for interacting with non-native polypeptides and mediating the 
functional specificity of Hsp70s [148]. We showed that prion variants of [RNQ+] showed 
differences in sensitivity to only variation in Sis1, and not in Hsp70 or Hsp104. Moreover, we 
found that such specificity also extends to the direct orthologs of Sis1 and Hdj1 (Fig. 1). Hdj1 
was unable to propagate weaker [PSI+] variants and s.d. medium [RNQ+], and impaired the 
propagation of the other s.d. [RNQ+] variants. Previous work with the bacterial DnaJ protein 
suggested that the G/F domain mediated substrate specificity [244]. However, our work clearly 
shows that other domains of Sis1 also play an important role. In the case of the weaker [PSI+] 
variants, the Sis1 CTD is necessary for propagation (Fig. 3), which agrees with this being the 
substrate-binding domain [224]. However, the deletion of the Sis1 DD did not affect propagation 
of either of these variants, suggesting that dimerization is not essential for propagation. By 
contrast, we found that propagation of the [RNQ+] variants relied on the G/M domain to different 
extents, in particular s.d. medium and s.d. very high [RNQ+]. Interestingly, these variants were 
the only structures eliminated by deletion of the CTD, and propagation was even affected by the 
DD (Fig. 3C). Moreover, it was only the Sis1-Hdj1 chimeras that had the Sis1 CTD that rescued 
propagation of s.d. medium [RNQ+] (Fig. 2). As the dimerization of Sis1 is proposed to increase 
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the affinity of Sis1 for substrates or for transfer to Hsp70, we suggest that s.d. medium and s.d. 
very high [RNQ+] are particularly recalcitrant substrates, such that Sis1 must function as a dimer 
in order for these variants to be properly processed. 
Structurally, X-ray crystallography has shown that the structures of the J domain and 
CTD of Sis1 and Hdj1 are very similar [225]. The CTD of these homo-dimeric proteins [224], 
forms a U-shaped cleft that binds substrate proteins [223] and part of the substrate-binding 
domain of Hsp70 [228]. Interestingly, this cleft is smaller in Hdj1, in which the distance between 
the monomer subunits is shorter as compared to Sis1 [245]. This might indicate that the 
decreased ability of Hdj1 to process all prion conformers is because its CTD has lower flexibility 
to bind larger, or more recalcitrant, substrates. Furthermore, the putative narrower range of 
clients for Hdj1 as compared to Sis1 might suggest that, through evolution from yeast to humans 
that included a large increase in the number of Hsp40s [148], Hdj1 may have become more 
specialized. 
 A previous study had observed that expression of Hdj1 was synthetically lethal with the 
presence of strong [PSI+] [97], which we did not reproduce here. However, as shown in that 
previous study [97], expression of Sis1-#CTD was toxic in strong [PSI+] cells (Fig. S2). We 
suggest that these differences are likely due to variation in genetic background, which is an 
important consideration in analyzing chaperone-amyloid interactions [215]. Nevertheless, as 
aggregates can sequester various chaperone machinery [246,247], it is feasible that Sup35 
aggregates in strong [PSI+] cells sequester Sis1 more than other prion variants, such that the 
already reduced capability of Sis1-#CTD (or Hdj1 in the previous work [97]) cannot maintain 
the essential functions of Sis1 in yeast. 
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 We had previously shown that mutations in the Hsp104 M domain affect propagation of 
the [RNQ+] variants differently [242]. However, in this study, we found that the ClpB-Hsp104 
chimeras similarly affected propagation of the [RNQ+] variants, with only the 444B chimera able 
to maintain Rnq1 aggregates. In light of the dramatic differences in sensitivity that the [RNQ+] 
variants have to alterations in Sis1, we now propose that the differential effects of mutations in 
the Hsp104 M domain are likely mediated through disrupting the interactions with co-
chaperones, particularly Sis1. Indeed, the s.d. high and m.d. high [RNQ+] variants were the most 
resistant to changes in the Hsp104 M domain [242], just as they were the most resistant to 
mutations in Sis1 (Fig. 3). This would agree with the finding that co-chaperones bind to and 
mediate the activity of the Hsp104 M domain [238]. 
It has long been recognized that [PSI+] is the only prion that is cured by over-expression 
of Hsp104 [243], which is due to Hsp104 outcompeting Ssa1 for binding to Sup35 aggregates, 
thus resulting in a non-productive interaction [221]. Our data further indicate that [PSI+] is more 
sensitive to changes in Hsp70 activity as compared to [RNQ+] (Fig. 5). By contrast, while the 
weaker [PSI+] variants show some dependence on Sis1 alterations, unlike the stronger [PSI+] 
variants, the [RNQ+] variants all show even more dependence on Sis1 as these structures were all 
eliminated by expression of Sis1-#G/F. Moreover, [PSI+] is less sensitive to Sis1-L268P, as 
compared to [RNQ+], indicating that [RNQ+] depends on the Sis1-Ssa1 interaction to a greater 
extent than [PSI+]. Taken together, these data make a strong argument that Sis1 plays a more 
intimate role in propagation of [RNQ+] as compared to [PSI+], which depends more on Ssa1 and 
Hsp104.  
Genetic and environmental changes can influence the formation and maintenance of 
distinct aggregate structures ([32,34,40,41] and Stein et al., in review). Indeed, many of these 
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changes are likely due to altering the ability of molecular chaperones to monitor protein quality 
control. Our study indicates that substrate processing of not only different substrates, but also 
different substrate conformers, can depend on a distinct set of chaperone machinery. Therefore, 
with the vital role that molecular chaperones play in maintaining proteostasis, elucidating the 
complex nature of chaperone-aggregate interactions is crucial to understanding protein 
conformational disorders and the pathological variation that is often observed. 
 
3.5 Materials and Methods 
3.5.1 Yeast Strains and Media 
 All yeast strains described in this study were derived from 74-D694 (ade1-14 ura3-52 
leu2-3,112 trp1-289 his3-!200) and are listed in Table S1. Standard culturing techniques were 
used throughout with $ YEPD (0.25% yeast extract, 2% peptone, 2% dextrose) or synthetic 
defined (SD) media (0.67% yeast nitrogen base without amino acids, 2% dextrose) lacking one 
or more nutrients to select for appropriate plasmids. Medium containing 1mg/mL 5-fluoroorotic 
acid (5-FOA) was used to select against URA3 plasmids in order to replace wild-type (WT) 
proteins with mutant constructs using the plasmid shuffle technique.  
 WT yeast strains were kind gifts from S. Liebman (L1751, L1943, L1945, L1767 [psi-], 
L1953, L1749, S12600, S12606) [24,31,108] and J. Weissman (2397, 2398) [69]. Construction 
of the sis1! strains containing pRS316-SIS1 (see Table S2 for plasmids used in this study) and 
the hsp104! strains containing pRS316-HSP104p-HSP104 were described previously (Stein et 
al., in review and [242]). To create the ssa2! strains, the kanMX4 cassette having flanking 
homology to the SSA2 promoter and terminator was amplified from pFA6a using 
oligonucleotides 0978 and 0979 (see Table S3 for oligonucleotides used in this study), followed 
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by transformation into yeast cells, and selecting for resistance to G418. To create the sse1! 
strains, the plasmid-based disruption cassette sse1!::LEU2 was digested with SacII/PstI, 
transformed into yeast, and Leu+ transformants were selected. All gene deletions were confirmed 
by colony PCR. 
 
3.5.2 Plasmid Construction 
 The following plasmids were kind gifts (see Table S2): Hsp104-ClpB constructs from J. 
Weissman [90], Sis1 mutant constructs from E. Craig, S. Lindquist, and D. Masison 
[74,97,100,104], pRS424GPD-HDJ1 from E. Craig [100], pRS315-SSA1 and pRS315-SSA1-21 
from D. Masison [234], pRS413GPD-FLAG-SSE1 and the sse1!::LEU2 disruption cassette from 
K. Morano [248]. Construction of pRS314-SIS1 was described previously (Stein et al., in 
review). To create pRS415GPD-SSA1, SSA1 was amplified using oligonucleotides 0219 and 
0220, digested with SpeI/HindIII, ligated with pRS415GPD digested with the same enzymes, 
and confirmed by sequencing. 
 Construction of the Sis1-Hdj1 chimeras was performed using bridge PCR with the 
indicated oligonucleotides and pRS316-SIS1 or pRS424GPD-HDJ1 as templates, unless 
otherwise noted: SHHH (S with 0229 and 1581, HHH with 1580 and 1471), HSHH (H with 1466 
and 1467, S with 1468 and 1469, HH with 1470 and 1471), HHSH (HH with 1466 and 1500, S 
with 1499 and 1566, H with 1565 and 1471), HHHS (HHH with 1466 and 1502, S with 1501 and 
0230), HSSH (HS with 1466 and 1583 using pRS414GPD-HSHH as template, SH with 1582 and 
1471 using pRS414GPD-HHSH as template), HHSS (HH with 1466 and 1500, SS with 1499 and 
0230), SSSH (SSS with 0229 and 1566, H with 1565 and 1471). Sis1 domains were demarcated 
as follows: J domain (1-66), G/F (67-121), G/M (122-179), CTD (180-352). Hdj1 domains were 
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demarcated as follows: J domain (1-66), G/F (67-108), G/M (109-161), CTD (162-340). All 
constructs with digested with SpeI/ClaI, ligated into pRS414GPD digested with the same 
enzymes, and confirmed by sequencing. 
 
3.5.3 Phenotypic Colorimetric Analysis 
 Overnight yeast cultures were normalized to OD600 0.4, serially diluted five-fold, and 
spotted to the indicated media. Plates were grown at 30°C for 6 days for SD-ade-leu, and for 3 
days for all other media, followed by overnight at 4°C for additional color development. 
 
3.5.4 Protein Analysis 
 Semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) for both Rnq1 and 
Sup35 proteins was performed as described previously with the indicated antibodies [32,242]. 
The solubility assay of Rnq1 was described elsewhere [78]. Briefly, cell lysates in detergent-
containing lysis buffer were subjected to ultracentrifugation at 80,000 rpm for 30 min at 4°C to 
separate into soluble and insoluble fractions that were analyzed by SDS-PAGE and western blot 
with a polyclonal "Rnq1 antibody. Well-trap assays were performed as described [34]. 
Additional antibodies used to analyze protein expression included: two different "Sis1 antibodies 
(here referred to as "Sis1.1 (COP-COP-080051, Cosmo Bio Co.) and "Sis1.2 (a kind gift from E. 
Craig)), "Hdj1 (ADI-SPA-400, Enzo Life Sciences), and "Pgk1 (A6457, Molecular Probes). 
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Figure 1. Hdj1 cannot maintain propagation of all prion variants of [PSI+] and [RNQ+]. 
(A) Normalized numbers of yeast sis1! cells expressing Sis1 or Hdj1 and propagating the 
indicated [PSI+] variant, as compared to [psi-] cells, were serially diluted five-fold and spotted 
on $ YEPD to monitor prion propagation by colony color. (B) [PSI+] and [psi-] cell lysates 
expressing Sis1 or Hdj1 were subjected to SDD-AGE and western blot using an "Sup35 




Figure 2. Prion propagation shows variant-specific dependence on Sis1-Hdj1 chimeras. (A) 
Schematic diagram of domain structure of Sis1, Hdj1, and one of the Sis1-Hdj1 chimeras, HSSH. 
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(B) Normalized numbers of yeast sis1! cells expressing Sis1, Hdj1, or the indicated Sis1-Hdj1 
chimera and propagating weak [PSI+] or Sc37, with [psi-] SIS1 cells as a control, were serially 
diluted five-fold and spotted on $ YEPD to monitor prion propagation by colony color. (C) Cell 
lysates propagating weak [PSI+] or Sc37 and expressing the indicated constructs were subjected 
to SDD-AGE and western blot using an "Sup35 antibody. (D) As in (C) with cells propagating 




Figure 3. Distinct Sis1 domains are involved in defining conformer specificity. (A) 
Normalized numbers of yeast sis1! cells expressing WT Sis1 or the indicated Sis1 mutant, and 
propagating weak [PSI+] or Sc37, with [psi-] SIS1 cells as a control, were serially diluted five-
fold and spotted on $ YEPD to monitor prion propagation by colony color. (B) Cell lysates 
propagating weak [PSI+] or Sc37 and expressing the indicated constructs, along with [psi-] cells 
expressing WT Sis1, were subjected to SDD-AGE and western blot using an "Sup35 antibody. 
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(C) Cell lysates propagating the indicated [RNQ+] variant and expressing WT Sis1 or the 
indicated Sis1 mutant, were separated by high-speed ultracentrifugation into total (T), soluble 




Figure 4. Sis1-Hsp70 interaction is required for propagation of all [RNQ+] variants. Cell 
lysates propagating the indicated [RNQ+] variant and expressing in place of WT Sis1 the Sis1-
L268P construct, which disrupts the interaction of Sis1 with Ssa1 in vitro [104], were separated 
by high-speed ultracentrifugation into total (T), soluble (S), and insoluble (I) fractions, followed 




Figure 5. [PSI+] variants, but not [RNQ+] variants, are sensitive to alterations in the Hsp70 
ATPase cycle. (A) The amount of soluble Rnq1 protein in ssa2! cells propagating the indicated 
[RNQ+] variant and expressing an extra copy of Ssa1 or Ssa1-21, or an empty vector (EV) 
control, was analyzed by well-trap assay. Cell lysates were incubated at 100°C (+) or room 
temperature (-) and subjected to SDS-PAGE and western blot using an "Rnq1 antibody. (B) 
Normalized numbers of ssa2! cells propagating strong [PSI+] and expressing an extra copy of 
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Ssa1 or Ssa1-21, or an empty vector (EV) control, were serially diluted five-fold and spotted 
onto the indicated media to monitor prion propagation by colony color (SD-leu) or cell growth 
(SD-leu-ade). (C) Wild-type cell lysates propagating the indicated [RNQ+] variant and over-
expressing Ssa1 or Sse1, as compared to an EV, were analyzed by well-trap assay as in (A). (D) 
SSE1 and sse1! cell lysates propagating the indicated [RNQ+] variant, as compared to [rnq-] 




Figure 6. [RNQ+] variants similarly rely on Hsp104-ClpB chimeras. Yeast hsp104! cells, 
propagating the indicated [RNQ+] variant, had WT Hsp104 replaced with ClpB or the indicated 
Hsp104-ClpB chimeras, with WT Hsp104 and an empty vector (EV) as controls. Cell lysates 
were subjected to SDD-AGE and western blot using an "Rnq1 antibody. 
 
 129 
3.8 Supplemental Figures and Tables 
 
Figure S1. Protein expression levels of Sis1-Hdj1 chimeras. Normalized concentrations of 
protein from cell lysates harboring the indicated construct was subjected to SDS-PAGE and 
western blot using two different "Sis1 antibodies ("Sis1.1 and "Sis1.2 as described in the 




Figure S2. Effect of Sis1 mutations on propagation of strong [PSI+] and Sc4. Normalized 
numbers of yeast sis1! cells expressing WT Sis1 or the indicated Sis1 mutant, and propagating 
strong [PSI+] or Sc4, with [psi-] SIS1 cells as a control, were serially diluted five-fold and 
spotted on $ YEPD to monitor prion propagation by colony color. 
 
 131 
Table S1. Yeast strains used in this study. 
Strain Description Reference 
2879 74-D694 Mat " sis1!::hphMX4 [psi-] [rnq-] Stein et al., in review 
2384 74-D694 Mat " sis1!::hphMX4 [psi-] s.d. low [RNQ+] Stein et al., in review 
2386 74-D694 Mat " sis1!::hphMX4 [psi-] s.d. medium [RNQ+] Stein et al., in review 
2468 74-D694 Mat " sis1!::hphMX4 [psi-] s.d. high [RNQ+] Stein et al., in review 
2470 74-D694 Mat " sis1!::hphMX4 [psi-] s.d. very high [RNQ+] 
Stein et al., 
in review 
2242 74-D694 Mat " sis1!::hphMX4 [psi-] m.d. high [RNQ+] Stein et al., in review 
2244 74-D694 Mat " sis1!::hphMX4 weak [PSI+] Stein et al., in review 
2240 74-D694 Mat " sis1!::hphMX4 strong [PSI+] Stein et al., in review 
2248 74-D694 Mat a sis1#::hphMX4 [PSI+] Sc4 Stein et al., in review 
2246 74-D694 Mat a sis1!::hphMX4 [PSI+] Sc37 Stein et al., in review 
2549 74-D694 Mat " ssa2!::kanMX4 [psi-] s.d. low [RNQ+] This study 
2638 74-D694 Mat " ssa2!::kanMX4 [psi-] s.d. medium [RNQ+] This study 
2692 74-D694 Mat " ssa2!::kanMX4 [psi-] s.d. high [RNQ+] This study 
2689 74-D694 Mat " ssa2!::kanMX4 [psi-] s.d. very high [RNQ+] This study 
2639 74-D694 Mat " ssa2!::kanMX4 [psi-] m.d. high [RNQ+] This study 
2818 74-D694 Mat " ssa2!::kanMX4 weak [PSI+] This study 
2756 74-D694 Mat " ssa2!::kanMX4 strong [PSI+] This study 
0116 74-D694 Mat " sse1!::LEU2 [psi-] [rnq-] This study 
0076 74-D694 Mat " sse1!::LEU2 [psi-] s.d. low [RNQ+] This study 
0078 74-D694 Mat " sse1!::LEU2 [psi-] s.d. medium [RNQ+] This study 
0477 74-D694 Mat " sse1!::LEU2 [psi-] s.d. high [RNQ+] This study 
0182 74-D694 Mat " sse1!::LEU2 [psi-] s.d. very high [RNQ+] This study 
0103 74-D694 Mat " sse1!::LEU2 [psi-] m.d. high [RNQ+] This study 
2641 74-D694 Mat " hsp104!::hphMX4 [psi-] s.d. low [RNQ+] [242] 
2642 74-D694 Mat " hsp104!::hphMX4 [psi-] s.d. medium [RNQ+] [242] 
2646 74-D694 Mat " hsp104!::hphMX4 [psi-] s.d. high [RNQ+] [242] 
2645 74-D694 Mat " hsp104!::hphMX4 [psi-] s.d. very high [RNQ+] [242] 
2643 74-D694 Mat " hsp104!::hphMX4 [psi-] m.d. high [RNQ+] [242] 
L1751 74-D694 Mat a [psi-] [rnq-] [31] 
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L1943 74-D694 Mat a [psi-] s.d. low [RNQ+] [31] 
L1945 74-D694 Mat a [psi-] s.d. medium [RNQ+] [31] 
L1767 [psi-] 74-D694 Mat a [psi-] s.d. high [RNQ+] [108] 
L1953 74-D694 Mat a [psi-] s.d. very high [RNQ+] [31] 
L1749 74-D694 Mat a [psi-] m.d. high [RNQ+] [31] 
S12600 74-D694 Mat a weak [PSI+] [24] 
S12606 74-D694 Mat a strong [PSI+] [24] 
2397 74-D694 Mat a [PSI+] Sc4 [69] 
2398 74-D694 Mat a [PSI+] Sc37 [69] 
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Table S2. Plasmids used in this study. 
Plasmid Description Reference 
5687 pRS316-SIS1 (alias pYW17, YCp50-SIS1) [74] 
6404 pRS314-SIS1 Stein et al., in review 
6331 p424GPD-HDJ1 [100] 
6687 pRS414GPD-SHHH This study 
6453 pRS414GPD-HSHH This study 
6504 pRS414GPD-HHSH This study 
6455 pRS414GPD-HHHS This study 
6683 pRS414GPD-HSSH This study 
6454 pRS414GPD-HHSS This study 
6685 pRS414GPD-SSSH This study 
S16928 pRS314-sis1-!G/F (alias PYW116) [74] 
S17036 pRS314-sis1-!G/M [100] 
S16927 pRS314-sis1-!CTD (alias PYW66) [74] 
6408 pRS314-sis1-!DD [97] 
6341 pRS314-sis1-!86-96 [100] 
6337 pRS314-sis1-!101-113 [100] 
6334 pRS314-sis1-D110G [100] 
6544 pRS314-sis1-L268P [104] 
6524 pRS315-SSA1 [234] 
6525 pRS315-SSA1-21 [234] 
6526 sse1!::LEU2 [248] 
6391 pRS415GPD-SSA1 This study 
6529 p413GPD-FLAG-SSE1 [248] 
6240 pRS315-HSP104p-ClpB [90] 
6241 pRS315-HSP104p-444B [90] 
6242 pRS315-HSP104p-BBB4 [90] 
6509 pRS315-HSP104p-HSP104 [90] 
6511 pRS315-HSP104p-4BBB [90] 
6512 pRS315-HSP104p-B44B [90] 
6513 pRS315-HSP104p-BB4B [90] 
6514 pRS315-HSP104p-4B4B [90] 
6516 pRS315-HSP104p-4BB4 [90] 
6517 pRS316-HSP104p-HSP104 [90] 
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Table S3. Oligonucleotides used in this study. 
 
Oligonucleotide Description Sequence 
0219 5' SpeI-Ssa1 5'GCACTAGTATGTCAAAAGCTGTCGG 
0220 3' HIII-Ssa1 5'GGGAAGCTTTTAATCAACTTCTTCAACG 
0229 5'SIS1-Spe1 5'ATACTAGTATGGTCAAGGAGACAAAA 
0230 3'SIS1-Cla1 5'TGATCGATATTTGCTTAGGATTACTATTAAA 
0978 5’SSA2-KO 5'CCAACAGATCAAGCAGATTTTATACAGAAATATTTATACATCGTACGCTGCAGGTCGAC 
0979 3’SSA2-KO 5'AGTAAAACTTTTCGGATATTTTACAGGGCGATCGCTAAGCATCGATGAATTCGAGCTCG 
1466 5’ HDJ1-J-SpeI 5'GCGACTAGTATGGGTAAAGACTACTAC 
1467 3’ HDJ1-J-sis1 5'CTAGCAGCCTCGAGACCGTAGCGGTCGAAGATCTCGC 
1468 5’ SIS1-G/F-hdj1 5'GCGAGATCTTCGACCGCTACGGTCTCGAGGCTGCTAG 
1469 3’ SIS1-G/F-hdj1 5'GGTGTCAAAGGGATTTCTGCCGCCAAAGAATTGTG 
1470 5’ HDJ1-G/M-sis1 
5'CACAATTCTTTGGCGGCAGAAATCCCTTTGAC
ACC 
1471 3’ HDJ1-ClaI 5'GCGATCGATCTATATTGGAAGAACCTG 
1499 5’ Sis1-G/M-hdj1-G/F 
5’GCTGAGTTCTTCGGTGGCAGTTCCCCATTCGG
TGGTGC 
1500 3’ HDJ1-G/F-sis1-G/M 
5’CACCACCGAATGGGGAACTGCCACCGAAGA
ACTCAGC 
1501 5’ Sis1-CTD-hdj1-G/M 
5’CCGCCCGAAAGAAGCAAGATGAAACAGTTC
AAGTTAATTTAC 









1579 3’Hdj1-J-sis1-G/F 5’CTAGCAGCCTCGAGACCGTAGCGGTCGAAGATCTCGCGC 
1580 5’Hdj1-G/F-sis1-J 5’CTCAAAAAAGGGAAATATATGATCAATACGGGGAGGAAGGCCTAAAG 
1581 3’Sis1-J-hdj1-g/f 5’CTTTAGGCCTTCCTCCCCGTATTGATCATATATTTCCCTTTTTTG 
1582 5’Sis1-G/M 5’CACAATTCTTTGGCGGCAGTTCCCCATTCGGTGGTG 
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The molecular chaperone network protects against the toxic misfolding and aggregation 
of proteins. Disruption of this network leads to a variety of protein conformational disorders. 
One such recently discovered example is limb-girdle muscular dystrophy type 1D (LGMD1D), 
which is caused by mutation of the HSP40 chaperone DNAJB6. All LGMD1D-associated 
mutations localize to the conserved G/F domain of DNAJB6, but the function of this domain is 
largely unknown. Here, we exploit the yeast Hsp40 Sis1, which has known aggregation-prone 
client proteins, to gain insight into the role of the G/F domain and its significance in LGMD1D 
pathogenesis. Strikingly, we demonstrate that LGMD1D mutations in a Sis1-DNAJB6 chimera 
differentially impair the processing of specific conformers of two yeast prions – [RNQ+] and 
[PSI+]. Importantly, these differences do not simply correlate to the sensitivity of these prion 
strains to changes in chaperone levels. Additionally, we analyzed the effect of LGMD1D-
associated DNAJB6 mutations on TDP-43, a protein known to form inclusions in LGMD1D. We 
show that the DNAJB6 G/F domain mutants disrupt the processing of nuclear TDP-43 stress 
granules in mammalian cells. These data suggest that the G/F domain mediates chaperone-
substrate interactions in a manner that extends beyond recognition of a particular client and to a 
subset of client conformers. We propose that such selective chaperone disruption may lead to the 
accumulation of toxic aggregate conformers and result in the development of LGMD1D and 
perhaps other protein conformational disorders.        
 
4.2 Introduction    
Maintenance of cellular homeostasis requires that proteins adopt a proper tertiary 
structure. Both genetic and sporadic modifications can impair this process, leading to protein 
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misfolding and the formation of protein aggregates that are present in many neuro- and 
myodegenerative diseases. Molecular chaperones, such as heat shock proteins (HSPs), help 
combat such aggregation, serving to refold substrates or target them for degradation. 
Consequently, dysfunction of this protective network of chaperones contributes to a variety of 
disorders. 
Dominantly inherited mutations in the HSP40 chaperone DNAJB6 cause a progressive, 
late-onset degenerative myopathy called limb-girdle muscular dystrophy type 1D (LGMD1D) 
[159-162]. DNAJB6 is expressed as two isoforms, DNAJB6a and DNAJB6b, with DNAJB6b 
suggested to be the principal mediator of LGMD1D pathogenesis [160]. DNAJB6b has three 
distinct domains that are conserved in many HSP40 proteins present from yeast to humans. The 
N-terminal J domain and C-terminal substrate-binding domain facilitate the interaction and 
processing of client proteins in cooperation with HSP70 [148]. In between these domains is a 
poorly understood region called the G/F domain that is rich in glycine and phenylalanine 
residues. All known LGMD1D-associated mutations localize to an eight amino acid stretch 
within the G/F domain. Disruption of the conserved G/F domain of DNAJB6 and similar DNAJ 
proteins can alter interactions with substrates, thereby highlighting the importance of the G/F 
domain [74,160,244]. However, it is unclear how this domain modulates HSP40 function and 
how mutation of this region can cause disease. 
Recently, the RNA-binding protein TDP-43 has emerged as a sensitive and specific 
marker of myodegeneration, and has been shown to form inclusions in LGMD1D [159,249]. 
Interestingly, TDP-43 has a domain that is rich in glutamine and asparagine (Q/N) residues that 
is reminiscent of the prion-forming domains (PFDs) of several yeast prion proteins [14,250]. 
This domain facilitates aggregation of TDP-43 into stress granules during heat shock and can be 
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functionally replaced with the Q/N-rich PFD of the Rnq1 protein that forms the prion [RNQ+] in 
the budding yeast Saccharomyces cerevisiae [64,250]. 
Yeast prions are self-propagating aggregate structures that template the conversion and 
recruitment of monomers, acting as epigenetic elements of inheritance to modulate cellular 
phenotypes [14]. This same conformational change underlies the mechanistic basis of prion 
diseases in mammals, and likely several other degenerative disorders [2]. One striking feature of 
prion proteins lies in their innate ability to form a variety of amyloid structures, called prion 
strains, each having a different aggregate conformation that differentially influences cellular and 
pathological phenotypes [20]. This property is not specific to prion proteins, however. In fact, 
many amyloidogenic proteins exist in a multitude of distinct self-propagating amyloid 
conformations [43,44], which likely contributes to the pathological variability observed in many 
amyloid disorders [251].  
Genetic and environmental modifiers likely play a role in the generation and selection of 
different amyloid conformers, a characteristic we recently described with the [RNQ+] prion 
[32,34,35,41]. Like the regulation of proteostasis in humans, molecular chaperones are intimately 
involved in the propagation of yeast prions. The Hsp40 Sis1 binds prion aggregates and, in 
cooperation with Hsp70 and Hsp104, fragments these aggregates into smaller seeds that can be 
transmitted to daughter cells [86]. Hence, such processing results in, and is required for, the 
continued maintenance of the prion state. Interestingly, the DNAJB6 G/F domain shares more 
homology with the G/F domain of Sis1 than any other yeast Hsp40 [159]. Moreover, the Sis1 
G/F domain modulates protein aggregation [74]. Yet, the role that this domain plays in substrate 
processing remains unclear. 
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Here, we used the LGMD1D mutations in DNAJB6 with a combination of mammalian 
and yeast models to investigate how the G/F domain contributes to protein homeostasis. We 
found that these mutations impaired the chaperone-client interaction in a manner that showed 
striking dependence on not only the client, but also the specific conformation of the substrate. 
Additionally, G/F domain mutations in another member of the HSP40 family, DNAJB1, resulted 
in loss of yeast viability, likely due to a loss-of-function in handling essential substrates. 
Collectively, our data suggest that the G/F domain of DNAJB6 plays a crucial role in 
recognizing particular client conformers. Such loss of surveillance activity might lead to the 
accumulation of a toxic species that contributes to LGMD1D pathogenesis. In addition, the 
conformer-specific effects may be one factor that underlies the observed variation in disease 
progression, a hallmark of prion strains and the variability observed in prion diseases.  
 
4.3 Results 
4.3.1 Homologous LGMD1D mutations in DNAJB1 impair cell growth and propagation of the 
[RNQ+] prion 
To examine the role of G/F mutations on LGMD1D pathogenesis, we turned to the yeast 
system, which has provided significant mechanistic insight into many human diseases [252,253]. 
The yeast Hsp40 Sis1 shares homology with DNAJB6 through the G/F domain (Fig. 1A). While 
DNAJB6b could not functionally replace the essential role of Sis1 in yeast cells (data not 
shown), the closest human homolog to Sis1, the HSP40 DNAJB1, can complement for loss of 
Sis1 [100]. In addition to yeast viability, DNAJB1 can complement for the required role that Sis1 
plays in the maintenance of the yeast prion [RNQ+] [74,100]. This function in protein aggregate 
processing requires Sis1’s G/F domain and, in particular, a subdomain of the G/F domain not 
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present in the yeast Hsp40 Ydj1 that is comprised of the amino acid stretch containing all three 
LGMD1D mutant residues in DNAJB6 [100] 
Therefore, we created each of the LGMD1D mutations in DNAJB1 to test their effect on 
[RNQ+] propagation using sis1! yeast cells. Strikingly, we found that cells expressing DNAJB1-
F90I (homologous to DNAJB6-F89I) were unable to grow without Sis1 expression, similar to the 
vector control (Fig. 1B). Moreover, cells expressing DNAJB1-P98R (homologous to DNAJB6-
P96R) had a slow growth phenotype even when SIS1 was co-expressed. By contrast, cells 
expressing DNAJB1-F94L (homologous to DNAJB6-F93L) showed no defect in viability. Thus, 
we assessed the propagation of the [RNQ+] prion in cells expressing DNAJB1-F94L in the 
absence of WT Sis1 using sedimentation analysis. The [RNQ+] state can be monitored by 
assessing the amount of soluble versus insoluble Rnq1 after fractionating cell lysates with high-
speed ultracentrifugation. As most all of the Rnq1 protein is sequestered into aggregates in 
[RNQ+] cells, Rnq1 accumulates in the pellet fraction [64]. In cells expressing WT DNAJB1, we 
found that the [RNQ+] prion was maintained as most of Rnq1 was in its aggregated, insoluble 
form (Fig. 1C), in agreement with previous work [100]. In stark contrast, much of Rnq1 was 
soluble in cells expressing DNAJB1-F94L, indicating that DNAJB1-F94L can functionally 
replace the essential roles of Sis1, but is defective in propagation of [RNQ+]. 
 
4.3.2 DNAJB6 mutations differentially impair prion propagation of [RNQ+] strains 
Because two of the LGMD1D mutations in DNAJB1 impaired cell growth, we created a 
chimeric protein to test the effect of all of the disease-linked mutations on [RNQ+] propagation. 
This chimera has the G/F domain of DNAJB6 in place of Sis1’s, leaving intact the other 
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functional domains of Sis1 (Fig. 2A). Hereafter, this chimera is referred to as SDSS, denoting the 
origins of each domain with “S” for Sis1, or “D” for DNAJB6. 
Using sis1! yeast cells, we replaced Sis1 with WT SDSS or LGMD1D mutant SDSS 
constructs. As controls, we used cells expressing WT Sis1 or Sis1-#G/F, which has the G/F 
domain deleted and is unable to propagate [RNQ+] [74]. We then monitored [RNQ+] 
propagation using sedimentation assays. In contrast to cells expressing WT Sis1, where most of 
Rnq1 was insoluble, expression of Sis1-#G/F resulted in a shift of Rnq1 to the soluble fraction, 
as expected from earlier studies [74] (Fig. 2B). This suggests that the presence of the G/F domain 
is required for Sis1 to recognize and maintain the self-propagating Rnq1 aggregate structure. 
Importantly, expression of WT SDSS phenocopied WT Sis1, indicating that this chimera can 
functionally replace WT Sis1 in maintaining the [RNQ+] prion. To our surprise, no soluble Rnq1 
was detected in lysates of cells expressing the LGMD1D mutant SDSS constructs. This suggests 
that the mutant chimera has no defect in the recognition and processing of the Rnq1 aggregates. 
However, amyloidogenic proteins, including Rnq1, exist in a variety of different self-
propagating structures [9,11,32,35]. Prion strains of [RNQ+] have been classified largely on two 
properties: their ability to induce the formation of the [PSI+] prion (low to very high rates), and 
the in vivo aggregation pattern observed by expressing Rnq1-GFP [31,120]. Cells propagating a 
single-dot (s.d.) [RNQ+] strain have predominantly one focus present, while multiple-dot (m.d.) 
[RNQ+] cells exhibit multiple foci. Thus, we hypothesized that the DNAJB6 G/F domain and the 
LGMD1D mutations might be differentially important in processing distinct aggregate 
structures. While we initially analyzed the m.d. high [RNQ+] strain (Fig. 2B), we extended our 
analysis to examine the propagation of four different [RNQ+] strains (Fig. 2C). First, we found 
that expression of WT SDSS resulted in most of the Rnq1 protein accumulating in the insoluble 
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fraction (s.d. low and s.d. very high [RNQ+] contain a small pool of soluble Rnq1 that is larger 
than that of other [RNQ+] strains [31]). Deletion of the G/F domain resulted in accumulation of 
Rnq1 in the soluble fraction for all [RNQ+] strains, indicating that the G/F domain is universally 
important for the maintenance of different Rnq1 aggregate structures. Remarkably, however, we 
found that the LGMD1D mutations differentially impaired the propagation of the [RNQ+] 
strains, despite being expressed at similar levels (Fig. S1A). Like m.d. high [RNQ+], the amount 
of soluble Rnq1 did not change in s.d. low [RNQ+] cells expressing any of the mutants. In 
contrast, in s.d. medium [RNQ+] cells, SDSS-F89I phenocopied the deletion of the entire G/F 
domain. There was also an accumulation of soluble Rnq1 in s.d. medium [RNQ+] cells 
expressing SDSS-P96R. Moreover, the F89I mutation eliminated the majority of Rnq1 
aggregates in s.d. very high [RNQ+] cells and increased the amount of soluble Rnq1 in s.d. high 
[RNQ+] cells. However, the P96R mutation did not affect s.d. high or s.d. very high [RNQ+]. 
These data suggest that LGMD1D mutations impair the role of the G/F domain in processing 
particular aggregate conformations of Rnq1. 
We next examined the effect of the LGMD1D mutations on the prion strain-specific 
distribution of Rnq1 aggregates using fluorescence microscopy with cells harboring WT or 
mutant SDSS and propagating either s.d. medium or m.d. high [RNQ+]. We found that 
expression of SDSS-F89I in s.d. medium [RNQ+] cells caused all of Rnq1-GFP to be diffuse, 
similar to [rnq-] cells harboring WT SDSS (Fig. 3). By contrast, the distribution of puncta was 
unchanged in mutant cells propagating m.d. high [RNQ+] (Fig. S1B), thereby confirming our 
solubility assay results. 
 
4.3.3 [RNQ+] strains rely on Sis1 expression to different degrees 
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As chaperone-mediated substrate processing is an intricate process, changes in chaperone 
expression have been shown to differentially affect strains of another yeast prion called [PSI+] 
[94,215]. As such, we hypothesized that the differential effects of the LGMD1D mutations may 
simply be due to [RNQ+] prion strains having different sensitivities to changes in Sis1 
expression. To test this, we down-regulated SIS1 and monitored the rate at which the Rnq1 
aggregates were lost using semi-denaturing agarose gel electrophoresis (SDD-AGE), a technique 
that resolves aggregates. Despite being unaffected by the LGMD1D mutations, we found that 
m.d. high [RNQ+] cells had a dramatic loss in Rnq1 aggregates by the fifth generation. By 
contrast, a comparable loss of Rnq1 aggregates was delayed in s.d. medium [RNQ+] cells, which 
was most affected by LGMD1D mutations, and occurred at the seventh generation (Fig. 4A). 
Moreover, the sensitivity to Sis1 expression of the other s.d. [RNQ+] strains, which were 
variably affected by the LGMD1D mutations, was similar to s.d. medium [RNQ+] (Fig. S1C). 
Importantly, steady state levels of Sis1 were similarly down-regulated to 2% of WT by the 
seventh generation (Fig. 4B). This indicates that the effect of the LGMD1D mutations on the 
propagation of the [RNQ+] strains does not correlate to the sensitivity of these prion strains to 
Sis1 expression. 
 
4.3.4 DNAJB6 mutations differentially impair propagation of [PSI+] strains 
We then asked if the LGMD1D mutations affected another known Sis1 substrate, the 
[PSI+] prion, which is formed by the translation termination factor Sup35 [24,95]. The presence 
of [PSI+], by sequestering Sup35 into aggregates, modulates translation termination. Thus, it is 
easily monitored using auxotrophic markers that have a premature termination codon (PTC), 
such as the ade1-14 allele [14]. [psi-] cells have soluble Sup35 that faithfully terminates 
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translation at the PTC. Thus, these cells cannot complete the adenine biosynthetic pathway and 
accumulate a metabolic intermediate that gives [psi-] colonies a red color. In contrast, [PSI+] 
cells can read through the PTC (called nonsense suppression), thus preventing accumulation of 
the red pigment. Interestingly, different prion strains of [PSI+] are linked to different levels of 
nonsense suppression: cells propagating stronger [PSI+] strains have more nonsense suppression 
and are light pink as compared to cells propagating weaker [PSI+] strains that are darker pink 
[24]. 
To test how the G/F domain and the LGMD1D mutations affect [PSI+] propagation, we 
used sis1! cells propagating four different [PSI+] structures: two weaker [PSI+] strains (Sc37 
and weak [PSI+]) and two stronger [PSI+] strains (Sc4 and strong [PSI+]) [24,25]. We first noted 
that all [PSI+] strains propagated, to some degree, when Sis1-#G/F was expressed, as indicated 
by a pink or white colony color that was distinct from [psi-] cells (Fig. 5A). As all [RNQ+] 
strains were eliminated by expression of Sis1-#G/F (Fig. 2), this suggests that Sup35 contrasts 
with Rnq1 as a Sis1 substrate, and thereby provides a good means of expanding our analysis. 
However, unlike previous reports [95], propagation of both weaker [PSI+] strains was impaired, 
as indicated by cells having a darker pink color on rich media. Propagation of Sc4 and strong 
[PSI+] was not affected by expression of Sis1-#G/F. This indicates that the G/F domain of Sis1 
plays a more significant role in propagation of weaker [PSI+] strains as compared to stronger 
[PSI+] strains, but [RNQ+] has the greatest dependence on this domain. 
Next, we analyzed the effect of the LGMD1D mutations in SDSS on [PSI+] propagation. 
None of the mutations affected the stronger [PSI+] strains (Fig. 5B). However, like the deletion 
of the G/F domain, the F89I mutation impaired the propagation of Sc37 and weak [PSI+]. 
Furthermore, as prion strains have different biochemical properties, we hypothesized that the 
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LGMD1D mutations might affect these properties without necessarily affecting the [PSI+] 
phenotype. Previously, it was shown that one of the major distinguishing features of [PSI+] 
strains is that weaker [PSI+] strains typically consist of larger Sup35 aggregates as compared to 
stronger [PSI+] strains and have more soluble Sup35 [117,118]. Therefore, in order to gain 
additional insight into how the LGMD1D mutations affect prion propagation, we analyzed 
aggregate size and soluble Sup35 using SDD-AGE. In agreement with our phenotypic analysis, 
we found that for Sc37 and weak [PSI+], expression of either SDSS-F89I or Sis1-#G/F resulted 
in a loss of aggregated Sup35 as well as an increased monomer pool (Fig. 5C and Fig. S2). 
Moreover, while expression of SDSS-P96R did not result in any detectable phenotypic change in 
cells propagating these weaker [PSI+] strains, lysates showed increased soluble Sup35. By 
contrast, the Sup35 aggregate size and amount of soluble Sup35 of cells propagating Sc4 and 
strong [PSI+] was not affected by expression of the LGMD1D mutations in SDSS. Therefore, 
like [RNQ+], these data show that the G/F domain and the LGMD1D mutants differentially 
affect propagation of distinct [PSI+] prion strains. 
 
4.3.5 LGMD1D mutations in DNAJB6 alter TDP-43 nuclear aggregation and disaggregation 
In order to examine the G/F domain mutations in a mammalian model of LGMD1D, we 
used TDP-43 as a pathological correlate, as it is known to aggregate in LGMD1D [159]. 
Moreover, TDP-43 contains a prion-like domain that mediates its aggregation [254]. This 
domain can be functionally replaced by the prion-forming domain of Rnq1 [250,254], thereby 
further connecting our yeast studies to a mammalian substrate. To test whether mutations in 
DNAJB6 affected TDP-43 aggregation, we heat shocked HeLa cells expressing TDP-43-
mCherry and WT or LGMD1D mutant DNAJB6b-GFP, which leads to the formation of nuclear 
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stress bodies of TDP-43 [250]. During heat shock and the following recovery, we monitored the 
presence and co-localization of TDP-43 nuclear stress bodies with DNAJB6b. Interestingly, we 
found that WT DNAJB6b and all mutant constructs similarly translocated to the nucleus during 
heat shock and co-localized with TDP-43 nuclear stress bodies (Fig. 6A and Fig. S3A). During 
recovery, we found that WT DNAJB6b enhanced the dissolution of these stress bodies, as 
compared to GFP controls (Fig. 6B,C). However, despite no defect in localization to TDP-43 
aggregates or differences in expression (Fig. S3B), every DNAJB6b mutant enhanced the 
formation and persistence of TDP-43 stress bodies (Fig. 6B,C).  
In addition, we monitored the amount of insoluble TDP-43 using differential detergent 
extraction and centrifugation. With expression of WT DNAJB6b or our GFP control, we found 
that TDP-43 entered an insoluble fraction upon heat shock and became soluble upon recovery 
(Fig. 6D). However, consistent with our immunofluorescence data, when LGMD1D mutants or 
DNAJB6b-#G/F was expressed, more TDP-43 was present in the insoluble fraction under 
normal conditions and upon heat shock, and persisted during the recovery period (Fig. 6D). 
We then performed a similar analysis without DNAJB6 over-expression, using 
fibroblasts derived from three independent LGMD1D patients harboring the DNAJB6-F93L 
mutation, as compared to three patient control fibroblasts. Importantly, these cells expressed 
DNAJB6b at similar levels (Fig. S3C). Again, upon heat shock and during recovery, we found 
that the mutant fibroblasts showed enhanced formation and delayed dissolution of TDP-43 
nuclear stress bodies (Fig. 7), a pattern also seen with endogenous TDP-43 (Fig. S3D,E). These 
data indicate that LGMD1D mutations abrogate the ability of DNAJB6b to resolve nuclear TDP-




Taken together, our study demonstrates that the LGMD1D mutations in the G/F domain 
of DNAJB6 disrupt client processing in both a substrate- and conformation-specific manner. 
This defines a novel disease pathomechanism in a protein aggregate disorder, as it is the first 
time, to our knowledge, that mutations associated with a chaperonopathy have client conformer-
specific effects. Specifically, when placed in the context of Sis1, DNAJB6’s G/F domain can 
efficiently recognize and process multiple protein aggregate conformers of the same protein (e.g. 
Rnq1 and Sup35). However, a single disease point mutation in this previously underappreciated 
region of DNAJ proteins abrogates processing of distinct protein aggregate conformers.  
One potential mammalian aggregation-prone protein with specificity to protein aggregate 
myopathies is TDP-43. We have previously established that TDP-43 accumulates in LGMD1D 
patient muscle and that TDP-43 is a potential DNAJB6 client protein [159,250]. Persistence of 
TDP-43 aggregates in DNAJB6-expressing cells and patient fibroblasts further demonstrates a 
DNAJB6-TDP-43 client interaction. In the context of a human protein aggregate disorder, our 
data now emphasize the expanded and crucial role that the G/F domain plays in protein 
aggregation by acting as the major regulator of substrate and conformer selectivity. This agrees 
with previous data with the bacterial DnaJ protein [244]. Two possibilities might explain the 
selectivity: either the G/F domain directly binds substrates, or it modulates the neighboring J 
domain and the interaction of this domain with Hsp70. Future studies will be necessary in order 
to distinguish between these two scenarios. In either case, we suggest that LGMD1D mutations 
in DNAJB6 do not abolish all of its chaperone function, but instead confer impaired chaperone 
surveillance in human skeletal muscle of distinct protein aggregate conformers, such as TDP-43 
or some other important client. Selectively disrupting substrate processing might then lead to the 
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accumulation of these particular aggregate conformers, followed by toxicity, and ultimately 
muscle degeneration (Fig. 8). 
DNAJB6 has previously been implicated in modulating the turnover of a number of 
different proteins [250,255-257]. Interestingly, many proteins can populate a variety of different 
aggregated structures or different folding intermediates [20,258]. Hence, the chaperone network 
is charged with the task of handling a large spectrum of substrate conformations in order to 
maintain cellular homeostasis. Moreover, while there are some common pathogenic mechanisms 
involved in protein misfolding disorders, there is also tremendous tissue specificity. DNAJB6 is 
one of the more abundant HSP40s in skeletal muscle, yet it is ubiquitously expressed and is more 
abundant in other tissues [259]. Therefore, it is intriguing to speculate that certain tissue-specific 
protein conformers, whether aggregated or simply unfolded, are more refractory to dissolution 
and cannot be resolved by DNAJB6 G/F domain mutants. 
By analyzing the LGMD1D mutations in a yeast model, we found striking differences 
between these mutations on phenotypic consequences. Expression of the homologous mutation 
of F89I showed the greatest effect in terms of cell viability using DNAJB1 and propagation of 
[RNQ+] and [PSI+] using SDSS. Indeed, previous work in zebrafish similarly showed that the 
F89I mutation caused more severe muscle degeneration than the F93L mutation [160]. This is 
also consistent with human LGMD1D: while the disease is typically late onset, patients with the 
F89I mutation have been reported to present with childhood onset weakness [260]. It is 
important to note, however, that even though there was no effect of SDSS-F93L on propagation 
of the m.d. high [RNQ+] strain, the homologous F94L mutation present in DNAJB1 impaired 
propagation. Therefore, we propose that different mutations may be associated with variation in 
disease severity by impairing Hsp40 function to different degrees. 
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Mutations in other DNAJ proteins have also been shown to cause disease, and the 
involvement of these proteins has been implicated in many other disorders [157]. As this family 
of chaperones has over 40 members in humans, there likely is a high level of specificity in 
cellular functions [148]. A variety of factors can influence this functional specificity. Here, we 
show that the Hsp40 G/F domain plays a major role in substrate conformer selectivity. Hence, 
when examining the mechanistic basis of chaperonopathies, our data suggest that substrate 
conformation is another important variable that may contribute to disease progression. 
 
4.5 Materials and Methods 
4.5.1 Yeast strains and media 
All yeast strains used in this study are derivatives of 74-D694 (ade1-14 his3-!200 leu2-
3,112 trp1-289 ura3-52). [RNQ+] and [PSI+] yeast strains were kind gifts from S. Liebman 
[24,31] and J. Weissman [25]. Standard culturing techniques were used. Rich media consisted of 
YPD (1% yeast extract, 2% peptone, 2% dextrose) or $ YPD (0.25% yeast extract, 2% peptone, 
2% dextrose) as indicated. Synthetic defined (SD) media (0.67% yeast nitrogen base without 
amino acids, 2% dextrose) lacking the specified nutrients was used to select for plasmids. To 
make the sis1! yeast strains, [rnq-] [psi-] cells were transformed with pRS316-SIS1. SIS1 was 
then deleted by first amplifying the hphMX4 cassette from pAG32 using oligonucleotides 1415 
and 1416 (see oligonucleotides listed in Table S1), having flanking homology to the SIS1 
promoter and terminator. The purified product was then transformed and cells resistant to 
hygromycin B were selected. Deletion of SIS1 was confirmed by the inability to grow on solid 
medium containing 1mg/mL 5-fluoroorotic acid (5-FOA), as expression of SIS1 is essential. 
These cells were then mated to [PRION+] cells, followed by sporulation of the diploids, and 
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selection of haploids that were resistant to hygromycin B. Replacement of WT Sis1 with the 
DNAJB1, SDSS, or Sis1 constructs was then performed by a plasmid shuffle technique using 
media containing 5-FOA to select against cells containing the URA3-marked SIS1 plasmid. 
 
4.5.2 Plasmid construction 
Plasmids pRS314-sis1-!G/F and pRS316CUP1-RNQ1(153-405)-GFP were kind gifts 
from S. Lindquist [74], and plasmids pTETr-SIS1, pRS316-SIS1, and pRS424GPD-DNAJB1 
were kind gifts from E. Craig [99,100]. Oligonucleotides used to clone the yeast plasmids are 
listed in Table S1. The endogenous SIS1 promoter was amplified with oligonucleotides 1454 and 
1455 and digested with SacI/SpeI, and the endogenous SIS1 terminator was amplified with 1456 
and 1457 and digested with ClaI/XhoI. These products were ligated into pRS314 to make an 
intermediate plasmid used to clone the other constructs. To make pRS314-SIS1, SIS1 was 
amplified with oligonucleotides 0229 and 0230, followed by SpeI/ClaI digestion and ligation. 
pRS314-SDSS was created by bridge PCR amplifying the N-terminal part with oligonucleotides 
0229 and 1618. The C-terminal part of this construct was amplified in two parts, using 
oligonucleotides 1617 and 0230, followed by using this PCR product as a template with 
oligonucleotides 1619 and 0230 to create the rest of the DNAJB6 G/F domain. The full-length 
SDSS construct was then amplified using the N-terminal and C-terminal products with 
oligonucleotides 0229 and 0230, followed by SpeI/ClaI digestion and ligation. Using pRS314-
SDSS, the LGMD1D mutations were created by bridge PCR using the following 
oligonucleotides: 1567 and 1568 (F89I), 1620 and 1621 (F93L), 1569 and 1570 (P96R). The 
SDSS chimera consists of Sis1 amino acid residues 1-84 and 124-352 flanking the DNAJB6 G/F 
domain residues 72-108. DNAJB1 mutants were made by bridge PCR using the following 
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oligonucleotides: 1539 and 1540 (F90I), 1492 and 1493 (F94L), 1541 and 1542 (P98R), 
followed by digestion with SpeI/ClaI and ligation with pRS424GPD. Finally, mammalian 
constructs of DNAJB6b were cloned using site-directed mutagenesis, digested with 
HindIII/XhoI, and ligated into vector pcDNA3.1 containing a GFP tag. DNAJB6b-#G/F 
consisted of a deletion of amino acid residues 87-97. 
 
4.5.3 Protein analysis 
Sedimentation analysis of Rnq1 was performed as described previously [75], and 
assessed by SDS-PAGE and western blot using an "Rnq1 antibody. SDD-AGE for [PSI+] yeast 
cells was performed as described elsewhere [242], and analyzed by western blot using an "Sup35 
antibody. For extraction and immunoblotting of mammalian cells, cells were washed twice with 
cold PBS, lysed in cold RIPA buffer (50mM Tris pH 8.0, 150mM NaCl, 1% Nonidet-p40 
(IGEPAL), 0.5% sodium deoxycholate, 0.1% SDS, 1mM phenylmethylsulfonyl fluoride, and 
protease inhibitor cocktail) for 30 min, and centrifuged at 10,000 rpm at 4oC for 10 min. Equal 
amounts of total protein (10%g/sample) were resolved by 10% SDS-PAGE and analyzed by 
western blot according to standard procedures. Antibodies used included: polyclonal rabbit 
"TDP-43 (Proteintech, 10782-2-AP, 1:1500), monoclonal mouse "DNAJB6 (Novus Biologicals, 
H00010049-M01, 1:500), monoclonal mouse "HSP70 (Enzo Life Sciences, ADI-SPA-810, 
1:1000), polyclonal rabbit "GAPDH (Cell Signaling Technologies, 2118, 1:1000), and Goat 
"Mouse-HRP and Goat "Rabbit-HRP (Jackson Immunoresearch Laboratories, 1:5000). 
For the TDP-43 sedimentation assay, HeLa cells (5x104) were seeded into 6-well plates 
and incubated in DMEM containing 10% FBS and 1% Pen/Strep at 37°C and 5% CO2. After an 
overnight incubation, the cells were co-transfected with Cherry-TDP-43-FL and either WT or 
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mutant versions of DNAJB6b. After a post-transfection period (24h), the cells were lysed in 
RIPA buffer. The lysates were fractionated first with sonication (10 cycles of 30” on, 30” off) 
followed by centrifugation at 40,000 rpm for 30 min at 4°C. The insoluble pellets were dissolved 
in Urea buffer (7M urea, 2M thiourea, 4% CHAPS, and 30mM Tris pH 8.5), subjected to SDS-
PAGE and western blotting using a polyclonal "TDP-43 antibody. For unknown reasons, the 
TDP-43-mCherry construct migrates as a doublet between 50-75 kDa, as previously described 
[261,262]. 
 
4.5.4 Prion analysis by fluorescence microscopy 
Imaging of live yeast cells was performed on a Zeiss Axiovert 200 Inverted Microscope 
equipped with a Zeiss 100x/1.4 NA oil objective. Overnight liquid cultures of cells harboring 
pRS316CUP1-RNQ1(153-405)-GFP were diluted to an OD600 of 0.2. After 1 hr of growth, 
50µM CuSO4 was added to cultures and cells were imaged after ~2.5 hrs of induction. 
Representative images of at least three independent experiments are shown. 
 
4.5.5 Time-course of prion loss 
Yeast sis1! cells expressing pTETr-SIS1 in place of pRS316-SIS1 were used to repress 
SIS1, as previously described [99]. pTETr-SIS1 expresses SIS1 from a tetracycline-repressible 
promoter, allowing for down-regulation of SIS1 by growing cells in media containing 
doxycycline, a tetracycline analog. Cultures were maintained in log phase and grown in the 
presence of 5µg/mL doxycycline. Samples were subjected to SDD-AGE and western blot using 
an "Rnq1 antibody following established protocols for the [RNQ+] prion [32], which does not 
 154 
reliably show Rnq1 monomer for unknown reasons. SDS-PAGE and western blot was used with 
an "Sis1 antibody (gift of E. Craig) and quantified by ImageJ. 
 
4.5.6 Yeast phenotypic assays 
To monitor cell growth or the [PSI+] status of yeast cells, overnight cultures were 
normalized by OD600, serially diluted five-fold, and spotted on the indicated media. The [PSI+] 
status was assessed by colony color on $ YPD plates that were incubated for 3 days at 30oC, 
followed by overnight incubation at 4oC for additional color development. Representative images 
of at least three independent experiments are shown. 
 
4.5.7 Mammalian cell culture and heat shock 
HeLa cells were cultured in high glucose formulation of Dulbecco's modified Eagle's 
medium (high glucose + glutamine, no sodium pyruvate) supplemented with 10% (vol/vol) fetal 
bovine serum and penicillin/streptomycin. Primary fibroblast cell lines were derived from patient 
skin biopsies and grown in FGM™-2 Fibroblast Growth Medium-2 (Lonza CC-4126) that is 
developed to support the growth of most primary human fibroblasts. 
For heat shock experiments, cells were transfected with Cherry-TDP-43 and either wild-
type or mutant versions of the GFP-DNAJB6b constructs, and maintained at 37°C. 24 hrs after 
transfection, cells were subjected to heat shock (42°C, 1 hr), then allowed to recover at 37°C for 
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Figure 1. Homologous LGMD1D mutations in DNAJB1 impair cell growth and [RNQ+] 
prion propagation. (A) Sequence comparison of the G/F domains of DNAJB6, DNAJB1, Sis1, 
and another yeast Hsp40 Ydj1, aligned with ClustalW2. Boxes surround the disease-linked 
mutations. (B) Yeast sis1! cells propagating m.d. high [RNQ+] and expressing the indicated 
construct were serially diluted five-fold and spotted onto rich media (YPD), or on media to select 
for loss (- Sis1) or co-expression (+ Sis1) of WT Sis1. (C) m.d. high [RNQ+] cell lysates 
expressing WT DNAJB1 or DNAJB1-F94L in place of Sis1 were separated by 
ultracentrifugation into total (T), soluble (S), and insoluble (I) fractions that were then subjected 
to SDS-PAGE and western blot using an "Rnq1 antibody. Data are representative of n & 3. 
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Figure 2. Maintenance of different [RNQ+] strains is differentially impaired by LGMD1D 
mutations in SDSS. (A) Domain structures of Sis1, DNAJB6b, and chimera SDSS. (B) m.d. 
high [RNQ+] cell lysates expressing WT Sis1, Sis1-#G/F, or the indicated SDSS construct were 
fractionated as in Fig. 1C, followed by SDS-PAGE and western blot using an "Rnq1 antibody. 





Figure 3. LGMD1D mutations modulate the aggregation pattern of Rnq1 in vivo. The Rnq1 
aggregation pattern in (A) [rnq-] cells or (B) s.d. medium [RNQ+] cells harboring the indicated 




Figure 4. Effect of LGMD1D mutations does not correlate to the sensitivity of [RNQ+] 
strains to Sis1 expression. (A) Cells propagating m.d. high or s.d. medium [RNQ+] had 
endogenous SIS1 replaced by pTETr-SIS1. Cells grown in the presence of doxycycline (Dox) had 
samples taken at the indicated number of generations (gen no.), followed by SDD-AGE and 
western blot using an "Rnq1 antibody. Data are representative of n = 3. (B) Western blot 




Figure 5. LGMD1D mutations in SDSS differentially impair propagation of [PSI+] strains. 
(A) Equivalent numbers of sis1! cells expressing WT Sis1 or Sis1-#G/F with the indicated 
[PSI+] status were serially diluted five-fold and spotted onto rich media to monitor the [PSI+] 
phenotype by color. (B) As in (A) with the indicated SDSS construct. Dotted lines represent 
different parts of the same plate cropped for clarity. (C) SDD-AGE analysis of cell lysates 
expressing the indicated SDSS construct. Data are representative of n = 4. 
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Figure 6. LGMD1D mutations in DNAJB6 alter TDP-43 nuclear aggregation and 
disaggregation. (A) Nuclear co-localization of DNAJB6b and TDP-43 upon heat shock. HeLa 
cells were co-transfected with TDP-43-mCherry and DNAJB6b-GFP (WT or F93L), subjected to 
heat shock at 42oC for 1 hr, followed by recovery for 2 hrs at 37oC. (B and C) As in (A), TDP-43 
nuclear stress body formation (B) and quantitation (C) in HeLa cells transfected with the 
indicated DNAJB6b construct. Data are represented as mean ± SEM with n = 4. (D) HeLa cells 
expressing the indicated construct were treated as in (A), lysed, and separated into total (T), 
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soluble (S), and insoluble (I) fractions that were then subjected to SDS-PAGE and western blot 




Figure 7. Dissolution of TDP-43 stress granules is disrupted in patient fibroblasts. TDP-43 
nuclear stress body formation (A) and quantitation (B) in LGMD1D patient (F93L) or control 
fibroblasts. Cells were transfected with TDP-43-mCherry and treated as in Fig. 6A with a 3 hr 




Figure 8. Schematic model of how mutations in DNAJB6 may contribute to LGMD1D 
pathogenesis. In skeletal muscle, various insults may lead to the misfolding of a substrate into a 
range of distinct aggregate conformers. (A) Wild-type (WT) DNAJB6 is capable of properly 
processing these misfolded conformers, which might include refolding the substrate into its 
native conformation. (B) In the case of LGMD1D, mutations in DNAJB6 impair the processing 
of particular conformers. This leads to the accumulation of this specific aggregate conformer, 
and ultimately to cellular toxicity and myocyte degeneration. 
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4.8 Supplemental Figures and Tables 
 
Figure S1. Maintenance of different [RNQ+] strains is differentially impaired by LGMD1D 
mutations in SDSS. (A) Western blot analysis of Sis1 and SDSS mutants in yeast cells. Cell 
lysates harboring the indicated construct were subjected to SDS-PAGE and western blot with an 
"Sis1 antibody along with an "Pgk1 antibody as a loading control. (B) Representative images of 
the Rnq1 aggregation pattern in m.d. high [RNQ+] cells harboring the indicated SDSS construct 
and expressing copper-inducible Rnq1-GFP. (C) Cells propagating the indicated [RNQ+] strain 
had endogenous SIS1 replaced by pTETr-SIS1. Cells were grown in the presence of doxycycline 
(Dox) with samples taken at the indicated number of generations (gen no.). Lysates were 




Figure S2. LGMD1D mutations in SDSS differentially impair propagation of [PSI+] 
strains. (A) Sc37 [PSI+] or [psi-] cell lysates expressing wild-type Sis1 or Sis1-#G/F were 
subjected to SDD-AGE and western blot using an "Sup35 antibody. (B) Weak and strong [PSI+] 
cells or [psi-] cells harboring the indicated SDSS construct were subjected to SDD-AGE and 




Figure S3. LGMD1D mutations in DNAJB6 alter TDP-43 nuclear aggregation and 
disaggregation. (A) Nuclear co-localization of DNAJB6b and TDP-43 upon heat shock. HeLa 
cells were co-transfected with TDP-43-mCherry and the indicated GFP-DNAJB6b mutant for 24 
hours and then subjected to heat shock at 42oC for 1 hr, or 42oC for 1 hr followed by recovery for 
2 hrs at 37oC. (B) Western blot analysis of HeLa cell extracts transfected with the indicated 
constructs as compared to untransfected cells (control), using antibodies against TDP-43, 
DNAJB6b, and HSP70, along with GAPDH as a loading control. All samples were run on the 
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same gel, but have been cropped for clarity. (C) Western blot analysis of patient fibroblasts from 
three independent control patients (C1, C2, C3) and three different patients from the same family 
having the DNAJB6-F93L mutation (P1, P2, P3), using antibodies against DNAJB6b and 
GAPDH. M: marker. (D and E) Nuclear stress body formation (D) and quantitation (E) of 
endogenous TDP-43 in LGMD1D patient (F93L) or control fibroblast lines, subjected to heat 
shock at 42oC for 1 hr, or 42oC for 1 hr followed by recovery for 2 or 3 hrs at 37oC. Data are 
represented as mean ± SEM with n = 4. 
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Table S1. Oligonucleotides used in this study. 
Oligonucleotide Description Sequence 
1454 5’ Sis1prom-SacI 5'CGCGAGCTCGCTAGTCGTTACTTTTC 
1455 3’ Sis1prom-SpeI 5'CGCACTAGTTATTAGTTCTGTATACTATAC 
1456 5’ Sis1term-ClaI 5'CGCATCGATTAGTAATCCTAAGCAAATATAA 
1457 3’ Sis1term-XhoI 5'CGCCTCGAGTTGGACTTACAAAAACTTC 
0229 5' Sis1-SpeI 5'ATACTAGTATGGTCAAGGAGACAAAAC 
0230 3' Sis1-ClaI 5'TGATCGATATTTGCTTAGGATTACTATTAAA 
1618 3' SDSS 5’CTGTCAAAATGACTTCCACCTCCTCCTCCACCATTTAATCCAGGACCACCAGGACCAAAGCTTG 
1617 5' SDSS 5’CCGTAACCCAGATGATGTCTTCAGGGAATTTTTTGGTGGAAGGGACCCATTCGGTGGTGCTGATGAC 
1619 5' SDSS linker 5’GGTGGAAGTCATTTTGACAGTCCATTTGAATTTGGCTTCACATTCCGTAACCCAGATGATGTCTTC 
1567 5’ dnajB6-F89I 
5’GACAGTCCATTTGAAATTGGCTTCACATTCCGTA
AC 
1568 3’ dnajB6-F89I 
5’GTTACGGAATGTGAAGCCAATTTCAAATGGACT
GTC 
1620 5’ dnajB6-F93L 
5’GAATTTGGCTTCACACTCCGTAACCCAGATGAT
G 
1621 3’ dnajB6-F93L 
5’CATCATCTGGGTTACGGAGTGTGAAGCCAAATT
C 
1569 5’ dnajB6-P96R 
5’GGCTTCACATTCCGTAACCGAGATGATGTCTTCA
GGG 
1570 3’ dnajB6-P96R 
5’CCCTGAAGACATCATCTCGGTTACGGAATGTGA
AGCC 
1415 5’ Sis1 KO 5’CATTCACATCAATATAATAGAGTATAGTATACAGAACTAATACAGCTGAAGCTTCGTACGC 
1416 3’ Sis1 KO 5’GTGATAAATTTATTTGAGTTTATAATTATATTTGCTTAGGATTACTAGCATAGGCCACTAGTGGATCTG 
1539 5’ dnajb1-F90I 
5’GTGCCAATGGTACCTCTATCAGCTACACATTCCA
TG 
1540 3’ dnajb1-F90I 
5’CATGGAATGTGTAGCTGATAGAGGTACCATTGG
CAC 
1492 5’ dnajb1-F94L 
5’CTCTTTCAGCTACACACTCCATGGAGACCCTCAT
G 
1493 3’ dnajb1-F94L 
5’CATGAGGGTCTCCATGGAGTGTGTAGCTGAAAG
AG 
1541 5’ dnajb1-P98R 
5’CACATTCCATGGAGACCGTCATGCCATGTTTGCT
G 
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5.1 Abstract 
 A wide range of cellular activity depends on the function of molecular chaperones. 
Through modulating the activity of Hsp70s, Hsp40 proteins are proposed to be major regulators 
of several aspects of protein quality control. Mutations in the Hsp40 DNAJB6 G/F domain 
disrupt the proteostasis network and cause the limb-girdle muscular dystrophy type 1D 
(LGMD1D), which exhibits an accumulation of protein aggregates and vacuoles in skeletal 
muscle. Recently, we have shown that these mutations selectively alter the processing of 
particular aggregate conformers. Here, we use yeast and the DNAJB6 ortholog Sis1 to explore 
what other Hsp40 functions are altered by the LGMD1D-associated mutations. We demonstrate 
that these mutations do not disrupt the role of Hsp40 in luciferase refolding or Sis1-mediated 
protein degradation. However, we found that over-expression of the LGMD1D-associated 
mutations exhibits Hsp70-dependent toxicity, likely through dysregulation of processing 
essential substrate proteins. Moreover, modulating the Hsp70 ATPase cycle partially suppressed 
the impaired processing of the [RNQ+] prion. We propose that the LGMD1D-associated 
mutations might cause hyperstimulation of Hsp70 activity and aberrant client processing. Hence, 
this work provides additional mechanistic insight into how the LGMD1D-associated mutations 
might disrupt DNAJB6 function, which could lead to more targeted therapeutic approaches. 
 
5.2 Introduction 
From translation to degradation, molecular chaperones monitor multiple aspects of the 
life cycle of a protein. The family of Hsp70 proteins consists of key players in maintaining the 
health of the proteome. As proteins are innately susceptible to misfolding and aggregation, a 
major function of Hsp70s is to refold these substrates or mediate the degradation of terminally 
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misfolded proteins. However, while Hsp70s function on the frontline to protect the cell, the 
family of Hsp40 co-chaperones serves as the functional operators [148]. Indeed, the large 
number of Hsp40s (41 in humans as compared to 11 Hsp70s [148]), with their distinct tissue 
expression patterns [259], provides a tremendous amount of specificity in dictating Hsp70 
function.  
Hsp40s are categorized into three classes [102]. The presence of a highly conserved J 
domain is the common feature among all three classes. This domain facilitates the interaction 
with Hsp70s and the stimulation of Hsp70 ATPase activity and substrate processing [263]. The 
structural features outside of the J domain determine the class of Hsp40. In general, class A (type 
I) proteins have a domain rich in glycine and phenylalanine (G/F), a zinc finger motif, and a C-
terminal substrate-binding domain. The generic structure of class B (type II) Hsp40s is similar 
without the zinc finger motif. All class A and several class B proteins also have a dimerization 
domain at the extreme C-terminus that facilitates Hsp40 dimerization and increases the affinity 
for substrates [264]. Type III (class C) Hsp40s, on the other hand, do not fall into one of these 
categories and consist of a number of disparate domains that help increase the functional 
specificity of the Hsp40 family [148]. 
While some Hsp40s function in particular organelles or have specific client proteins, 
others act as general housekeeping proteins that can interact with a wide range of substrates 
[148]. However, it is suggested that the capacity of Hsp40s, and molecular chaperones in 
general, to monitor protein folding can be overwhelmed. Indeed, a loss of proteostatic control 
can occur through an increased burden of misfolded proteins that leads to protein aggregation 
[154]. There is a large number of unrelated proteins that aggregate and are associated with 
numerous diseases called protein conformational disorders [2]. Interestingly, a subset of protein 
 173 
conformational disorders, called chaperonopathies, highlight the importance of molecular 
chaperones in protein quality control, as these diseases are caused by a mutation in a molecular 
chaperone, including a number of different Hsp40 proteins [157]. One such example is a type of 
myopathy called limb-girdle muscular dystrophy type 1D (LGMD1D), which is caused by 
mutations in the Hsp40 DNAJB6 [159-162]. 
DNAJB6 is involved in regulating the turnover of several different substrates, indicating 
it likely plays a general role in protein quality control [250,255-257,265-268]. Indeed, one of the 
striking features of LGMD1D is the aggregation of several different proteins [159,160]. 
Interestingly, all of the LGMD1D-associated mutations that have been identified to date have 
been found in a short stretch of the G/F domain of DNAJB6 ([159-162] and personal 
communication). In addition to DNAJB6, disruption of the G/F domain in similar DNAJ proteins 
can impair substrate processing [74,244,269]. Recently, we extended the results of these studies, 
showing that mutations in the G/F domain not only affect the processing of particular substrates, 
but particular conformations of those substrates (Stein et al., in review). Yet, the underlying 
mechanism for how the G/F mutations impair Hsp40 function remains unclear. 
In this study, we take advantage of the yeast system and the homology between DNAJB6 
and the yeast Hsp40 Sis1, to provide mechanistic insight into how the LGMD1D-associated 
mutations affect DNAJB6 function. Despite showing that the G/F domain is involved in 
refolding heat-denatured luciferase in vivo, we show that the LGMD1D mutations do not affect 
processing of this substrate. Moreover, we found that there is no impact on Sis1-mediated protein 
degradation or induction of the heat shock response. However, the LGMD1D-associated 
mutations show striking toxicity when over-expressed that relies on an interaction with Hsp70, 
suggesting that the mutants cause aberrant processing of essential substrates. We propose that the 
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LGMD1D-associated mutations in DNAJB6 might cause hyperstimulation of Hsp70 ATPase 
activity, which leads to dysregulation of the turnover of certain substrates, or substrate 
conformers, that play a critical role in maintaining the integrity of skeletal muscle. 
 
5.3 Results 
5.3.1 LGMD1D Mutations do not affect Luciferase Refolding 
Hsp40s are proposed to dictate the specificity of substrate processing and monitoring 
protein quality control [148]. In line with this, we have previously shown that LGMD1D-
associated mutations impair the propagation of particular conformers of the [RNQ+] and [PSI+] 
prions in yeast (Stein et al., in review). We now wanted to test the extent to which these 
mutations impaired Hsp40 processes. First, we explored the selectivity of the LGMD1D 
mutations in altering substrate processing. Prion aggregates are considered to be rich in ! sheets 
[20]. Hence, we asked if the mutations would similarly affect the processing of aggregated 
substrates that are not ! sheet-rich. One substrate commonly used is heat-denatured luciferase, 
the refolding of which is an Hsp40-dependent process [89,104,270].  
To test whether LGMD1D-associated mutations affect the refolding of luciferase, we 
used sis1! yeast cells that expressed in place of WT Sis1 our previously described Sis1-DNAJB6 
chimeras, referred to as SDSS. As controls, we used WT Sis1 and the deletion construct Sis1-
#G/F, which was shown to impair the refolding of luciferase in vitro [104]. We grew each of 
these strains at 44°C in order to denature luciferase, followed by monitoring the efficiency of 
luciferase refolding during a two hour recovery period at 30°C. As expected, Sis1-#G/F reduced 
the ability of cells to refold luciferase as compared to WT Sis1 (Fig. 1), which agrees with the 
previous in vitro studies [104]. However, we found that none of the SDSS chimeras, WT or 
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mutant, significantly altered the ability to refold luciferase in [rnq-] cells (Fig. 1). The same was 
true in cells propagating the m.d. high [RNQ+] prion variant (data not shown), which we had 
previously shown was maintained in the presence of the SDSS chimeras (Stein et al., in review). 
This suggests that the LGMD1D-associated mutations might selectively alter interactions with 
substrates that are prone to forming aggregates rich in ! sheets. 
 
5.3.2 Sis1-Mediated Protein Degradation is not altered by LGMD1D Mutations 
In response to heat shock, DNAJB6b translocates to the nucleus and aids in resolving 
stress granules containing TDP-43 [250]. Similarly, Sis1 mediates the nuclear translocation and 
processing of cytosolic substrates [140,271], as well as the cytosolic degradation of other 
substrates [272]. Such Sis1-mediated translocation and degradation was recently shown using the 
model substrate, CG*, which consists of the cytosolic carboxypeptidase Y* fused to GFP [271]. 
Hence, we asked if the LGMD1D-associated mutations might impair the function of Sis1 in 
mediating the degradation of CG*. To test this, we monitored the kinetics of CG* turnover in 
[rnq-] and m.d. high [RNQ+] cells expressing WT Sis1, Sis1-#G/F, or the SDSS chimeras. When 
WT Sis1 was expressed, we found that CG* degraded rapidly (Fig. 2). Interestingly, none of the 
Sis1 constructs affected the turnover of CG*, even when the entire G/F domain was deleted. 
Moreover, these effects were independent of [RNQ+], as both [rnq-] and m.d. high [RNQ+] cells 
showed similar rates of CG* turnover. We had previously shown that the LGMD1D-associated 
mutations in DNAJB6 did not affect the translocation of DNAJB6 to the nucleus (Stein et al., in 
review). As CG* is translocated to the nucleus [271], our data agree with our previous results 
that the LGMD1D-associated mutations do not affect nuclear translocation. However, unlike our 
previous data using TDP-43 (Stein et al., in review), processing of CG* was unaffected. 
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5.3.3 Cellular Heat Shock Response is Normal in the Presence of LGMD1D Mutations  
In response to stress, cells will induce the expression of molecular chaperones, and 
particularly heat shock proteins, to counteract any cellular damage to proteins [273]. The 
transcription factor Hsf1 is the master regulator of the heat shock response, acting to induce 
expression of genes that have a heat shock element (HSE) in their promoter [273]. Interestingly, 
Hsf1 activity is regulated by Hsp70s, which repress Hsf1 activity under basal conditions, as well 
as activate the heat shock response when stress is sensed [274]. Therefore, as Hsp40s modulate 
the activity of Hsp70s, we asked whether the LGMD1D-associated mutations affected induction 
of the cellular heat shock response. We transformed [rnq-] and m.d. high [RNQ+] cells with a 
plasmid that expresses LacZ under the control of a promoter containing four heat shock 
elements. With the use of this plasmid, !-galactosidase activity serves as a direct measure of the 
heat shock response. After growing cells expressing each of the Sis1 and SDSS constructs at 
39°C for one hour and measuring the !-galactosidase activity, we found that there were no 
significant changes in the heat shock response with any of the constructs (Fig. 3 and data not 
shown). This suggests that the role of the LGMD1D-associated mutations in causing disease is 
not through alteration of the Hsp70-dependent induction of the heat shock response. 
 
5.3.4 Toxic Over-Expression of LGMD1D Mutants is Hsp70-Dependent 
 It has been shown that over-expressing Sis1-#G/F dominantly impairs yeast cell viability 
and propagation of the [RNQ+] prion [104], indicating the importance of the G/F domain in 
substrate processing. We wondered whether the LGMD1D-associated mutations would similarly 
affect cell viability. To test this, we made the homologous Sis1 mutations in the residues that are 
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conserved between Sis1 and DNAJB6. This included Sis1-F106L (homologous to DNAJB6-
F93L) and Sis1-F115I (homologous to DNAJB6-F100I). We then over-expressed these mutants, 
along with WT Sis1, in [rnq-] and m.d. high [RNQ+] cells. Strikingly, while cells over-
expressing WT Sis1 grew similar to the empty vector control, over-expression of both Sis1 
mutants greatly inhibited cell growth (Fig. 4). Such toxicity was independent of [RNQ+] status 
and could not be explained by any differences in expression (Fig. S1). 
 Interestingly, a secondary mutation in Sis1 was previously identified that suppressed the 
toxicity of Sis1-#G/F over-expression [104]. This mutation, Sis1-L268P, resides in the C-
terminal substrate-binding domain of Sis1 and was demonstrated to disrupt the interaction of 
Sis1 with the Hsp70 Ssa1 in vitro [104]. Therefore, we hypothesized that this mutation might 
also suppress the toxicity caused by the LGMD1D-associated mutations in Sis1. Indeed, making 
the second-site L268P mutation completely rescued the toxicity (Fig. 4). However, deletion of 
the Sis1 dimerization domain [224] did not suppress toxicity of the Sis1-F115I mutation. Taken 
together, these data suggest that over-expression of the LGMD1D-associated mutations in Sis1 
impairs cell viability in a manner that depends on the interaction of Sis1 with Hsp70, but not on 
Sis1 dimerization. 
 
5.3.5 Loss of Hsp70 Nucleotide Exchange Factor Partially Rescues Prion Propagation 
 We have demonstrated that the LGMD1D-associated mutations can impair propagation 
of particular prion conformers, especially s.d. medium [RNQ+] (Stein et al., in review). Similar 
to the Sis1-DNAJB6 chimeras that we had tested previously, we found that expression of Sis1-
F115I also eliminated the ability of s.d. medium [RNQ+] to propagate, as indicated by using a 
well-trap assay (Fig. 5). This assay determines the amount of Rnq1 protein that is soluble: for 
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[RNQ+] samples that have Rnq1 in an aggregated form, the aggregates will not break down in 
unboiled fractions and will not be able to enter an SDS-PAGE gel [189]. By contrast, the soluble 
Rnq1 in [rnq-] cells will enter the gel even in the unboiled fraction. 
Since we found that the toxicity of the LGMD1D-associated mutations in Sis1 was 
mediated through the interaction with Hsp70, we asked whether modulating Hsp70 activity 
would rescue prion propagation. While Hsp40s promote an ADP-bound state of Hsp70 that has 
high affinity for substates, nucleotide exchange factors (NEFs) also play a crucial role in the 
Hsp70 ATPase cycle by stimulating the exchange of ADP to ATP to release substrates and allow 
for additional substrate binding [148]. Therefore, we deleted SSE1, one of the primary Hsp70 
NEFs in yeast, and used a well-trap assay to test the effect of Sis1-F115I on propagation of s.d. 
medium [RNQ+]. Like SSE1 cells, we found that all of the Rnq1 protein was in its aggregated 
state in sse1! cells when WT Sis1 was expressed, as indicated by the absence of Rnq1 in the 
unboiled fraction, suggesting that loss of SSE1 did not affect prion propagation of s.d. medium 
[RNQ+] (Fig. 5). Moreover, all of the Rnq1 protein is soluble and can enter the SDS-PAGE gel 
in the unboiled fractions of [rnq-] sse1! cells, along with SSE1 cells propagating s.d. medium 
[RNQ+] and expressing Sis1-F115I.  However, there is significantly less soluble Rnq1 protein in 
sse1! cells expressing Sis1-F115I, indicating it is sequestered in Rnq1 aggregates. This suggests 
that loss of SSE1 delays the loss of the s.d. medium [RNQ+] prion. This provides additional 





 Here, we have provided additional mechanistic insight into the effects of the mutations 
associated with LGMD1D, and how they might contribute to pathogenesis. It was previously 
demonstrated that DNAJB6 can process substrates having of a polyglutamine expansion 
[256,275,276] and that LGMD1D-associated mutations can impair such processing of these 
aggregation-prone substrates [160]. This was also seen using the RNA-binding protein TDP-43 
that formed nuclear stress granules (Stein et al., in review). We had extended these studies by 
showing that LGMD1D-associated mutations in DNAJB6 orthologs show tremendous selectivity 
and disrupt the processing of only particular conformers of the [RNQ+] and [PSI+] prions (Stein 
et al., in review). We now show additional specificity of these mutations.  
We found that the LGMD1D-associated mutations do not alter the processing of heat-
denatured luciferase (Fig. 1). Unlike the previously analyzed substrates, luciferase represents 
another aggregated substrate, but one that is not thought to form an ordered ! sheet-rich 
structure. Moreover, the LGMD1D mutations did not affect the role that Sis1 plays in mediating 
the proteasomal degradation of a model misfolded cytosolic protein (Fig. 2). As this model 
substrate is degraded in the nucleus [271], this would suggest that the LGMD1D-associated 
mutations do not affect Hsp40 localization, which agrees with our previous results with DNAJB6 
(Stein et al., in review). Collectively, these data support the view that Hsp40s are major 
determinants of functional specificity in the cell [148]. We propose that the LGMD1D-associated 
mutations impair certain Hsp40 functions (e.g. processing of substrates that form ordered 
aggregates), but not other functions (e.g. processing of particular amorphous substrates). 
In addition to the selectivity that occurs between Hsp40s and substrates, another layer of 
selectivity operates through the interaction of Hsp40s with Hsp70s. While Hsp40s can act 
independently of Hsp70s, the general view is that Hsp40 function is often determined through its 
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interaction with Hsp70 [148]. The J domain of Hsp40s, in particular an HPD motif within the J 
domain, is required for stimulating the activity of Hsp70 [222]. In the case of Sis1, its interaction 
with Hsp70 is essential to yeast viability, as disruption of the HPD motif with the H34Q 
mutation causes inviability [150]. Moreover, the ability of Hsp40s to bind substrates is also 
essential, as loss of the substrate-binding domains of Sis1 and a related Hsp40 Ydj1 reduces cell 
growth when these domains are lost separately, and results in inviability when both domains are 
lost as there is some overlap in function between these Hsp40s [277]. Hence, it is clear that 
Hsp70-dependent substrate processing is an essential Hsp40 function in yeast. We found that 
over-expression of the LGMD1D-associated mutations in the G/F domain of Sis1 is toxic (Fig. 
4), and this is suppressed by a secondary mutation in the substrate-binding domain of Sis1, 
L268P, that impairs the interaction with Hsp70 [104]. These data suggest that the LGMD1D-
associated mutations likely disrupt the processing of essential substrates. We propose that these 
mutations might cause hyperstimulation of Hsp70 ATPase activity. In the case of Hsp40 over-
expression, the stoichiometric ratios of Hsp40 and Hsp70 are altered, causing aberrant processing 
of essential proteins that is mitigated by disrupting the interaction between Sis1 and Hsp70 using 
the L268P mutation.  
Additionally, such aberrant processing might also be the underlying factor for processing 
prion aggregates. When maintaining the normal stoichiometric ratios of Hsp40 and Hsp70, the 
LGMD1D-associated mutations disrupt the processing of particular prion variants (Stein et al. in 
review, and data not shown). This might result from certain prion conformers being sensitive to 
over-stimulation of Hsp70. Loss of NEF activity would slow the ATPase cycle and thus the 
recycling of Hsp70 monomer, potentially allowing for normal substrate processing. This would 
explain why deletion of the NEF SSE1 partially rescues prion propagation in the presence of 
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Sis1-F115I (Fig. 5). There are at least two possibilities that could explain how mutations in the 
Hsp40 G/F domain cause hyperstimulation of Hsp70: 1) disrupting the spatial orientation of the 
Sis1 domains and consequently the interaction with Hsp70, or 2) altering Hsp70 interaction if the 
G/F domain binds to Hsp70 directly. Nevertheless, in vitro studies are necessary to specifically 
look at the relationship between DNAJB6 and Hsp70 to test these possibilities.  
There are 11 Hsp70s in humans, but 41 different Hsp40s [148], and Hsp40s have very 
different tissue expression and activity [259]. In addition to the 13 different NEFs, this indicates 
that a complex network acts to modulate the function and ATPase cycle of Hsp70, and its 
involvement in many aspects of protein quality control. Indeed, the selectivity provided by 
Hsp40s may contribute to the increasing number of disorders, that have varying pathological 
features, that are linked to mutations in Hsp40 proteins [157]. Moreover, the role of DNAJB6 in 
causing LGMD1D indicates that myopathies can no longer be viewed simply as diseases caused 
by defects in scaffold proteins [278]. Our study highlights the selectivity of the LGMD1D-
associated mutations, indicating how dysregulation of only certain Hsp40 functions can lead to 
disease.  
 
5.5 Materials and Methods 
5.5.1 Yeast Strains, Plasmids, and Media 
 All yeast strains used in this study are derived from 74-D694 (ade1-14 his3-!200 leu2-
3,112 trp1-289 ura3-52) and were grown using standard techniques. YPD media (1% yeast 
extract, 2% peptone, 2% dextrose) or synthetic defined (SD) media (0.67% yeast nitrogen base 
without amino acids, 2% dextrose) lacking a particular nutrient to select for plasmids, was used 
as indicated. Wild-type (WT) [RNQ+] and [rnq-] strains were kind gifts from S. Liebman [31]. 
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Construction of sis1! [rnq-] and [RNQ+] strains was described previously (Stein et al., in 
review). Replacement of WT Sis1 was performed by a plasmid shuffle technique using media 
containing 1mg/mL 5-fluoroorotic acid (5-FOA) that selects against the URA3-marked SIS1 
plasmid. The s.d. medium [RNQ+] sse1! strain was made using a plasmid-based sse1!::LEU2 
disruption construct (kind gift from K. Morano [248]) that was digested with SacII/PstI and 
transformed into sis1! cells propagating s.d. medium [RNQ+] and expressing SIS1 from a 
URA3-marked plasmid. Transformants were selected on SD-leu and deletion of SSE1 was 
confirmed by colony PCR. 
 The following plasmids were kind gifts: pRS314-sis1-!G/F from S. Lindquist [74], and 
pRS316-SIS1 and pRS314-sis1-L268P from E. Craig [100,104]. Construction of pRS314-SIS1 
and SDSS chimeras was described previously (Stein et al., in review). Mutations in SIS1 were 
created using bridge PCR with the indicated oligonucleotides, digested with SpeI/ClaI and 






5'GCCAAAGAATTGTGAAATAATATTGAAAGCATC), double mutations with sis1-L268P 
(5'GTTTCTCTAGTTATCCATCTG and 5'GTTTCTCTAGTTATCCATCTG using pRS314-
sis1-F106L, pRS314-sis1-F115I, or pRS314-sis1-L268P as templates as necessary). To create 
pRS414GPD-sis1-!DD-F115I, 5'ATACTAGTATGGTCAAGGAGACAAAAC and 
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5’CGCATCGATTTATGGATAGTCCACTTTATATTTTAC were used, followed by digestion 
with SpeI/ClaI, and ligation with pRS414GPD that was digested with the same enzymes. 
 
5.5.2 Luciferase Refolding 
Yeast expressing the indicated construct from the pRS314 vector in place of pRS316-
SIS1 were transformed with pRS316GPD-luciferase, a kind gift from B. Bukau [220]. Refolding 
of luciferase was then monitored as described in previous studies [90,242]with modifications. 
Yeast cultures were grown to mid-logarithmic phase at 30°C, followed by growth at 37°C for 
one hour, then heat shocked at 44°C for one hour to induce aggregation of luciferase. 20µg/mL 
cycloheximide (Sigma) was added to each culture 50 min into heat shock. After heat shock, cells 
recovered at 30°C with 100µl samples taken at the indicated times, added to 50µl of 1mM beetle 
luciferin (Promega). Luminescence was measured on a single tube luminometer (Berthold 
Detection Systems) with a delay time of 2 sec and a read time of 6 sec. Luminescence was 
normalized to the pre-heat shock value taken after growth at 37°C. 
 
5.5.3 CG* Degradation Assay 
Monitoring CG* turnover was performed as described previously [271]. Yeast expressing 
the indicated construct from the pRS314 vector in place of pRS316-SIS1 were transformed with 
pRS313-CG*, a kind gift from U. Hartl [271]. Cultures were grown at 30°C until mid-
logarithmic phase. 100µg/mL cycloheximide (Sigma) was added to each culture and samples 
were removed at the indicated times. Cell pellets were lysed by alkaline lysis that was adapted 
from previous studies [272,279]. Briefly, cells were resuspended in 0.1M NaOH and incubated at 
room temperature for 5min, followed by washing in H2O and pelleting at 3,000 rpm for 3 min. 
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Cells were resuspended in denaturing lysis buffer (60mM Tris-HCl pH 6.8, 2% SDS, 2mM 
DTT), boiled at 100°C for 10 min, and pre-cleared at 3,000 rpm for 3 min. Equal volumes of cell 
lysates and sample buffer (60mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 2mM EDTA, 5% !-
mercaptoethanol, bromophenol blue) were analyzed by SDS-PAGE and western blot using an 
"GFP antibody (Roche). 
 
5.5.4 Heat Shock Response 
The indicated yeast strains were transformed with a plasmid expressing LacZ, from a 
promoter having four heat shock elements, a kind gift from S. Lindquist. Cultures were grown 
until mid-logarithmic phase at 30°C, followed by growth at 39°C for one hour. Samples were 
then lysed and luminescence was measured as described previously [280], followed by 
normalization to protein concentration. 
 
5.5.5 Genetic Analysis 
WT yeast strains that were [rnq-] or harboring m.d. high [RNQ+] were transformed with 
the indicated pRS414GPD constructs (pRS414GPD-SIS1 was a kind gift from S. Lindquist [74]). 
Overnight cultures were normalized to OD600, followed by spotting five-fold serial dilutions onto 
YPD and SD-trp and growth at 30°C for 3 days. 
 
5.5.6 Protein Analysis 
 Yeast samples were lysed with glass beads in buffer (100mM Tris pH 7.5, 200mM NaCl, 
1mM EDTA, 5% glycerol, 0.5mM DTT, 3mM PMSF, 50mM N-Ethylmaleimide (NEM), 
complete protease inhibitor from Roche) and pre-cleared at 6,000 rpm for 15 sec. Protein 
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concentration of cell lysates was then normalized. For well-trap assays, samples were incubated 
for 5 min at room temperature or 100°C in sample buffer (50mM Tris-HCl pH 6.8, 10% glycerol, 
2% SDS, 100mM DTT), then analyzed by SDS-PAGE and western blot using an "Rnq1 
antibody. Expression of Sis1 mutants was determined similarly using "Sis1 (a kind gift from E. 
Craig) and "Pgk1 antibodies. 
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Figure 1. Luciferase refolding is unaffected by LGMD1D mutations. The capability of 
refolding luciferase was measured in [rnq-] sis1! yeast cultures harboring the indicated construct 
and a plasmid expressing luciferase. Yeast were subjected to heat shock to induce luciferase 
aggregation, followed by recovery at 30°C. Luminescence was measured at the indicated times 
during recovery and normalized to the luminescence before heat shock, with the amount of 




Figure 2. LGMD1D mutations do not impair Sis1-mediated protein degradation. The ability 
to mediate protein turnover was monitored in (A) [rnq-] and (B) m.d. high [RNQ+] sis1! yeast 
cultures harboring the indicated construct and a plasmid expressing CG*. After addition of 
cycloheximide, samples were harvested at the indicated times, lysed, and subjected to SDS-




Figure 3. The heat shock response is unchanged in the presence of LGMD1D mutations. 
[rnq-] sis1! yeast cultures expressing the indicated construct, along with a plasmid expressing 
LacZ from a promoter containing four heat shock elements, were grown at 39°C for one hour to 
induce the heat shock response. Samples were harvested, lysed, and !-galactosidase activity was 
measured and normalized to protein concentration to give random luminescence units 
(RLU)/s/µg protein. Data are represented as mean ± SEM with n = 3, with no significant 




Figure 4. Impaired Hsp40-Hsp70 interaction rescues the toxicity associated with over-
expressing homologous LGMD1D mutations in Sis1. Wild-type [rnq-] and m.d. high [RNQ+] 
yeast cells were transformed with plasmids that over-expressed the indicated Sis1 construct, or 
an empty vector control (EV). Cultures were normalized and five-fold serial dilutions were 
spotted on medium to select for the plasmid (SD-trp), or medium that provides no selection 
(YPD). Images are represented of at least three independent experiments. 
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Figure 5. Deletion of SSE1 suppresses the prion loss caused by a homologous LGMD1D 
mutant. Analysis of prion propagation in SSE1 and sse1! strains harboring s.d. medium 
[RNQ+], along with a [rnq-] sse1! strain, expressing either WT Sis1 or Sis1-F115I. Cell lysates 
were incubated at room temperature (-) or 100°C and subjected to SDS-PAGE and western blot 
using an "Rnq1 antibody. Rnq1 that is not sequestered in aggregates will enter the gel in the 
unboiled sample and indicates destabilization of the [RNQ+] prion.  
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5.8 Supplemental Figures 
 
Figure S1. Expression of homologous LGMD1D-associated mutations in Sis1. Western blot 
analysis showing expression of the indicated Sis1 constructs. Cell lysates were subjected to SDS-










Chapter 6: Conclusions and Future Directions 
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6.1 Summary 
6.1.1 Prion Variants and Molecular Chaperones 
Amyloid polymorphism and its effects on phenotypic variation can be viewed from a 
variety of different levels, from biophysical and biochemical levels to genetic and cellular levels. 
In Chapters two and three, I utilized concepts from each of these areas to examine the structural 
variation of prion strains. Yeast prion variants of [PSI+] have served as the foundation for 
studying amyloid polymorphism for several years. I extended this analysis by using the prion 
variants of [RNQ+] to study the structural diversity of amyloid in comparison to [PSI+]. In so 
doing, I broadened the foundation for examining prion strains, and demonstrated that a large 
network of factors can modulate amyloid polymorphism and the associated phenotypic 
consequences. 
The overarching principle that was proposed from the work with [PSI+], is that prion 
propagation relies on an equilibrium between the fragmentation of aggregates and the ability of 
monomer to join a preexisting aggregate (fiber growth) [25]. This principle is likely applicable to 
both the pathological amyloid of protein conformational disorders and to the functional amyloid 
associated with a variety of different cellular processes. From an intuitive standpoint, this 
principle makes sense. If fiber growth is increased relative to fragmentation, then larger 
aggregates accumulate that have reduced ability to spread spatially and propagate. However, if 
fiber fragmentation is increased relative to growth, then this may result in the clearance of the 
aggregate. This balance was proposed to explain how prion strains can influence phenotype: 
different prion strains have different equilibrium points and thus distinct abilities to catalyze 
conformational conversion and sequester monomer [25]. Arguably, neither my work, nor any 
work from other groups using other proteins, refutes this principle. However, what I have 
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demonstrated, along with others, is that the factors that dictate this equilibrium are complex and 
not as simple as what was originally proposed [28,34,38]. The novel factors that I found to 
influence this equilibrium include a role for non-canonical sequence elements, distinct chaperone 
binding sites, and different dependencies on chaperone interactions and processing. 
It was previously suggested that the balance between fiber fragmentation and growth was 
dictated by the stability of the aggregates and the size of the amyloid core [25,26]. The less 
stable Sup35 aggregates of strong [PSI+] had a high degree of fragmentation and growth, 
resulting in a small soluble pool of Sup35 as much of the Sup35 in the cell is incorporated into 
aggregates. Using the [RNQ+] variants, I found that s.d. very high [RNQ+] provides the most 
striking counterexample [34]. Utilizing RRP to analyze [RNQ+] in an analogous fashion as 
[PSI+], s.d. very high [RNQ+] had a similarly strong phenotype as strong [PSI+], but propagated 
a stable structure and had a relatively large soluble pool of Rnq1. Moreover, m.d. high [RNQ+], 
while also having a strong phenotype, a small pool of soluble protein, and low stability, had a 
larger aggregate size, in contrast to the trends of strong [PSI+]. These examples show that the 
amount of soluble protein, aggregate size, and aggregate stability do not always correlate or 
predict where the equilibrium point is between fragmentation and growth. Indeed, this might 
suggest that this equilibrium is not simply between monomeric protein and aggregated protein, 
but of multiple oligomeric intermediates. 
Unlike [PSI+] variants, which are proposed to have a contiguous stretch of Sup35 that 
forms the aggregate structure, I found that the [RNQ+] variants have a surprising amount of 
diversity in the sequence elements that are important for prion propagation. First, these 
amyloidogenic regions of Rnq1 that are involved in prion propagation are not contiguous, 
suggesting that Rnq1 might utilize a different category of packing arrangement as compared to 
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Sup35. Second, the region outside of the Rnq1 prion-forming domain (PFD) played a strain-
dependent role in prion propagation, at least in part, through facilitating monomer addition to 
aggregates. This suggests that the so-called prion-like domains that are Q/N-rich, which have 
been identified in numerous human proteins [8], are likely not the only important part of the 
primary structure that influences the aggregation of disease-related proteins. This agrees with the 
fact that other prion proteins, such as PrP and HET-s, are not Q/N-rich [2].  
In addition to the direct effect on propagation of distinct prion variants, I found that the 
Rnq1 amyloidogenic regions were also important for modulating the phenotypic manifestations 
of [RNQ+] [34]. More specifically, mutation of certain regions influenced how well [RNQ+] 
induced the formation of [PSI+], with particular mutations enhancing [PSI+] formation. It is 
possible that the large Q/N-rich PFD of Rnq1 allows for a level of redundancy not seen when 
analyzing shorter peptides or proteins that are not Q/N-rich. This redundancy may allow for a 
moveable amyloid core, whereby the Rnq1 protein can still aggregate despite disruption of so-
called ‘nonessential regions’ that are not needed for nucleated conversion, but the structure has 
been slightly altered. This might suggest that Rnq1 can form a larger spectrum of different prion 
variants than other proteins that have less sequence redundancy, which would be quite striking 
considering the wide variety of structures already observed for other proteins [172,173]. 
The other major factor that my work reveals as contributing to the equilibrium between 
aggregate fragmentation and growth, is the diversity in which chaperones interact and process 
different structures. While a binding site in Rnq1 for the Hsp40 chaperone Sis1 had been 
previously identified [37], I found that Sis1 was capable of binding other parts of the Rnq1 
protein [34]. Moreover, it appeared that the dependence of these alternative sites varies in a prion 
variant-dependent fashion. For instance, propagation of the s.d. very high [RNQ+] variant 
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showed striking reliance on the C-terminal A10 amyloidogenic region (a putative Sis1 binding 
site), more so than any of the other [RNQ+] variants. This suggests that prion conformation 
determines the exposure of chaperone binding sites, or how these sites are used.  
In addition, I found that the chaperone machinery that utilizes these chaperone binding 
sites can vary. One interesting example is that faithful propagation of s.d. medium [RNQ+] and 
s.d. very high [RNQ+] depended on the dimerization domain of Sis1. Also, the [PSI+] variants 
showed greater dependence on Hsp70 function as compared to Sis1. Hence, in addition to prion 
variants having different exposed sites for interaction, these data indicate several other possible 
ways of influencing the equilibrium between fiber fragmentation and growth: 1) what 
chaperone(s) bind the exposed sites, 2) the affinity with which chaperone(s) bind, and 3) the 
ability (or inability) of chaperones to process the prion aggregates and whether other co-
chaperones are needed. These factors, in part, might help explain the distinct cofactor 
requirements of various PrPSc strains [39]. 
Collectively, Chapters two and three showed other important variables that distinguish 
prion variants. For the prion protein, this might include different, non-adjacent regions of the 
prion protein that 1) serve as the template to catalyze conformational conversion, 2) facilitate 
monomer addition, or 3) are available for chaperone binding. Moreover, the different 
requirements of the chaperone machinery for distinct prion variants is another important factor. 
Hence, in addition to biochemical properties influencing the prion variant-dependent balance of 
fiber fragmentation and growth, these other variables play a major role in dictating structural 
variation and its associated phenotypic variation. 
 
6.1.2  DNAJB6 and LGMD1D 
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 Mutations in the Hsp40 DNAJB6 cause the protein aggregate myopathy known as limb-
girdle muscular dystrophy type 1D (LGMD1D). These mutations all localize to a short stretch in 
the G/F domain of DNAJB6 [159-162]. In Chapters four and five, I exploited the conservation of 
the G/F domain that is present in DNAJB6 and the yeast Sis1, both type II Hsp40s, to gain 
insight into the pathogenesis of LGMD1D. Furthermore, this demonstrated the application of my 
findings from Chapters two and three and the broad utility of the yeast prion model. 
 By making the homologous disease-associated mutations in Sis1, DNAJB1, the chimera 
SDSS, as well as DNAJB6, I demonstrated the crucial role that the mutated residues play in 
modulating the function of Hsp40s and the G/F domain. First, mutation of DNAJB6 impaired its 
ability to resolve nuclear stress granules of TDP-43. Second, mutation of DNAJB1 and Sis1 
resulted in slow growth phenotypes, likely through disrupting the Hsp70-mediated processing of 
essential substrates. Finally, mutation of SDSS disrupted the propagation of particular prion 
variants.  
 In demonstrating that the LGMD1D-associated mutations do not alter other Hsp40 
functions, these data suggest that the G/F domain is involved in mediating the selectivity of 
substrate processing in an Hsp70-dependent fashion. In the case of muscle tissue, where protein 
quality control is highly regulated [281], chaperones are constantly responsible for the turnover 
of proteins. It is easy to envision that these proteins are damaged or misfolded to form a variety 
of different conformations having different regions of the protein exposed and available for 
chaperone binding. The LGMD1D-associated mutations might alter the ability of DNAJB6 to 
bind these different conformers or properly transfer them to Hsp70 to be processed. Indeed, as I 
showed that disrupting the interaction of mutant Hsp40 with Hsp70 could rescue particular 
growth phenotypes, this suggests that the LGMD1D mutations alter the regulation of the Hsp40-
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Hsp70 complex. Moreover, since we found differential effects between the mutants, it is 
conceivable that there are different degrees of Hsp40-Hsp70 dysfunction depending on the 
DNAJB6 mutant.  
Taken together, in light of the mutation- and conformer-specific effects seen with 
disruption of the G/F domain, my data indicate that subtle differences in the interplay between 
the proteostasis network with particular client conformers might contribute to the observation 
that patients with LGMD1D show a range of disease onset and pathology [159,163]. Hence, 
these data suggest that amyloid polymorphism, or even different conformations of folding 
intermediates, is an important consideration when studying chaperonopathies in the future. 
 
6.2 Elucidate the Biophysical and Biochemical Basis of Prion Strains 
6.2.1 Structural Polymorphism in [RNQ+] Variants 
 The ability of structural differences to manifest as variation in phenotype is a widespread 
phenomenon [20]. An increasing number of examples are likely to be found both with 
pathological amyloid as well as functional amyloid. In order to elucidate how structure dictates 
phenotype, it is important to extend beyond the numerous biochemical and genetic assays, which 
have provided significant information, but act as surrogates of structural information. 
Accomplishing this with the large, insoluble amyloid structures remains technically challenging, 
but there are certain strategies that have proven fruitful.  
To determine how the [RNQ+] variants are structurally distinct and can induce the 
formation of [PSI+] to different extents, Rnq1 aggregates should be first isolated from [RNQ+] 
yeast cells and used to seed the aggregate formation of recombinant full-length Rnq1 in order to 
obtain a large quantity of purified aggregates. As I have shown the importance of the N-terminal 
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non-PFD, it will be crucial to use the full-length Rnq1 protein rather than just the Rnq1-PFD, as 
is generally done. After confirming that the same aggregate conformation has been maintained 
by transforming the aggregates back into yeast cells and testing variant-dependent properties 
(e.g. [PSI+] induction), structural data can be obtained using hydrogen-deuterium exchange 
combined with mass spectrometry or NMR. This will help indicate which amino acid residues 
are protected in the ! sheet amyloid core. Also, magic-angle spinning NMR could be used to 
interrogate the structure of the [RNQ+] variants by determining the dynamics of particular 
residues, as recently done with fibers of Sup35NM [38]. 
Additionally, as Rnq1 does not contain any endogenous cysteine residues, cysteine 
mutations can be made throughout the protein to use in combination with structural probes. 
Isolated Rnq1 aggregates from yeast cells would be used to seed the conformational change of 
the cysteine mutants. It will be important to confirm that such mutations do not grossly alter the 
amyloid structure by determining that the biochemical properties of the [RNQ+] variants are 
maintained. These Rnq1 mutants can then be coupled to the fluorophores pyrene or acrylodan to 
monitor the exposure of these residues to solvent using fluorescence. The cysteine residues could 
also be coupled to a paramagnetic spin label for use with EPR to determine the dynamics of 
these residues.  
There are some alternative approaches that are less direct ways of getting structural 
information, but would still help determine how regions of the protein are packed. By generating 
a variety of monoclonal antibodies that recognize a particular peptide region in Rnq1, an ELISA 
could be performed to probe the regions of the Rnq1 aggregates that are exposed and available to 
bind the antibody, as well as detecting the affinity with which the antibody binds. In fact, I have 
already determined that one of the polyclonal "Rnq1 antibodies that we generated does not 
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recognize the PFD of Rnq1, which would provide a good starting point to probe the packing of 
the N-terminal domain in different [RNQ+] variants. This assay could then be adapted for use 
with a denaturant, as done with the conformation-dependent immunoassay (CDI), to determine 
what regions become exposed when the aggregates break down with increasing concentrations of 
denaturant.  
As another less direct way of identifying structural differences, isolated Rnq1 aggregates 
could be used to seed recombinant mutant Rnq1 having certain amyloidogenic regions disrupted. 
If the region of interest were typically incorporated in the amyloid core of a given [RNQ+] 
variant, then the wild-type aggregates would have a reduced ability to catalyze the 
conformational change and aggregate formation of the mutant monomer. This could easily be 
monitored using the amyloid-binding dye Thioflavin T. These assays should help elucidate the 
exact role of the amyloidogenic regions of Rnq1 in prion propagation. 
Finally, a major complementary question in the field is determining the size or nature of 
the aggregate species that is responsible for prion transmission. A different size of species might 
be important for propagation of distinct strains. Indeed, as the [RNQ+] variants have a large 
distribution of aggregate sizes, it is conceivable that the size of the “infectious” species is 
different for each [RNQ+] variant. As such, yeast lysates should be fractionated by sucrose 
gradient, isolated, and transformed into naïve [rnq-] cells expressing RRP to determine which 
fraction is most infectious for each of the [RNQ+] variants. This would provide insight into how 
the [RNQ+] variants might differentially interact with Sup35 (see below) by showing the size of 
Rnq1 aggregate that is the interacting partner. It would also be informative as to the role of 
oligomeric species with different conformations in amyloid diseases.  
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6.2.2 Analysis of PrPSc Strains in Yeast 
Studies with [PSI+] were the first to provide a biochemical and biophysical explanation 
for how variation in Sup35 aggregates causes differences in phenotype. With PrPSc strains, there 
are many correlations made between the biochemical properties and pathology, but a causal 
connection remains lacking. Moreover, certain PrPSc strains are biochemically similar [30], as I 
showed was also true for some [RNQ+] variants. By using chimeric proteins that fuse PrP to the 
MC domains of Sup35, this would provide a much more tractable system for analyzing the link 
between PrPSc structural variation and phenotype. Strains of PrPSc could be transformed into cells 
expressing the PrP-MC fusion and analyzed in an analogous fashion as [PSI+]. Moreover, 
changing the allele of PrP, would provide an easy and quick means of testing the strength of the 
species barrier, which is especially a concern nowadays since chronic wasting disease is endemic 
to populations of deer and elk in the United States and Canada [282]. 
 
6.3 Determine how Heterologous Prion Proteins Interact to Influence Strain-Mediated 
Phenotypes and Prion Transmission 
6.3.1 Influence of [RNQ+] on Formation of [PSI+]  
Understanding the biophysical basis of structural differences is crucial to elucidating how 
the [RNQ+] variants influence phenotypic variation by inducing the formation of [PSI+] to 
different extents. However, the other important factor that dictates this phenotypic variability is 
how Sup35 interacts with the [RNQ+] variants. Interestingly, it is postulated that one 
contributing factor in the pathogenesis of protein conformational disorders is the co-aggregation 
of heterologous proteins, and a variety of different proteins have been found in amyloid plaques 
[283]. Moreover, distinct strains of "-synuclein have been shown to induce the formation of tau 
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inclusions to different extents [171]. Hence, understanding the underlying mechanism of how 
heterologous proteins interact could provide significant insight into disease etiology.  
One model for how [RNQ+] induces [PSI+] formation suggests that Rnq1 aggregates 
physically interact with Sup35 to cross-seed [PSI+][60]. We have genetic evidence to support 
this model (Stein and True, unpublished results). In order to gain additional support and 
determine what regions of Sup35 and Rnq1 interact, Rnq1 aggregates should be isolated from 
yeast cells propagating distinct [RNQ+] variants, and amplified using recombinant Rnq1 as 
mentioned above. Then, cross-linking assays should be performed with these aggregates and 
recombinant Sup35. The cross-linked products could then be digested with trypsin and analyzed 
by mass spectrometry. This would provide the best evidence to date that polymorphic amyloid 
structures differentially interact with other proteins. 
Besides the direct interaction between Rnq1 aggregates and [PSI+], we have shown that 
over-expression of Sis1 can enhance [PSI+] formation [34], suggesting that it might act as a 
cofactor to facilitate conversion to [PSI+]. To identify other cofactors that might also be 
involved, a library of plasmids over-expressing much of the yeast genome could be transformed 
into cells propagating the s.d. medium [RNQ+] variant and screened for enhanced (or reduced) 
levels of [PSI+] formation. This could then be checked in cells propagating the other [RNQ+] 
variants to determine if the cofactors are similarly involved. Additionally, as most of the yeast 
deletion library is [RNQ+] [284], this library could be screened for enhanced (or reduced) 
formation of [PSI+]. These assays would help identify novel factors that might contribute to the 
differential ability of the [RNQ+] variants to induce [PSI+], and furthermore, what factors might 
be involved in the aggregation of disease-related proteins. 
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6.3.2 Conservation of [RNQ+] and the Species Barrier 
Of the yeast prions, the [RNQ+] prion is the one that is found most commonly in wild 
yeast isolates [285]. We recently identified different [RNQ+] variants in these wild isolates [35]. 
Interestingly, many different genetic polymorphisms have also been found in the RNQ1 gene 
[286], and different fungal species have different RNQ1 alleles as compared to the reference 
sequence in Saccharomyces cerevisiae. These different alleles could be expressed in S. 
cerevisiae propagating different [RNQ+] variants, followed by determining whether the [RNQ+] 
prion is maintained. This information would serve two purposes: 1) it would further elucidate 
what primary structure elements are important for the [RNQ+] variants, and 2) it would help 
determine what types of structures (if any) could exist with a particular RNQ1 allele in the wild. 
This information would reveal what parts of the Rnq1 protein help control the species barrier, 
and the extent to which [RNQ+], as a regulatory epigenetic element, is phylogenetically 
conserved. 
 
6.4 Elucidate how Interactions between Molecular Chaperones and Substrates are 
modulated 
6.4.1 Interplay between Sis1 and [RNQ+] Variants 
 My work and that of others demonstrates that molecular chaperones and other cofactors 
can differentially interact with polymorphic amyloid structures [34,39]. While this phenomenon 
is clear, the basis of these differences is still poorly understood; for instance, how Sis1 interacts 
and processes different aggregate structures. As such, it is first important to obtain definitive 
evidence that the [RNQ+] variants expose different chaperone binding sites and Sis1 binds to 
different regions of the Rnq1 protein. To do this, Sis1 should be immunoprecipitated from wild-
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type [RNQ+] cells, cross-linked, digested with trypsin, and analyzed by mass spectrometry. This 
would help confirm whether Sis1 binds different amyloidogenic regions of Rnq1 depending on 
the [RNQ+] variant. A complementary approach was presented above in which isolated Rnq1 
aggregates should be used to seed the aggregate formation of mutant Rnq1 having one of the 
amyloidogenic regions mutated, and monitoring aggregation using Thioflavin T. If these regions 
act as chaperone binding sites, then the rate at which aggregates form should be comparable to 
the self-seeding of wild-type Rnq1. 
Chaperones might also have distinct affinities for the same binding site, depending on the 
aggregate structure. My work suggests this might be the case with Sis1 and Rnq1. This 
hypothesis should be tested using isothermal titration calorimetry with Sis1 (recombinant or 
purified from yeast) titrated with purified wild-type or mutant Rnq1 aggregates of different 
[RNQ+] variants. Comparing the [RNQ+] variants with just wild-type Rnq1 would show whether 
Sis1 has different affinity for Rnq1 as a whole. However, disrupting particular putative binding 
sites should help show the degree to which Sis1 binds these regions as compared to wild-type 
Rnq1. Moreover, this could be done with various Sis1 mutants to determine the importance of 
particular Sis1 domains in binding Rnq1. In addition, it might also be feasible to make cysteine 
mutations at candidate regions in Rnq1 and Sis1 and perform cross-linking assays. This could 
help reveal, for instance, whether the Sis1 G/F domain physically binds substrates, or if its 
critical role in [RNQ+] propagation is through modulating other Hsp40 functions. Collectively, 
this information would provide mechanistic details for how chaperones bind and interact with 
distinct substrate conformers. 
With regards to the Sis1 G/F domain, it was striking to find that all of the [RNQ+] 
variants required the presence of the Sis1 G/F domain for propagation, while the [PSI+] variants 
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showed less dependence on this domain. It would be interesting to screen for a novel [RNQ+] 
variant that does not rely on the Sis1 G/F domain and perform biochemical and structural studies 
on this novel prion variant. This could be done by expressing Sis1-#G/F in [rnq-] cells that 
express RRP, and selecting for cells that have spontaneously converted to [RRP+], similar to 
what we have done previously (Appendix A) [32]. Comparing this prion variant to the other 
[RNQ+] variants I have characterized might show what is structurally different about these latter 
variants that necessitates the presence of the Sis1 G/F domain. 
 Finally, to determine novel parts of Sis1 that influence the relationship between Sis1 and 
[RNQ+], mutations in SIS1 that disrupt [RNQ+] propagation could be identified by first 
randomly mutating SIS1 by error-prone PCR. Then, this mutant library should be expressed in 
place of wild-type Sis1 in [RNQ+] cells expressing RRP to screen for cells that can no longer 
propagate [RNQ+]. A similar test could be done with [PSI+]. Moreover, I found a number of 
Sis1 mutants that impaired the variant-specific propagation of [RNQ+]. Screening for rescue of 
these phenotypes would help determine the mechanism of how these Sis1 regions are involved in 
propagating specific [RNQ+] variants. As both cis- and trans-acting factors could be involved in 
mediating the effects of the Sis1 mutants, the screens could involve the use of an over-expression 
plasmid library, mutating yeast with EMS, or with a second-site suppressor mutant Sis1 library 
for Sis1 mutants of particular interest. 
 
6.4.2 Factors of the Proteostasis Network that Influence Propagation of Prion Strains 
Interestingly, the genetic background influences the interaction of Sis1 with [RNQ+] 
[215], suggesting that the proteostasis network might be altered in different cell types. At the 
most basic level, this could simply be differences in gene or protein expression, as was shown 
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with Sis1 [215]. Hence, genomic analysis, including genome sequencing and RNA-Seq, should 
be performed between genetic backgrounds of interest (e.g. 74-D694 and W303) to identify 
novel factors that could influence prion propagation.  
In thinking about species and organism differences, recently it was found that the Hsp110 
from the malarial parasite Plasmodium falciparum prevented aggregation of Sup35, and it was 
suggested that this chaperone has a particularly potent ability in handling Q/N-rich substrates 
[287]. To gain a better understanding of the apparent enhanced functionality of this chaperone, it 
could be expressed in yeast to determine if it is similarly capable of handling different prion and 
non-prion aggregates, and even whether it can functionally replace the role of Hsp104 as a 
disaggregase. Furthermore, purifying recombinant Hsp110 would allow for the biochemical 
characterization of this chaperone that would provide additional insight into its function and 
ability to handle misfolded substrates having distinct conformations. Comparing this information 
to human chaperones might reveal ways in which chaperone activity should be modulated and 
enhanced. 
 
6.4.3 Effects of LGMD1D-Associated Mutations on DNAJB6 Function 
Despite my work demonstrating the selective impairment of LGMD1D-associated 
mutations on Hsp40 functions, there are several areas that need to be addressed in order to obtain 
a clear picture of the effects of these mutations. First, how the mutations in DNAJB6 affect the 
interaction with Hsp70 should be analyzed in vitro with recombinant protein. It is important to 
determine whether the mutations affect the binding to Hsp70 and Hsp70 ATPase activity. 
Additionally, a variety of substrates could be used to analyze Hsp70-mediated substrate refolding 
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in vitro. These assays would elucidate whether the role that the LGMD1D-associated mutations 
play in disease could involve a disrupted interaction between DNAJB6 and Hsp70.  
If any alteration in Hsp70 function is observed, there are a number of chemical 
compounds that could be analyzed that modulate specific aspects of Hsp70 function [288]. These 
compounds could be used in an attempt to rescue the deficits caused by the DNAJB6 mutations. 
Additionally, screening for secondary cis or trans factors that rescue the defects in substrate 
processing would provide significant insight into the mechanistic underpinnings of LGMD1D 
and how mutations in DNAJB6 cause disease. One of the best tools to accomplish this would be 
using the DNAJB1-F90I mutant that caused inviability when expressed in yeast (Chapter 4). 
Second-site suppressors could be identified in DNAJB1 after mutagenizing this construct using 
error-prone PCR. Additionally, the over-expression plasmid library should also be screened for 
novel trans-acting factors. My preliminary results using over-expression of various candidate 
proteins (including an Hsp70 and nucleotide exchange factors) were all negative.  
In addition to the interaction of DNAJB6 with other chaperones, another important 
variable that likely contributes to the development of LGMD1D is what substrates are being 
misprocessed. Expression of DNAJB1-P98R, as well as over-expression of the LGMD1D-
associated mutations in Sis1, does not cause inviability, but still causes a slow-growth 
phenotype. This is likely due to the sequestration or aberrant processing of essential substrates. It 
is possible that these substrates are aggregating or concentrating in particular locations in the 
yeast cell. As such, using a sedimentation assay and mass spectrometry, these essential substrates 
could be identified, which might reveal particular types of substrates that are misprocessed and 
contribute to muscle degeneration in LGMD1D patients. Additionally, conducting a similar 
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proteomic analysis on the aggregates in patient tissue would also provide significant information 
into disease pathogenesis. 
Finally, while I demonstrated the conformer-specificity of the LGMD1D-associated 
mutations using yeast prion variants, it is important to translate these findings to mammalian 
cells and determine if the same phenomenon exists. In order to do this, distinct conformers of 
TDP-43 or another DNAJB6 client must be isolated. Then, it can be tested whether the DNAJB6 
mutants are defective in the refolding or resolution of these conformers. 
 
6.5 Determine Cellular Processes and Trans-Acting Factors that Influence Formation 
and Propagation of Prion Strains 
6.5.1 Influence of Translation Efficiency on Prion Formation 
 Most cases of protein conformational disorders are sporadic [2]. Hence, it remains 
unclear what causes proteins to misfold and aggregate in these cases, and form different amyloid 
structures. As nascent polypeptides are considered to be more thermodynamically unstable as 
compared to folded proteins, I hypothesize that variation in translation and the ribosome quality 
control machinery might be a contributing factor. One means of testing this is by using 
constructs having the same amino acid sequence, but changing the codons in order to disrupt the 
organism-specific codon bias (i.e. organisms have a greater preference for particular codons than 
others, likely in part, because of differences in tRNA levels) [289]. We have designed constructs 
of Rnq1 having codons optimized for use in yeast, which should enhance the rate of translation, 
and disoptimized codons, which should cause ribosomes to pause. Interestingly, I have 
preliminary evidence that the disoptimized construct of Rnq1 spontaneously forms the [RNQ+] 
prion at the highest rate, followed by wild-type Rnq1, and then the optimized Rnq1 (Stein and 
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True, unpublished results). This suggests that slowing translation enhances prion formation. 
Determining whether the distribution of prion variants that forms changes when the translation 
rate is altered would help shed light on how prion variants sporadically form. Similarly, deletion 
or over-expression of particular candidates of the ribosome quality control machinery to 
determine the effect on prion formation and propagation would also help elucidate the role that 
mRNA translation plays in protein misfolding and the formation of prion strains.  
 
6.5.2 Cellular Factors that Contribute to Prion Formation 
 I have shown that over-expression of Sis1 enhances [PSI+] formation in [RNQ+] cells 
[34]. Other groups have focused on the ability of over-expressed Q/N-rich proteins or chaperones 
to modulate the formation of [PSI+] and [URE3] [60,115,290]. Yet, in these cases, there remains 
a dependence on a Q/N-rich protein to act as the nucleating factor for prion formation, with 
[RNQ+] often serving as the Q/N-rich entity. Hence, it remains unclear what other factors might 
influence the spontaneous formation of prions, specifically of [RNQ+]. Analyzing what factors 
influence the ability of Rnq1 to convert to its prion state would provide a means of identifying 
novel factors that regulate aggregate formation. To do this, the over-expression plasmid library 
expressing most all of the yeast genome could be transformed into [rnq-] cells harboring RRP 
and screened for enhanced spontaneous formation of [RNQ+], which we have shown is generally 
a pretty rare event (~3x10-6) [32]. The distribution of prion variants that forms could also be 
determined for a subset of candidates to determine if certain cellular factors bias the formation of 
particular aggregate conformers, as we have shown to be true by altering extracellular growth 
conditions [41]. As I have demonstrated that Sis1 interacts with [RNQ+] variants differently, one 
intriguing possibility is that increased (or decreased) expression of Sis1 might bias the formation 
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of different [RNQ+] variants. Follow-up studies could then analyze certain factors in mammalian 
cells with any number of disease-related proteins. 
 One interesting candidate is human SERF1a (MOAG-4 in Caenorhabditis elegans, 
YDL085C-A in S. cerevisiae), which is a small, highly conserved protein having an undefined 
function, but which promotes amyloid formation [291,292]. Deletion or over-expression of 
SERF1a or YDL085C-A in yeast and determining the distribution of prion variants that form 
would show whether this protein could be involved in modulating amyloid polymorphism and 
the pathological variation observed with protein conformational disorders. Additionally, 
identifying novel factors involved in the propagation of prion variants is also an important area 
for investigation, as this might provide new targets for intervention of the amyloid cascade. 
Hence, it should be tested whether deletion of YDL085C-A alters the propagation of particular 
prion variants. 
 
6.5.3 Influence of Localization and Clearance on Prion Variants 
 Another mechanism that might influence the ability of distinct aggregate structures to 
dictate phenotypic variation is where the aggregates localize. It is easy to envision that 
aggregates of one prion variant might localize predominantly to one part of the cell, whereas 
aggregates of another prion variant might localize to a different part of the cell. This would result 
in distinct interactions with subcellular organelles, and likely different cellular responses. It has 
been recognized that yeast have distinct compartments to partition misfolded proteins called the 
JUNQ and the IPOD [293]. Substrates that are ubiquitinated and targeted for proteasomal 
degradation are targeted to the JUNQ, whereas terminally aggregated substrates, such as both the 
[RNQ+] and [URE3] prions, have been found to localize to the IPOD [293]. However, an 
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uncharacterized [RNQ+] variant was used in this analysis. Interestingly, manipulation of the 
ubiquitin proteasome system can direct substrates from one compartment to the other 
compartment. Therefore, the dynamics of localization between the JUNQ and the IPOD should 
be determined for particular prion variants of [PSI+] or [RNQ+], and whether they localize to 
other parts of the cell. To minimize the possibility of artifacts that can arise with over-expression 
of tagged proteins, ideally this would be performed using immunohistochemistry. 
 Additionally, just as prion variants can have distinct abilities to incorporate monomeric 
protein into aggregates, it is also possible that the clearance mechanisms of certain aggregate 
structures are different. My work has already shown that chaperones differentially interact with 
distinct conformers [34], but other parts of protein quality control might also be different. Hence, 
using pulse-chase studies, it should be tested whether the turnover of Rnq1 is different in cells 
propagating different [RNQ+] variants. Additionally, Rnq1 could also be differentially 
ubiquitinated when a certain [RNQ+] variant is present. If the clearance mechanisms are altered 
for different prion variants, this could influence how quickly monomer is sequestered, or in the 
case of human disease, how quickly the aggregates spread. 
 
6.6 Conclusions  
The phenomenon of amyloid polymorphism is a feature that spans numerous disease-
related proteins, and is also present in functional amyloid [2,10,20,294]. The work presented in 
this dissertation reveals the complicated nature underlying the variation in amyloid structure and 
how it influences phenotypic variability. In the coming years, it will be important to gain a better 
understanding of precisely what the structural differences are and how such variation modulates 
the interaction with the proteostasis network. This will be critical to elucidating how amyloid 
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polymorphism influences variation in pathology in the case of protein conformational disorders, 
or phenotype in the case of the regulatory processes that involve functional amyloid.  
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Abstract
Prion strains (or variants) are structurally distinct amyloid conformations arising from a single polypeptide sequence.
The existence of prion strains has been well documented in mammalian prion diseases. In many cases, prion strains
manifest as variation in disease progression and pathology, and in some cases, these prion strains also show distinct
biochemical properties. Yet, the underlying basis of prion propagation and the extent of conformational possibilities
available to amyloidogenic proteins remain largely undefined. Prion proteins in yeast that are also capable of
maintaining multiple self-propagating structures have provided much insight into prion biology. Here, we explore the
vast structural diversity of the yeast prion [RNQ+] in Saccharomyces cerevisiae. We screened for the formation of
[RNQ+] in vivo, allowing us to calculate the rate of spontaneous formation as ~2.96x10-6, and successfully isolate
several different [RNQ+] variants. Through a comprehensive set of biochemical and biological analyses, we show
that these prion variants are indeed novel. No individual property or set of properties, including aggregate stability
and size, was sufficient to explain the physical basis and range of prion variants and their resulting cellular
phenotypes. Furthermore, all of the [RNQ+] variants that we isolated were able to facilitate the de novo formation of
the yeast prion [PSI+], an epigenetic determinant of translation termination. This supports the hypothesis that [RNQ+]
acts as a functional amyloid in regulating the formation of [PSI+] to produce phenotypic diversity within a yeast
population and promote adaptation. Collectively, this work shows the broad spectrum of available amyloid
conformations, and thereby expands the foundation for studying the complex factors that interact to regulate the
propagation of distinct aggregate structures.
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Introduction
Protein misfolding disorders refer broadly to a class of
human diseases associated with the failure of a protein or
peptide to adopt its native, functional conformation [1]. Such
misfolding can lead to the formation of fibrillar aggregates
called amyloid. Amyloid fibers typically form as a β sheet-rich
structure in a self-replicating process [2]. These highly ordered
arrangements of β sheets are formed from non-covalent
interactions of neighboring polypeptides in which the β strands
run perpendicular to the fibril axis [1,3]. This fundamental
architecture is shared among a variety of proteins associated
with unrelated protein conformational disorders, including
Alzheimer’s disease and Type II diabetes [4]. Interestingly,
significant conformational variation can exist while still
maintaining this generic amyloid structure [5]. Such amyloid
polymorphism has been most studied in the context of prion
strains, but recent data suggest that it is a common feature of
many amyloidogenic proteins [6,7,8].
Prion diseases, also called transmissible spongiform
encephalopathies (TSEs), represent a subset of protein
misfolding disorders that are invariably fatal [9]. These
diseases include bovine spongiform encephalopathy (BSE) in
cattle and Creutzfeldt-Jakob disease (CJD) in humans. TSEs
develop when the host-encoded prion protein, PrPC, assumes
the abnormal β sheet-rich PrPSc conformation [10]. This
infectious structure self-propagates by sequestering native
PrPC and templating further conversion to PrPSc [11,12].
Initial transmission experiments with PrPSc encountered what
is now known as the “species barrier” [13]. This refers to the
observation that transmission of PrPSc between two different
species is typically far less efficient than transmission within the
same species [14]. This barrier may be partially due to changes
in amino acid sequence, but can also be due to changes in the
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self-propagating structure of the protein itself. Indeed, even
within a single species, pathological variation in TSEs and
different biochemical signatures of PrPSc have been observed,
leading to the isolation of distinct PrPSc types [15,16]. These
different types of PrPSc are called prion strains, and represent
amyloid conformations of PrP that are structurally unique. In
many cases, different prion strains show differences in
biochemical properties, such as protease resistance or
denaturant sensitivity, which correlate with variation in
pathology and the time course of disease [17,18,19,20,21,22].
However, in other cases, prion strains have been isolated that
vary in pathology, yet remain biochemically indistinguishable,
according to the levels of sensitivity available with current
assays [23]. Moreover, while genetic polymorphisms in PrP
bias the formation of particular conformations of PrPSc, a single
primary sequence can propagate a multitude of distinct prion
strains [14]. Indeed, it has been estimated that the range of
heterogeneity seen in samples from patients with sporadic CJD
represents over 30 distinct prion strains [24,25]. Clearly, the
structural limits of amyloid polymorphism of prion strains are
quite large.
Interestingly, functionally distinct prion proteins exist in fungi
such as the yeast Saccharomyces cerevisiae [26,27]. Yeast
prion proteins share many of the same misfolding and
aggregation characteristics as the proteins associated with
human protein conformational disorders. As such, yeast has
provided a tractable model system to investigate many facets
of protein aggregation and prion biology, including that of prion
strain diversity. As in mammals, prion strains in yeast (termed
prion variants) are conformationally distinct, self-propagating
amyloid structures. This formation of amyloid in yeast leads to
changes in cellular phenotypes, which typically resemble a
loss-of-function phenotype of the prion protein [28,29,30,31].
One of the most well-studied prion proteins in S. cerevisiae is
the translation termination factor Sup35. Sup35 is the eRF3
that normally exists in a complex that functions to recognize
stop codons in mRNA and facilitate the release of polypeptide
chains from ribosomes [32,33]. Conversion of Sup35 into its
prion form, [PSI+], establishes a loss-of-function phenotype
that is dominant and inherited in a non-Mendelian fashion [31].
In [PSI+] cells, much of the Sup35 is sequestered into prion
aggregates, thereby impairing translation termination and
causing readthrough of stop codons (also known as nonsense
suppression) [34,35].
[PSI+] variants have been broadly classified into categories
based on the degree of nonsense suppression [36]. Two well-
characterized variants are strong [PSI+] and weak [PSI+]. Cells
propagating the strong [PSI+] variant exhibit a greater amount
of nonsense suppression as compared to cells propagating the
weak [PSI+] variant [36]. Studies of strong and weak [PSI+] led
to a model that proposed an explanation for how differences in
the biochemical properties of these [PSI+] variants correlate
with differences in biological phenotypes [5,37,38,39,40,41].
This model posits that decreased fiber stability results in
increased fragmentation, thereby giving rise to a greater
number of prion seeds, and thus more fibril "free ends" that can
recruit and sequester natively-folded Sup35 [39]. Ultimately,
the more “free ends” available are hypothesized to correlate to
an increased rate of fiber growth that, in the case of the [PSI+]
prion, modulates the strength of the nonsense suppression
phenotype as the efficiency of translation termination is linked
to the size of the soluble, active pool of Sup35 [41].
Interestingly, these trends have been recapitulated with some
PrPSc strains, as lower aggregate stability correlated with a
shorter incubation period and earlier onset of disease [42].
However, this correlation between aggregate stability and fiber
growth does not explain differences in all PrPSc strains [21], or
even in prion variants of another yeast prion, [RNQ+] [43].
Indeed, even with the [PSI+] prion, there may be multiple ways
to acquire phenotypically similar prion variants [39,44,45]. Such
differences highlight the remarkable conformational diversity of
amyloid and the fact that there may be several ways to
generate amyloid variant structures from a single polypeptide
sequence.
The [RNQ+] prion, comprised of the Rnq1 protein, is also
called [PIN+] for [PSI+]-inducible, as it is required for the de
novo formation of all [PSI+] variants in vivo [46,47,48,49,50]. It
has been hypothesized that Rnq1 aggregates facilitate the
formation of [PSI+] by interacting with soluble Sup35 and acting
as an imperfect template to cross-seed the formation of [PSI+]
[46]. Interestingly, a set of [RNQ+] variants was isolated that
differ in their relative ability to influence the formation of [PSI+]
[51]. Cells harboring some [RNQ+] variants afforded low levels
of [PSI+] formation, while [PSI+] formed much more readily in
cells propagating other [RNQ+] variants. Such cross-seeding
between heterologous proteins may in fact be a common
feature among protein conformational disorders [52]. Recently,
variants of α-synuclein, the protein that misfolds and
aggregates in Parkinson’s disease, have been reported to
differentially influence the formation of tau inclusions [53].
However, what properties allow some amyloid structures to
promote heterologous cross-seeding more efficiently than
others remains unanswered.
Additional biochemical characterization of the [RNQ+]
variants suggested that the variation in [PSI+] formation likely
resulted from underlying structural differences between [RNQ+]
variants and subsequent changes in the interaction with Sup35
[54,55,56]. However, as Rnq1 has no known function in its
monomeric state, identification of spontaneously formed [RNQ
+] cells has been cumbersome. As such, most of the [RNQ+]
variants investigated to date were isolated by screening for
[PIN+] cells (which turned out to be [RNQ+]) that had formed
the [PSI+] prion [51]. Therefore, the conformational diversity
observed in the set of previously characterized spontaneous
[RNQ+] variants remains limited to aggregate structures of
Rnq1 that are capable of inducing [PSI+].
Here, we explore the degree of structural variation that is
possible with the [RNQ+] prion when not linked to the ability to
induce [PSI+]. We isolated a novel set of spontaneously formed
[RNQ+] variants using a chimeric [RNQ+] reporter protein
(RRP) that allowed us to phenotypically monitor the [RNQ+]
status of a cell. The large set of [RNQ+] variants that we
isolated exhibited a wide range of phenotypes, differing in
terms of their [RRP+] phenotype, mitotic stability, aggregate
size and stability, distribution pattern of aggregates in vivo, and
in the ability to induce [PSI+]. We show that all of the [RNQ+]
Structural Variation of the [RNQ+] Prion
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variants we obtained and analyzed in this study are distinct
from those originally isolated [51]. These findings demonstrate
the tremendous amount of conformational diversity that can be
generated from a single amyloidogenic protein. By expanding
the number of existing [RNQ+] variants, we are poised to better
understand what factors dictate the ability of a given prion
variant to form, propagate, and cause a particular phenotype.
This will provide insight into the structural basis of prion strains
and may help elucidate the mechanisms underlying
pathological variation in protein misfolding diseases and the
species transmission barrier of prion diseases.
Materials and Methods
Yeast Strains, Plasmids, and Media
All S. cerevisiae strains used in this study were derivatives of
74-D694 (ade1-14 ura3-52 leu2-3,112 trp1-289 his3-Δ200).
Yeast harboring the s.d. low, s.d. medium, s.d. high, s.d. very
high, or m.d. high [RNQ+] variants were kind gifts from Dr.
Susan Liebman [51,54]. Construction of the yeast strains
expressing RRP ([RNQ+] reporter protein) used to
phenotypically monitor the [RNQ+] prion were previously
described [57]. Briefly, by the pop-in/pop-out method, SUP35
was replaced with the RRP gene encoding a fusion protein
consisting of the prion-forming domain of Rnq1 and the M and
C domains of Sup35. [psi-] [RNQ+] strains propagating the
novel [RNQ+] variants described in this study were created by
mating the [RNQ+] RRP strains to a wild-type 74-D694 [psi-]
[rnq-] strain, and sporulating to obtain haploids containing
SUP35 instead of RRP. The presence of SUP35 and the
absence of RRP were confirmed by colony PCR and western
blot.
pEMBL-SUP35 was created through a similar process as a
previously described pEMBL-SUP2 plasmid [58]. The SUP35
promoter was first amplified using oligonucleotides 5'-
CGCCTCGAGGACGACGCGTCACAGTG and 5'-
CCCGGATCCTGTTGCTAGTGGGCAGATATAG, digested
with XhoI/BamHI, and ligated into pEMBL-yex4 (2μ, URA3).
The SUP35 open reading frame and terminator were then
amplified using oligonucleotides 5'-
CGCGGATCCACTAGTATGTCGGATTCAAACCAAGG and 5’-
GGGGAGCTCGTGATTGAAGGAGTTGAAACCTTGC,
digested with BamHI/XbaI, and ligated, thereby disrupting the
GAL-CYC1 promoter of pEMBL-yex4.
Yeast were grown at 30°C in YEPD (complete media
containing 2% dextrose, 2% peptone, 1% yeast extract) or
synthetic dextrose (SD) media (2% dextrose, 0.67% yeast
nitrogen base without amino acids) lacking the indicated
nutrients to select for transformed plasmids, [PSI+] cells, or
[RNQ+] RRP cells. As indicated, ¼YEPD plates containing
0.25% yeast extract were used to better visualize colony color
phenotypes. Transient growth on YEPD containing 3mM
guanidine hydrochloride (GdnHCl) was used to check curability
of the [PRION+] status, as GdnHCl inhibits the chaperone
Hsp104 that is required for prion propagation [59,60,61].
Prion Color Assay
The yeast strain 74-D694 harbors the ade1-14 allele having
a premature nonsense mutation that can be used to easily
monitor the [PSI+] status of cells [62]. Soluble Sup35 in [psi-]
cells functions to faithfully terminate translation at the
premature stop codon. As such, these cells are unable to
complete the adenine biosynthetic pathway, cannot grow on
medium lacking adenine, and appear red when grown on a rich
medium, such as YEPD, due to the accumulation of a
metabolic intermediate in the pathway. Conversely, the
aggregation of Sup35 in [PSI+] cells results in readthrough of
the nonsense mutation in ade1-14, thereby allowing cells to
grow on medium lacking adenine. The extent of nonsense
suppression can vary depending on the prion variant that
propagates and the associated degree of Sup35 sequestration.
When Sup35 is efficiently sequestered in strong [PSI+] cells,
colonies are white and grow robustly on SD-ade. In contrast,
weak [PSI+] cells do not sequester Sup35 as efficiently and are
pink in color on YEPD and grow less well on SD-ade. As
described previously, RRP can functionally replace Sup35.
Analogous to Sup35, RRP co-aggregates with Rnq1 in [RNQ+]
cells, but remains soluble and is functional in translation
termination in [rnq-] cells [57]. The RRP construct in 74-D694
allows [RNQ+] variants to be distinguished phenotypically in
the same manner as [PSI+] variants. Before evaluating color
phenotypes, YEPD plates were moved from 30°C to 4°C for at
least one day to allow the colony color to develop.
Spontaneous [RNQ+] Formation
The spontaneous formation of [RNQ+] was quantified using a
[rnq-] strain expressing RRP and following previously described
methods with some modifications [57,63]. This strain was
transformed with pRS415-ura3-197, a kind gift from Dr.
Yoshikazu Nakamura, that carries an allele of URA3 with a
nonsense mutation (UGA) at W197, which is suppressed in
[PSI+] and [RNQ+] RRP cells [64]. Eight single transformants
were independently grown in SD-leu to an OD600 of ~1.6. 150μl
of each culture was plated onto SD-ade-ura medium to select
for colonies that could suppress both the ade1-14 and
ura3-197 alleles. These plates were incubated at 30°C
overnight, moved to 4°C for two weeks (as cold has been
shown to enhance de novo prion formation [46]), and then
incubated at 30°C for another two weeks. All colonies that had
acquired the white or pink phenotype indicative of ade1-14 and
ura3-197 suppression were counted and spotted onto YEPD,
YEPD containing 3mM GdnHCl, and SD-ade. Colonies were
scored as true [RNQ+] if growth on YEPD+3mM GdnHCl
resulted in a permanent color change from white or pink to red,
thereby demonstrating curability of the [RRP+] phenotype.
The total number of cells plated on the SD-ade-ura medium
for each independent culture was determined by plating 200μl
of a 1:10,000 dilution of the overnight culture onto SD-leu,
which selected for the presence of pRS415-ura3-197. The total
number of cells plated on SD-ade-ura for each culture was
calculated by multiplying the number of colonies counted on
SD-leu by a dilution factor of 52,500, calculated as follows: (#
of colonies on SD-leu/200μl) * 10,000 * 150μl * 7 SD-ade-ura
plates.
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Mitotic Stability of [RNQ+]
The mitotic stability of [RNQ+] was determined as previously
described [43]. Independent colonies of each [RNQ+] variant
expressing RRP were grown overnight in YEPD to an OD600 of
~2.5. 250μl of a 1:10,000 dilution of each culture was plated
onto 13cm diameter YEPD plates. Mitotic loss of the [RNQ+]
prion was scored as any red colony or any colony exhibiting
red sectoring. Over 1,500 colonies were counted for each
[RNQ+] variant. The percentage of mitotic loss was calculated
by dividing the number of red and red sectoring cells by the
total number of cells. [RNQ+] variants were characterized as
mitotically stable if the percentage of prion loss was less than
0.5%. Additionally, cells were grown in YEPD medium
overnight and normalized by OD600, followed by spotting 5-fold
serial dilutions of cells onto ¼YEPD, YEPD+3mM GdnHCl, and
SD-ade plates. Plates were incubated at 30°C for 3 days for
the rich media and 7 days for SD-ade.
Thermal Stability Assay
To analyze the stability of Rnq1 aggregates, cells were
washed and lysed with 425-600μm acid-washed glass beads
(Sigma-Aldrich) by vortexing in buffer containing 100mM Tris-
HCl pH 7.5, 200mM NaCl, 1mM ethylenediaminetetraacetic
acid (EDTA), 5% glycerol, 0.5mM dithiothreitol (DTT), 50mM N-
ethylmaleimide (NEM), 3mM phenylmethylsulfonyl fluoride
(PMSF), and Roche complete mini protease inhibitor cocktail
for 3 min at high speed at 4°C twice with a 5 min incubation on
ice in between. After adding an equal volume of RIPA buffer
(50mM Tris-HCl pH 7.0, 200mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS) following lysis, cell debris
was removed by centrifugation at 3,300g for 15 seconds. Pre-
cleared lysates were incubated in sample buffer (50mM Tris-
HCl pH 6.8, 10% glycerol, 2% SDS, 100mM DTT) and treated
for 5 minutes across a temperature gradient ranging between
45-95°C, and also at 25°C and 100°C. Samples were analyzed
by SDS-PAGE. When subjected to higher temperatures, Rnq1
aggregates are solubilized and able to enter the SDS-PAGE
gel. Protein separated by SDS-PAGE was then transferred to
PVDF membrane for western blotting with an anti-Rnq1
antibody. ImageJ was used to quantify the resulting bands. All
readings were normalized to the 100°C band, and the results
were plotted using Origin 8.1 software.
Semi-Denaturing Detergent Agarose Gel
Electrophoresis
SDD-AGE was performed as previously described with slight
modifications [57]. Yeast cells were lysed by vortexing with
glass beads as described above in buffer containing 25mM
Tris-HCl pH 7.5, 100mM NaCl, 1mM EDTA, Roche complete
mini protease inhibitor, 0.5mM DTT, 3mM PMSF, 5μg/mL
pepstatin, and 40mM NEM. Cell debris was cleared by
centrifugation at 3,300g for 30 sec. Lysates were incubated
with sample buffer (60mM Tris-HCl pH 6.8, 5% glycerol, 2%
SDS) for 7 minutes at room temperature and 40μg of protein
was separated on a 1.5% Tris-glycine agarose gel. Protein was
transferred to PVDF membrane overnight and analyzed by
western blot using an anti-Rnq1 antibody.
[PSI+] Induction
The de novo formation of [PSI+] was monitored as previously
described [43,57]. Yeast propagating different [RNQ+] prion
variants were transformed with pEMBL-SUP35. At least three
independent overnight cultures were started for each prion
variant in SD-ura and grown to an OD600 of 0.6-1.5. Each
culture was diluted roughly 1:8,000 in water before plating
250μl onto 13cm diameter ¼YEPD plates and incubated at
30°C for 5 days, followed by overnight incubation at 4°C for
color development. [PSI+] colonies were scored as any white/
pink colonies or colonies having white/pink sectoring. More
than 1,200 colonies were scored for each [RNQ+] variant.
Previous studies have reported that only ~12% of the white/
pink sectoring colonies are the result of nonheritable amyloids
that cause Sup35 over-expression-dependent nonsense
suppression, while the rest contain bona fide [PSI+] [57,65]. As
an alternative means of assessing [PSI+] induction, overnight
cultures were normalized by OD600 and spotted in 5-fold serial
dilutions onto ¼YEPD, YEPD+3mM GdnHCl, and SD-ade.
Plates were incubated at 30°C for 3 days for the rich media and
9 days for SD-ade.
To characterize the [PSI+] variants that formed, ~300
individual [PSI+] colonies of each [RNQ+] variant were spotted
onto ¼YEPD, YEPD+3mM GdnHCl, and SD-ade. Plates were
incubated at 30°C for 3 days for the rich media and 6 days for
SD-ade. Based primarily on growth on SD-ade, [PSI+] variants
that were confirmed curable after transient growth on YEPD
+3mM GdnHCl were classified as one of the following: very
weak (≤3 colonies in the spot), weak (growth covering up to
50% of the spot), medium (growth covering 50-90% of the
spot), or strong (dense growth covering >90% of the spot in
addition to white colonies present on ¼YEPD). 
Microscopy
When expressed in [RNQ+] cells, Rnq1-GFP decorates
Rnq1 aggregates to form fluorescent foci in prion variant-
specific patterns, while remaining diffuse in [rnq-] cells [48,55].
Cells were transformed with the copper inducible
pRS316CUP1-RNQ1(153-405)-GFP, a kind gift from Dr. Susan
Lindquist, as used in previous studies [48,55]. Overnight
cultures were grown to an OD600 of ~1.0 in SD-ura before
backdiluting to an OD600 of 0.2 in SD-ura containing 50μM
CuSO4 for ~2.5 hours prior to imaging. Samples were prepared
on agar pads (3% wt/vol in liquid SD-ura) and plated directly
onto VWR 3in x 1in, 1mm thick microscope slides. Fisherbrand
No.#1.5 microscope coverslips were secured with nail polish.
Images were collected using a Zeiss Axiovert 200 Inverted
Microscope equipped with a Zeiss 100x/1.4 NA oil objective.
Slidebook 5.0 (Intelligent Imaging Innovations) was used to
analyze captured images and deconvolve (no neighbors
algorithm) GFP Z-stacks.
Results
Rate of spontaneous [RNQ+] formation
In analyzing the conformational diversity of the [RNQ+] prion,
we first wanted to quantify the rate of spontaneous [RNQ+]
formation and compare it to what was previously described for
Structural Variation of the [RNQ+] Prion
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e79582
[PSI+] and other yeast prions. As the [RNQ+] prion has no
easily observable phenotype other than its essential role in
[PSI+] induction, we used a chimeric protein called RRP ([RNQ
+] reporter protein), which we created previously to monitor the
[RNQ+] status of cells [57]. RRP consists of the prion-forming
domain (PFD) of Rnq1 (amino acids 153-405) fused to the M
and C domains of Sup35 (amino acids 124-685), such that the
fusion retains functionality in translation termination. In its
soluble form, RRP acts as the functional equivalent to Sup35
by faithfully recognizing stop codons to terminate translation.
However, in [RNQ+] cells, RRP and Rnq1 co-aggregate to
cause global [PSI+]-like nonsense suppression.
To screen for the spontaneous formation of [RNQ+], we used
a 74-D694 [rnq-] strain with the endogenous SUP35 gene
replaced by RRP. This strain harbored the [PSI+] and [RRP+]
suppressible ade1-14 and ura3-197 alleles. As such, to monitor
conversion to [RNQ+], we plated overnight cultures onto SD-
ade-ura medium to select for cells that could suppress the
premature stop codons in both alleles in a [RRP+]-dependent
manner. Cells were scored as [RNQ+] if phenotypic curability
was demonstrated after growth on medium containing
guanidine hydrochloride (YEPD+3mM GdnHCl), which inhibits
the chaperone Hsp104 required to propagate yeast prions
[59,60,61]. Sedimentation assays were used to confirm the
[RNQ+] status of a subset of these colonies by the presence of
Rnq1 in the insoluble fraction (data not shown). Of the ~9.7x107
cells plated on SD-ade-ura and >2,600 colonies spotted, 288
[RNQ+] colonies were identified (Table 1). This gave a rate of
~2.96x10-6 for the spontaneous formation of [RNQ+], which is
slightly higher than the rate of [PSI+] formation previously
reported [63].













 1 54 136 7.14 7.56
 2 33 265 13.91 2.37
 3 34 355 18.64 1.82
 4 41 350 18.38 2.23
 5 34 164 8.61 3.95
 6 33 202 10.61 3.11
 7 26 212 11.13 2.34
 8 33 168 8.82 3.74
Total  288 1852 97.23 2.96
Eight independent overnight cultures of [rnq-] cells (ura3-197, ade1-14) expressing
RRP were plated onto SD-ade-ura to select for nonsense suppressors, and to SD-
leu to calculate the total number of colonies plated. [RNQ+] colonies were
identified by curability after transient growth on YEPD+3mM GdnHCl.
doi: 10.1371/journal.pone.0079582.t001
Spontaneous [RNQ+] formation yields mixed
population of [RNQ+] variants
Interestingly, the spontaneously formed [RNQ+] colonies
showed differences in growth on SD-ade, indicative of varying
levels of nonsense suppression (data not shown). As the
degree of nonsense suppression is a measure of distinct prion
variants of [PSI+] [36] and [RNQ+] using RRP [43], this
suggested that multiple [RNQ+] variants had formed
spontaneously in our screen.
We wanted to isolate a subset of conformationally distinct
[RNQ+] variants in order to perform a more extensive analysis
on what types of aggregate structures were formed. Previous
studies have shown that one property that can differ with
variants of [PSI+] and [RNQ+] is the frequency of loss during
mitotic division [36,43]. Therefore, to examine mitotic stability,
overnight cultures of yeast harboring a large subset of our
spontaneous [RNQ+] variants expressing RRP were plated
onto YEPD. This produced a wide range of colorimetric
phenotypes that were initially categorized as either stable or
unstable. Stable [RNQ+] variants exhibited colonies that had a
homogenous [RRP+] phenotype of one colony color (Figure
1A). Unstable [RNQ+] variants, on the other hand, displayed
heterogeneous [RRP+] phenotypes, often within a single
colony (Figure 1B). Some of these unstable [RNQ+] variants
displayed a high frequency of mitotic loss, as indicated by the
presence of red sectors or colonies that were entirely red.
Other unstable [RNQ+] variants showed a mix of non-red
colonies, including colonies that exhibited sectors of various
shades of pink, and appeared similar to previously reported
yeast strains harboring “undifferentiated” and “unspecified”
variants of [PSI+] [66,67].
Four [RNQ+] variants were selected that had a stable colony
color phenotype with little mitotic loss (<0.25%). These
mitotically stable variants differed in the degree of [RRP+]-
mediated nonsense suppression, and are referred to hereafter
as strong [RNQ+] (white colonies), medium [RNQ+] (light pink),
weak [RNQ+] (medium pink), and very weak [RNQ+] (dark
pink). This classification helps distinguish our [RNQ+] variants
from the [RNQ+] variants previously described, in which the
nomenclature corresponded to different levels of [PSI+]
induction and the pattern of Rnq1-GFP fluorescence [51,55].
To compare these two sets of [RNQ+] variants phenotypically,
we spotted serial dilutions of normalized cells onto ¼YEPD and
SD-ade plates (Figure 1C). Relative growth on SD-ade showed
that very weak [RNQ+], weak [RNQ+], and medium [RNQ+]
displayed intermediate growth between that of s.d. medium
[RNQ+] and m.d. high [RNQ+], whereas strong [RNQ+] had
more robust [RRP+]-mediated nonsense suppression and
growth that was comparable to that of m.d. high [RNQ+].
Seven mitotically unstable [RNQ+] variants were also chosen
for further analysis. C3 and G6 exhibited high frequencies of
mitotic loss, while A5, B1, D3, E1, and G4 displayed a
heterogeneous mixture of non-red sectoring [RRP+]
phenotypes. For instance, many E1 colonies were dark pink
with light pink sectors, while many B1 colonies were white with
light pink sectors. These phenotypes can be contrasted with
true mitotic loss, which is represented by sectoring to red.
Interestingly, upon subsequent restreaking, the sectoring
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phenotypes of A5 and C3 stabilized into homogenous
populations of colonies (data not shown).
[RRP+] phenotype does not correlate with [PSI+]
induction
As the original [RNQ+] variants were classified by their ability
to template the formation of [PSI+], we wanted to determine the
efficiency with which our spontaneously formed [RNQ+]
variants facilitated conversion to [PSI+]. We began by
generating [psi-] [RNQ+] strains with each of our [RNQ+]
variants. We obtained haploids expressing SUP35 in place of
RRP by mating the RRP-expressing strains to [psi-] [rnq-] cells
to obtain diploids, followed by random sporulation or tetrad
dissection and selecting haploids of the appropriate genotype.
Interestingly, we noticed that there were two distinct
populations of [RNQ+] RRP B1 colonies with contrasting [RRP
+] phenotypes, one white with extensive light pink sectors (B1
P/W) and the other predominately white with very minor pink
sectoring (B1 W). We proceeded with the independent mating
of cells having each of these phenotypes to determine whether
differences in [RRP+] phenotypes of clones from the same
population would be reflected in [PSI+] induction efficiency.
Both the diploids and haploids we obtained following
sporulation were red in colony color, as these [psi-] [RNQ+]
cells now had soluble wild-type Sup35 to function in faithful
translation termination.
In order to assess how well each [RNQ+] variant could
facilitate [PSI+] induction, we transformed the progeny we
generated with a plasmid over-expressing Sup35. After
overnight growth in selection medium to maintain expression of
Figure 1.  Spontaneous [RNQ+] formation produces multiple variants with unique [RRP+] phenotypes.  Cultures of cells
expressing RRP and harboring a spontaneous [RNQ+] variant were plated onto YEPD and scored for color and sectoring
phenotypes. [RNQ+] variants were characterized as (A) stable or (B) unstable. Representative pictures are shown for each variant.
(C) Normalized numbers of cells expressing RRP and harboring the indicated [RNQ+] variant were plated in 5-fold serial dilutions
onto ¼YEPD and SD-ade media. Dotted lines denote where spots from the same plate have been cropped for clarity.
doi: 10.1371/journal.pone.0079582.g001
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the transformed plasmid, cells were plated onto ¼YEPD plates.
Any pink/white colonies or colonies with pink/white sectoring
were scored as [PSI+], and the rate of [PSI+] formation was
calculated as the number of those colonies divided by the total
number of cells plated (Figure 2A). For comparison, we also
confirmed the rates of [PSI+] formation for the previously
published [RNQ+] variants, along with [rnq-] cells.
Confirming our previous results [43], the efficiency of [PSI+]
induction for the previously described s.d. low, s.d. medium,
and m.d. high [RNQ+] variants positively correlated with their
[RRP+] phenotypes. Higher [PSI+] induction corresponded to a
stronger [RRP+] phenotype. However, as we previously
observed with [RNQ+] variants formed from transforming in
vitro fibers [43], this trend did not hold for our set of stable
[RNQ+] variants. Strong [RNQ+] and very weak [RNQ+]
induced [PSI+] at fairly similar frequencies (45% and 54%
respectively), while medium [RNQ+] and weak [RNQ+]
exhibited lower rates of [PSI+] induction comparable to that of
s.d. low [RNQ+]. Interestingly, many of our unstable [RNQ+]
variants induced the formation of [PSI+] at higher rates relative
to our stable [RNQ+] variants. Six of the eight unstable [RNQ+]
variants induced [PSI+] very efficiently, at rates between
50-70%, while D3 and G6 facilitated [PSI+] induction at slightly
lower rates of ~40%.
Knowing that different [RNQ+] variants can promote the
formation of [PSI+] to different extents, we were interested in
determining whether the distinct amyloid structures of our
[RNQ+] variants would bias the formation of particular [PSI+]
variants, as reported in studies with other [RNQ+] variants
[55,56]. To quantitatively evaluate the [PSI+] variant profile that
corresponded to each of our [RNQ+] variants, we spotted
newly induced [PSI+] colonies onto a set of ¼YEPD, YEPD
+3mM GdnHCl, and SD-ade plates. Growth on SD-ade after six
days of incubation at 30°C was used as the primary
determinant in scoring the strength of each [PSI+] variant as
very weak, weak, medium, or strong (Figure 2B-C). All 12
[RNQ+] variants appeared capable of inducing multiple variants
of [PSI+], but the vast majority of the [PSI+] variants were
categorized as very weak [PSI+] or weak [PSI+]. Indeed, A5
induced no strong variants of [PSI+]. In contrast, strong [RNQ
+], very weak [RNQ+], and B1 P/W induced noticeably stronger
[PSI+] variants than the other [RNQ+] variants in the subset.
Interestingly, while B1 P/W and B1 W supported similar rates of
[PSI+] formation, B1 P/W induced markedly stronger variants of
[PSI+] than B1 W. Finally, as with the rate of [PSI+] induction,
no correlation appeared to exist between the [RRP+]-mediated
nonsense suppression phenotype of the four stable [RNQ+]
variants and their corresponding induced [PSI+] variant profile.
To further investigate the extent to which our spontaneously
formed [RNQ+] variants can induce conversion to [PSI+], we
generated 28 more [psi-] [RNQ+] haploids expressing SUP35
in place of RRP as described above. These yeast strains
propagated other [RNQ+] variants that had spontaneously
formed in our initial screen. To monitor [PSI+] induction
capacity, we over-expressed Sup35 as above and spotted
normalized numbers of cells onto ¼YEPD and SD-ade plates
(Figure 2D). As the overall growth of [PSI+] colonies on SD-ade
is presumably influenced by both the rate of [PSI+] induction
and the strength of the [PSI+] variant induced, we used this as
a qualitative measure of [PSI+] induction efficiency by
comparing the growth on SD-ade to that of the five previously
published [RNQ+] variants and a [rnq-] control strain.
Surprisingly, even though we screened for [RNQ+] formation
independent of the ability to form [PSI+], all 28 spontaneously
formed [RNQ+] variants were able to induce [PSI+] to some
degree. By comparing our [RNQ+] variants to those previously
published, we further scored the [PSI+] induction capacity of
our [RNQ+] variants as low, medium, high, or very high (Figure
2E). Interestingly, an overwhelming majority of our [RNQ+]
variants (22 out of 28) were categorized as inducing [PSI+] at
low or medium levels. We identified E5 as an outlier in the data
set in displaying robust growth on SD-ade, even greater than
that of s.d. very high [RNQ+].
Rnq1-GFP aggregation patterns of [RNQ+] variants
In addition to [PSI+] induction levels, fluorescence
microscopy was also utilized to identify the original [RNQ+]
variants as potentially distinct structures [55]. With expression
of an inducible Rnq1(153-405)-GFP fusion construct [48,55],
[rnq-] cells were shown to display diffuse fluorescence. In [RNQ
+] cells, however, the fluorescent signal was localized in
discrete, cytosolic foci. Two distinct GFP aggregation patterns
emerged among the [RNQ+] variants: single-dot (s.d.), in which
cells had one focus of GFP fluorescence, or multiple-dot (m.d.)
where cells had multiple foci. As such, we set out to examine
the Rnq1(153-405)-GFP fluorescence characteristics of 12 of
the [RNQ+] variants that we had isolated.
Previous studies have reported that, in their respective yeast
strains, both the s.d. and m.d. Rnq1-GFP fluorescence patterns
form with great efficiency, appearing in >75% of s.d [RNQ+]
cells or >50% of m.d. [RNQ+] cells, respectively [55,68]. We
recapitulated these findings for s.d. low [RNQ+], but also found
that m.d. high [RNQ+] displayed a third Rnq1-GFP pattern as
the dominant population (Figure 3A). This pattern was
characterized by many petite foci (p.f.) that were much smaller
and fainter in intensity than those observed with the s.d. and
m.d. patterns.
When analyzing the Rnq1-GFP aggregation patterns of our
stable and unstable [RNQ+] variants, we found that these
variants often did not fall into a strict bimodal classification of
s.d. or m.d. (Figure 3B-C). Instead, we observed a gradient of
patterns, which varied in the relative proportions of s.d., m.d.,
and p.f. cells (Table 2). Placed at one end of the spectrum, s.d.
low [RNQ+] and our medium [RNQ+] had ~85-95% of foci-
containing cells having the s.d. pattern. Although the majority of
very weak [RNQ+], A5, and C3 cells similarly had the s.d.
pattern, these variants also had an appreciable number of cells
(~15-25%) that harbored the m.d. fluorescence pattern. In
contrast, at the other end of the spectrum, the Rnq1-GFP
aggregate pattern of m.d. high [RNQ+] consisted of both p.f.
and m.d. patterns in >90% of cells. While strong [RNQ+] cells
also predominately displayed the p.f. pattern, the m.d. pattern
was not observed. Interestingly, several of our [RNQ+] variants
showed intermediate phenotypes on this spectrum. For
instance, weak [RNQ+] and B1 W showed all three patterns
with no dominant population easily recognizable, thereby
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Figure 2.  The [PSI+] induction rate and [PSI+] variant distribution is variable.  (A) The induction of [PSI+] by over-expressing
Sup35 in our 12 [RNQ+] variants was analyzed quantitatively by counting the number of [PSI+] colonies that formed on ¼YEPD
plates from at least three independent experiments. Error bars represent standard error. Nonsense suppression by nonheritable
amyloid due to the over-expression of Sup35 has been previously shown to only account for a small percentage of white/pink
sectoring colonies (B) Example of scoring the newly induced [PSI+] variants as very weak (vw), weak (w), medium (m), or strong (s)
by spotting [PSI+] colonies onto ¼YEPD, YEPD+3mM GdnHCl, and SD-ade media. (C) Counts of [PSI+] variants were plotted as a
fraction of total [PSI+] colonies scored. (D) Example plate of scoring the ability of spontaneous [RNQ+] variants to induce [PSI+]
upon Sup35 over-expression. [PSI+] induction efficiency was scored into one of four classifications by assessing colony growth on
SD-ade relative to that of five previously described [RNQ+] variants: low (ranges from no growth to less growth than s.d. medium),
medium (growth equivalent to s.d. medium to less than s.d. high), high (growth equivalent to s.d. high to less than s.d. very high),
and very high (growth equivalent to s.d. very high or greater). (E) The types of [RNQ+] variants that spontaneously formed
categorized based on the levels of [PSI+] induction.
doi: 10.1371/journal.pone.0079582.g002
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highlighting the extent of conformational diversity present in our
spontaneous [RNQ+] variants.
Spontaneous [RNQ+] variants propagate thermally
stable amyloid structures
In vitro studies of Sup35 suggested that strong [PSI+] arises
from amyloid fibers that have a relatively shorter protected core
as compared to Sup35 aggregates of weak [PSI+] [40]. This
difference in amyloid core length was found to positively
correlate with fiber stability: the longer core of weak [PSI+]
resulted in greater stability than strong [PSI+] [39]. Similarly, we
found previously that more stable amyloid fibers of Rnq1-PFD
produced weaker prion variants of [RNQ+], while less stable
Figure 3.  Spontaneously formed [RNQ+] variants show
diversity in Rnq1-GFP aggregation patterns.  Cells were
transformed with a plasmid expressing Rnq1(153-405)-GFP
under the CUP1 promoter. Prior to imaging, transformants
were transferred to induction medium containing 50μM CuSO4
and grown for ~2.5 hours. A variety of fluorescence patterns
were observed, including: a single focus, large multiple foci,
and numerous petite foci. Arrows identify petite foci that are
fainter and smaller. Representative images in differential
interference contrast mode (DIC) and under a GFP-emitted
light filter (GFP) are shown for (A) previously published [RNQ+]
variants and [rnq-], (B) all of the stable [RNQ+] variants, and
(C) a subset of the unstable [RNQ+] variants.
doi: 10.1371/journal.pone.0079582.g003
fibers propagated stronger [RNQ+] variants [43]. The resultant
differences in phenotype with different [PSI+] and [RNQ+]
variants were initially attributed to the ability of fibers to
produce more free ends that are required for sequestering and
converting monomeric protein [40]. Thus, less stable fibers
produce more active “seeds” that convert soluble protein to the
prion conformer faster, resulting in stronger biological
phenotypes.
We were interested in determining whether the stability of
our stable and unstable [RNQ+] variants would show a similar
relationship with either their [RRP+] phenotype or efficiency in
[PSI+] induction. Using thermal denaturation as an indicator of
stability, we subjected cell lysates of our [RNQ+] variants to a
temperature gradient and analyzed the samples by SDS-PAGE
and western blot to determine the temperature at which 50% of
the Rnq1 protein was liberated from the aggregates.
Aggregates of all 12 [RNQ+] variants were shown to be very
thermal stable with melting temperatures (Tm) ranging from
80-95°C (Figure 4A-B). Rnq1 aggregates from medium [RNQ+]
cells displayed the greatest sensitivity to temperature, with a Tm
~80°C, contrasting sharply with strong [RNQ+], in which Rnq1
aggregates remained largely intact at 90°C. While aggregates
of s.d. low [RNQ+] showed a stability similar to our [RNQ+]
variants, m.d. high [RNQ+] remained a striking outlier of all
known [RNQ+] variants in exhibiting a Tm below 60°C, as
demonstrated previously [54].
SDD-AGE reveals variant-specific differences in
aggregate size distribution
Previous studies with the [PSI+] and [RNQ+] prions have
shown that the SDS-resistant, higher molecular weight protein
Table 2. Rnq1-GFP fluorescence patterns show diversity
among [RNQ+] variants.
[RNQ+] Variant Rnq1-GFP Characterization
[rnq-] Diffuse fluorescence
s.d. low One large focus (s.d.)
m.d. high Multiple large foci (m.d.) and numerous petite foci (p.f.)
strong Majority p.f.
medium Majority s.d.
weak Diversity: p.f., s.d., and m.d. present
very weak Majority s.d., also m.d. present
A5 Majority s.d., also m.d. present
B1 P/W Roughly 50% p.f., 50% s.d.
B1 W Diversity: p.f., s.d., and m.d. present
C3 Majority s.d., also m.d. present
D3 Roughly 50% p.f., 50% s.d.
E1 Majority p.f., low percentage of s.d.
G4 Majority p.f., low percentage of s.d.
G6 Majority p.f., low percentage of s.d.
[RNQ+] variants expressing Rnq1(153-405)-GFP were characterized by the
relative number of GFP aggregate-containing cells with single-dot (s.d.), multiple-
dot (m.d.), or petite-foci (p.f.) fluorescence patterns. For each [RNQ+] variant, Z-
stacks of at least 150 cells were analyzed.
doi: 10.1371/journal.pone.0079582.t002
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aggregates can be resolved from the monomeric species and
visualized using semi-denaturing detergent agarose gel
electrophoresis (SDD-AGE) and western blot [37,54].
Furthermore, distinct prion variants can show different sizes of
aggregates by SDD-AGE. For instance, many weak [PSI+] cell
lysates harbor noticeably larger Sup35 aggregates than strong
[PSI+] [37,39]. Slight differences also exist between some of
the previously characterized [RNQ+] variants [54]. Therefore,
we asked whether SDD-AGE analysis of our 12 stable and
unstable [RNQ+] variants would reveal any additional
differences in structural properties of the Rnq1 aggregates.
Indeed, with cell lysates harboring each of our [RNQ+]
variants, we found reproducible differences in aggregate
distribution between many of the [RNQ+] variants of our subset
(Figure 5). The higher molecular weight species of strong [RNQ
+], medium [RNQ+], weak [RNQ+], B1 W, and G6 consistently
migrated with a similar size as that of the previously published
s.d. [RNQ+] variants (Figure 5 and data not shown). Other
[RNQ+] variants, however, including very weak [RNQ+], C3,
D3, and G4 contained a species that migrated slightly faster.
A5 exhibited minor differences in aggregate distribution across
multiple trials. Interestingly, B1 P/W and B1 W displayed
modest, but reproducible differences as Rnq1 aggregates of B1
W were slightly larger than those found in B1 P/W lysates,
despite having formed initially in the same colony. In striking
contrast, E1 was the most unique and showed the bulk of the
aggregated Rnq1 propagating in larger structures as compared
to the other variants. Moreover, the aggregates of medium
[RNQ+] consistently appeared much fainter in intensity, a
property also observed with m.d. high [RNQ+] (data not
shown).
Discussion
In this study, we describe the isolation and characterization
of several novel [RNQ+] variants that formed spontaneously in
vivo. In the process of isolating these variants, we were able to
estimate the rate of spontaneous [RNQ+] formation to be
Figure 4.  Aggregates of spontaneous [RNQ+] variants show similar thermal stability.  Cell lysates were incubated for five
minutes at different temperatures, run on an SDS-PAGE, and analyzed by western blot using an anti-Rnq1 antibody. The amount of
soluble Rnq1 of both the (A) stable [RNQ+] variants and (B) unstable [RNQ+] variants was quantified with ImageJ and graphed as a
percentage of soluble Rnq1 at 100°C. One representative experiment is shown, but in all cases, data were highly reproducible.
doi: 10.1371/journal.pone.0079582.g004
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~2.96x10-6. It was previously reported that the spontaneous
rate of [PSI+] formation in [psi-] [RNQ+] yeast cells was
5.8x10-7 [63]. Hence, even when a high [RNQ+] variant is
available to facilitate the formation of [PSI+], the de novo
formation of [RNQ+] under our growth conditions occurs about
5 times more frequently. This places Rnq1 alongside other
yeast prion proteins that all have a higher rate of formation than
[PSI+], and are thought to have a functional role in the cell [69].
Moreover, while the ability to induce [PSI+] was not a
requirement for isolation, every [RNQ+] variant analyzed in this
study was shown to facilitate [PSI+] formation to some degree.
These data suggest that the [RNQ+] prion, rather than simply
acting as a promiscuous amyloid, might actually function to
induce the formation of [PSI+] [70]. Although use of the RRP
chimera remains the only way to easily measure the rate of
[RNQ+] formation, one caveat here is that an extra copy of the
Rnq1-PFD as part of RRP may contribute to a higher rate of
spontaneous [RNQ+] formation.
In addition to being able to phenotypically monitor the
formation of [RNQ+] with the use of RRP, the chimera also
allowed us to identify distinct structures of aggregated Rnq1.
After extensively characterizing the cellular and biochemical
properties of 12 of the [RNQ+] variants that formed, we found
that these different structures are indeed novel. While it is clear
that no single property can fully differentiate between structural
isomers of [RNQ+], when the properties we analyzed are
Figure 5.  SDS-resistant aggregates of spontaneously
formed [RNQ+] display modest, variant-specific
differences in aggregate distribution.  Aggregate distribution
of [RNQ+] variants was analyzed using SDD-AGE by loading
normalized amounts of protein from cell lysates onto an
agarose gel containing SDS. Rnq1 was visualized by western
blot using an anti-Rnq1 antibody.
doi: 10.1371/journal.pone.0079582.g005
considered collectively, each of our [RNQ+] variants displays a
unique set of characteristics that distinguishes it from the
others, as well as from the previously described [RNQ+]
variants.
Four of the [RNQ+] variants we isolated and characterized
were mitotically stable, but differed in their [RRP+] phenotype.
In contrast to [PSI+] variants and [RNQ+] variants formed from
in vitro fibers that were previously reported [39,43], the degree
of nonsense suppression of each of the stable [RNQ+] variants
described in this study did not correlate to differences in
stability or any of the other properties we examined.
Among the eight unstable [RNQ+] variants within our set,
many displayed some degree of prion loss through mitotic
division. While previous studies have documented a transient
stage of mitotic instability in cells harboring newly induced [PSI
+] and [RNQ+] [50,55], several of our [RNQ+] isolates were
able to maintain their sectoring to red phenotypes through both
restreaking and storage (data not shown). Strikingly, some of
our unstable [RNQ+] variants exhibited more complex colony
color phenotypes, such as A5, B1, D3, E1, and G6, in which
colonies displayed sectors of various shades of pink. These
findings suggest that multiple [RNQ+] variant types may have
formed within the clonal population arising from a single cell.
The B1 [RNQ+] variant epitomizes this observation, as our
initial streak of cells harboring this prion variant produced white
colonies with varying amounts of light pink sectoring, solid light
pink colonies, and solid white colonies. Evidence of a single
yeast strain harboring multiple prion conformations has also
been observed with [PSI+]. Recently, clones isolated from a
single [PSI+] colony exhibited a range of transmission profiles
across an intra-species barrier, leading authors to propose that
an ensemble, or cloud, of [PSI+] variants had been propagating
in the parent cell [71]. Similarly, others have described an
“unspecified” [PSI+] phenotype that was characterized by white
colonies that sectored to pink, which gave rise to progeny
carrying weak [PSI+], strong [PSI+], or unspecified [PSI+] [67].
In contrast to the “cloud” hypothesis, these authors consider an
alternative possibility in which a single [PSI+] structure
responsible for the unspecified [PSI+] phenotype is able to
undergo a conformational maturation process into more than
one distinct [PSI+] variant. Similarly, fibers of α-synuclein that
were formed in vitro were recently shown to undergo a
maturation process and form distinct aggregate conformations
over time [53]. Both the “cloud” and “maturation” models may
be applicable to our unstable [RNQ+] variants. Presumably, a
host of factors, which also include competition between prion
variants [51] and strain mutation [72], may play a role in
dictating how prions propagate and which variants ultimately
emerge phenotypically.
The original set of [RNQ+] variants (referred to as [PIN+]
variants) was obtained by over-expressing Sup35 in [psi-] [rnq-]
cells and selecting for cells that converted to [PSI+] [51]. As de
novo formation of [PSI+] requires [RNQ+] (which is the prion
responsible for [PIN+]), [RNQ+] contemporaneously formed in
these cells. In contrast, our [RNQ+] variants were isolated in a
different manner using [RRP+]-mediated nonsense
suppression, allowing us to obtain [RNQ+] variants with no
connection to [PSI+] formation. Surprisingly, we found that all
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40 of the spontaneous [RNQ+] variants induced [PSI+] at some
level, albeit many facilitated [PSI+] formation at low to medium
levels. These findings highlight the intrinsic relationship
between [RNQ+] and [PSI+], and support the possibility that
[RNQ+] functions primarily as a regulatory element in initiating
the formation of [PSI+] [70].
Many groups have speculated on the role of [PSI+] in nature,
either as a harmful pathogenic state [73] or as a beneficial
mechanism of generating heritable phenotypic diversity in
response to stressful or shifting environmental conditions
[74,75,76,77]. In the latter case, it is hypothesized that [PSI+]-
mediated nonsense suppression allows translation of coding
sequences downstream of stop codons, thereby creating novel
gene products that may facilitate the evolution of new traits
[76,78]. While reduced fidelity in translation termination could
be deleterious, cells forming particular [PSI+] variants may in
fact produce heritable, advantageous phenotypes that allow
survival of the population without requiring immediate genetic
change. Indeed, when cells were subjected to a range of
environmental stresses, a correlation was found between the
severity of stress and the frequency of [PSI+] formation,
suggesting that cells may induce [PSI+] when a rapid adaptive
response is needed [75]. With the discovery of [PIN+] as an
essential factor for de novo [PSI+] formation, a two-prion
system of epigenetic translation regulation was proposed [50].
The findings that we present here highlight the extent of
conformational diversity that exists for the [RNQ+] prion. Such
structural variation of [RNQ+] may contribute to differentially
modulating the switch into a [PSI+] state, and influence the
expansive phenotypic diversity observed with [PSI+]-dependent
traits [76].
By isolating a number of novel [RNQ+] variants and adding
to those previously described, we show the widespread
variability in structures that the Rnq1 protein can assume. A
high number of conformational possibilities have also been
shown for [PSI+] [71,73], making the classification into strong
and weak [PSI+] variants overly simplistic. We speculate that
such diversity is not limited to these prion proteins, but may
exist with many amyloidogenic proteins. Indeed, it was recently
suggested that PrP may form over 30 distinct prion strains in
humans [24]. Therefore, studying the numerous structural
variants of [RNQ+] may help elucidate what biochemical
properties or cellular factors contribute to the prion variant that
propagates and how it manifests phenotypically.
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